fibrinogen has been researched along with Disease Models, Animal in 575 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 112 (19.48) | 18.7374 |
1990's | 75 (13.04) | 18.2507 |
2000's | 135 (23.48) | 29.6817 |
2010's | 209 (36.35) | 24.3611 |
2020's | 44 (7.65) | 2.80 |
Authors | Studies |
---|---|
Ahmed, Z; Grover, LM; Logan, A; Matthews, J; Surey, S | 1 |
Chen, H; Cheng, F; Eriksson, JE; Huang, Y; Jia, B; Khan, FU; Liu, L; Liu, X; Pang, Y; Su, D; Tsai, HI; Wang, C; Wang, D; Wang, L; Wu, Y; Xu, Z; Yang, R; Zhang, H; Zhang, W; Zhu, H; Zhu, X | 1 |
Bugge, TH; Cap, AP; Chun, EM; Cullis, PR; Flick, MJ; Francisco, B; Groeneveld, DJ; Hur, WS; Juang, LJ; Kastrup, CJ; La Prairie, B; Leung, J; Luyendyk, JP; Palumbo, JS; Robertson, MK; Silva, LM; Strilchuk, AW | 1 |
Ali, BH; Beegam, S; Elzaki, O; Ferdous, Z; Greish, YE; Nemmar, A; Tariq, S; Zaaba, NE | 1 |
Jiang, M; Lin, ZH; Liu, H; Ma, ZN; Wang, ZY; Xie, ZL; Yang, F; Yang, L; Zhou, L | 1 |
Ahmed, B; Anbiah, B; Greene, MW; Habbit, NL; Hassani, I; Heslin, MJ; Kuhlers, P; Lipke, EA; Mobley, JA | 1 |
Chen, T; Gao, Q; Hai, S; Han, M; Hu, J; Huang, D; Li, X; Luo, X; Ning, Q; Wang, H; Wang, X; Wu, D; Wu, W; Xi, D; Yan, W; You, J | 1 |
Baskina, OS; Beregovykh, VV; Ivanov, SV; Korotchenko, SA; Lapshin, RD; Markin, SS; Mukhina, IV; Semenov, AM; Semenov, MP | 1 |
Etscheid, M; Kanse, SM; Kim, JY; Leergaard, TB; Manna, D | 1 |
Ding, Y; Fu, Y; Jiao, S; Tan, N; Xu, W; Zhang, K; Zhu, C | 1 |
Yan Mm, J; Yu Mm, Y | 1 |
Dorman, B; Kozar, RA; Wu, F; Zeineddin, A | 1 |
Asato, C; Bennett, JC; Han, CY; Ringgold, K; St John, A; Stern, SA; Wang, X; Wenthe, A; White, NJ | 1 |
Bian, Y; Bian, Z; Fukui, Y; Hu, X; Ishiura, H; Liu, X; Morihara, R; Sun, H; Yamashita, T; Yu, H | 1 |
Chen, J; Huang, J; Li, W; Luo, X; Ning, Q; Wan, X; Wang, M; Xi, D; Xu, M; Yang, M; Yuen, MF; Zhang, Z | 1 |
Cao, Y; Davis, JM; Deng, X; Dong, JF; Doursout, MF; Ghosn, J; Holcomb, JB; Ko, TC; Wade, CE; Wang, R; Yang, B; Yu, Q | 1 |
Cao, H; Cui, X; Guo, H; Han, C; Wang, S; Wang, W; Zheng, M; Zheng, W | 1 |
Fan, C; Li, W; Liu, K; Mao, C; Wang, J; Wang, Z | 1 |
Halder, SK; Milner, R | 1 |
Burcham, LR; Deng, L; Doran, KS; Head, SR; Heinrichs, DE; Horswill, AR; Johnson, PM; Kwiecinski, JM; Schilcher, K | 1 |
Porkka, F; Rodriguiz, RM; Subramaniyan, S; Terrando, N; Velagapudi, R; Wetsel, WC; Xiong, C | 1 |
Cardeman, L; Crispi, CP; de Andrade, CM; de Nadai Filho, N; Fonseca, MF; Mendes, FLF; Portari, EA | 1 |
Buchberger, AR; Gundry, RL; Kassem, IS; Keppel, TR; Salmon, AE; Skumatz, CMB; Waas, M; Young, JB | 1 |
Choe, CU; Jensen, M; Müller, C; Schwedhelm, E; Zeller, T | 1 |
Aufricht, C; Bukosza, EN; Gebeshuber, CA; Hamar, P; Hummel, K; Huttary, N; Kornauth, C; Kratochwill, K; Krieger, S; Nöbauer, K; Oszwald, A; Razzazi Fazeli, E; Schachner, H; Szénási, G | 1 |
He, H; Li, S; Li, X; Su, L; Tang, J; Yang, L; Yang, M; Zong, H; Zong, Q | 1 |
Cap, AP; Dubick, MA; Martini, WZ; Rodriguez, CM | 1 |
Aponte, AM; Beard, RS; Eitnier, RA; Guo, X; Meegan, JE; Nelson, PR; Wang, F; Wu, MH; Yang, X | 1 |
Bao, Z; Jia, D; Jian, Q; Li, J; Liu, B; Liu, H; Moeller, CJ; Pan, Q; Yi, C; Zhang, P; Zhu, J | 1 |
Arai, H; Fujiwara, T; Hijikata, W; Maruyama, T; Mizuno, T; Murashige, T; Ogata, A; Ouchi, K; Seki, H; Yokota, S | 1 |
Jensen, JR; Sachetto, ATA; Santoro, ML | 1 |
Levi, M; Thachil, J | 1 |
Gao, D; Li, L; Li, RS; Liu, ZJ; Niu, M; Wang, JB; Wu, SN; Xiao, XH; Zhang, CE; Zhang, L | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Dong, LJ; Hang, HF; Tang, XB; Wang, AF; Xu, YJ; Yang, F; Zhang, H | 1 |
Cheng, SX; Dong, X; Hong, S; Pan, P; Song, W; Song, WF; Zhang, QL; Zhang, XZ; Zheng, DW | 1 |
Chen, H; He, A; He, Q; Luo, Y; Tao, A; Yan, J; Zhang, C | 1 |
Bender, M; Ehrlich, A; Gaertner, F; Hoffknecht, M; Leunig, A; Li, R; Lipsky, S; Löf, A; Lorenz, M; Marel, AK; Marx, C; Massberg, S; Nicolai, L; Pekayvaz, K; Petzold, T; Pick, R; Pircher, J; Raude, B; Reichel, CA; Rosenberger, G; Saleh, I; Schiefelbein, K; Schulz, C; Stark, K; Uhl, B; Walzog, B; Weckbach, L; Xia, S; Zhang, Z; Zheden, V | 1 |
Di Sanza, C; Fish, RJ; Garieri, M; Lukowski, SW; Neerman-Arbez, M; Vilar, R | 1 |
Arai, H; Fujiwara, T; Hijikata, W; Mizuno, T; Murashige, T; Ogata, A; Ohuchi, K; Seki, H; Tahara, T; Yokota, S | 1 |
Di Sanza, C; Fish, RJ; Freire, C; Neerman-Arbez, M | 1 |
Bongarzone, ER; Cologna, SM; Crocker, SJ; Domowicz, MS; Givogri, MI; Heller, GJ; Issa, Y; Marshall, JN; Marshall, MS; Nguyen, D; Pathmasiri, KC; Rue, E; Sands, MS; Tai, LM; van Breemen, RB | 1 |
Chipman, AM; Kozar, RA; Wu, F | 1 |
Akassoglou, K; Chan, JP; Gao, HX; Mendiola, AS; Merlini, M; Rubenstein, JL; Ryu, JK | 1 |
Hifumi, T; Ito, T; Yamamoto, A | 1 |
Bóta, A; Cherpokova, D; Farkas, ÁZ; Farkas, VJ; Feller, T; Kellermayer, MZ; Kiss, B; Kolev, K; Komorowicz, E; Longstaff, C; Sorvillo, N; Szabó, L; Varjú, I; Wacha, A; Wagner, DD | 1 |
Ajjan, RA; Ali, M; Ariëns, RAS; Bailey, MA; Baker, SR; Baranauskas, A; Cheah, LT; Connell, SD; Cubbon, RM; Duval, C; Feller, T; McPherson, HR; Naseem, KM; Philippou, H; Raslan, Z; Ridger, VC; Yuldasheva, NY | 1 |
Abe, K; Bian, Y; Bian, Z; Feng, T; Hu, X; Morihara, R; Omote, Y; Shi, X; Sun, H; Tadokoro, K; Takemoto, M; Yamashita, T; Yu, H | 1 |
Akassoglou, K; Davalos, D; Merlini, M; Schuck, R; Tognatta, R; Yan, Z | 1 |
Alam, JM; Badraoui, R; Bouali, N; Chira, A; El Feki, A; Elkahoui, S; Kallel, C; Saeed, M; Saoudi, M | 1 |
Bertlich, M; Bettag, SA; Canis, M; Desinger, H; Ihler, F; Weiss, BG | 1 |
Chang, CJ; Du, YF; Hu, CY; Hung, HC; Li, HY; Lin, CH; Ou, HY; Wang, SH; Wu, HT; Wu, P | 1 |
Liu, Z; Lu, Y; Wang, H; Xu, X; Zhao, Y; Zheng, C | 1 |
Afroz, S; Khan, RA; Mallick, N; Riaz, A | 1 |
Govitrapong, P; Isarankura-Na-Ayudhya, C; Kitidee, K; Klosen, P; Pannengpetch, S; Wongchitrat, P | 1 |
Eckert, MJ; Lallemand, MS; Marko, ST; Martin, MJ; McClellan, JM; Moe, DM; Smith, JP | 1 |
Chen, R; Chen, X; Dong, X; Huang, X; Huang, Z; Jiang, X; Lin, H; Lin, X; Wu, X; Yang, X | 1 |
Bracaglia, C; Caiello, I; Chatel, L; De Benedetti, F; de Min, C; Ferlin, WG; Grom, AA; Marasco, E; Pascarella, A; Prencipe, G; Strippoli, R | 1 |
De Pablo, D; Fernández-Aceñero, MJ; García-Vásquez, C; Gómez García de Las Heras, S; Pastor Idoate, C | 1 |
Potla, R; Wu, H; Wu, Y; Yu, Y; Zheng, Z | 1 |
Cho, M; Choi, G; Choi, WS; Chung, Y; Corry, DB; Kang, CY; Khalmuratova, R; Kheradmand, F; Kim, BS; Kim, HS; Kim, JO; Kubo, M; Landers, CT; Lee, JE; Lim, H; Park, YJ; Shim, I; Shin, HW; Tanaka, S; Tung, HY | 1 |
Bicknell, AB; Flora, GD; Gibbins, JM; Holbrook, LM; Sahli, KA; Sandhar, GK; Sasikumar, P; Schenk, MP; Stainer, AR | 1 |
Chen, Y; Ding, J; Dong, J; Ye, X | 1 |
Arnoux, F; Auger, I; Balandraud, N; Lambert, NC; Mariot, C; Peen, E; Roudier, J | 1 |
Binnebösel, M; Eickhoff, RM; Heise, D; Klinge, U; Klink, CD; Kroh, A; Neumann, UP; Rübsamen, K | 1 |
Houng, AK; Reed, GL; Singh, S | 1 |
Chaubet, F; Collet, JP; Ghebouli, R; Jandrot-Perrus, M; Letourneur, D; Loyau, S; Maire, M; Michel, JB; Saboural, P | 1 |
Casini, A; Neerman-Arbez, M | 1 |
Bongarzone, ER; Elackattu, V; Givogri, MI; Hebert, AK; Lipton, HL; Lu, QR; Marshall, J; Marshall, MS; Moyano, AL; Pituch, KC; Rapolti, DI; Reiter, CR; Son, KN; Steplowski, J; Ulloa, V; Wang, H | 1 |
Chen, L; Feng, Y; Guo, B; Han, X; Li, QJ; Shu, C; Wan, YY; Wang, X; Yang, F; Zha, H; Zhang, L; Zhou, J; Zhu, B; Zhu, Y | 1 |
Ai, G; Huang, J; Luo, X; Ma, K; Ning, Q; Wan, X; Xi, D; Xiao, F; Yan, W; Yu, H | 1 |
Cardona, AE; Cardona, SM; Carpio, VH; Keiser, PH; Ochoa, LF; Pal, R; Solomon, OD; Stephens, R; Vargas, G; Wilson, KD | 1 |
Bailey, C; Bartlett, CA; Black, AMB; Clarke, TO; Dunlop, SA; Fitzgerald, M; Giacci, MK; Gough, A; McGonigle, T; Smith, NM; Swaminathan Iyer, K | 1 |
Gu, J; Hong, J; Lin, C; Wang, S; Wang, W | 1 |
Halder, SK; Kant, R; Milner, R | 1 |
Fuchigami, H; Manabe, S; Matsumura, Y; Yasunaga, M | 1 |
Abdel Moneim, AE; Abdelhabib, S; Almeer, RS; El-Khadragy, MF | 1 |
Dai, J; Fan, C; Huang, SY; Jin, N; Li, WZ; Liu, K; Long, R; Wang, J; Wang, ZH; Yang, Y; You, Y | 1 |
Chattopadhyay, P; Deka, RC; Gogoi, D; Mukherjee, AK; Pal, A; Paul, S | 1 |
Huang, J; Liu, Y; Luo, X; Ning, Q; Shen, G; Wan, X; Wang, H; Xi, D; Yan, W; Yu, H | 1 |
Akassoglou, K; Davalos, D; Ellisman, M; Gill, TM; Merlini, M; Mucke, L; Muthukumar, G; Nelson, RB; Rafalski, VA; Rios Coronado, PE; Ryu, JK; Seeley, WW; Subramanian, KS; Syme, CA | 1 |
Hu, BJ; Zhu, JZ | 1 |
Barathi, VA; Chong, YS; Hysi, P; Juo, SH; Karnani, N; Ngo, CS; Pan, H; Saw, SM; Seow, WJ; Tompson, SW; Vithana, E; Whisenhunt, KN; Young, TL | 1 |
Bugge, TH; Flick, MJ; Gao, Z; Lum, AG; Moutsopoulos, NM; Mullins, ES; Shaw, MW; Silva, LM; Tran, C | 1 |
Alsop, SNA; Bassel, LL; Caswell, JL; Clark, ME; Hewson, J; Kaufman, EI; Sharif, S; Siracusa, L; Stinson, KJ; Vulikh, K | 1 |
Banerjee, A; Girish, A; Hickman, DA; Huang, S; Luc, N; Ma, Y; Miyazawa, K; Sekhon, UDS; Sen Gupta, A; Sun, M | 1 |
Hagisawa, K; Kinoshita, M; Saitoh, D; Sakai, H; Seki, S; Takeoka, S; Takikawa, M | 1 |
Campello, E; Ilich, A; Key, NS; Simioni, P | 1 |
Bhan, C; Chakraborty, P; Dash, SP; Dipankar, P; Kumar, P; Sarangi, PP | 1 |
Briquez, PS; Hubbell, JA; Lutolf, MP; Martino, MM; Ranga, A | 1 |
Aoyama, A; Bando, T; Chen, F; Date, H; Hijiya, K; Motoyama, H; Nakajima, D; Ohsumi, A; Okita, K; Sakamoto, J; Sato, M; Yamada, T | 1 |
Caballero, AR; Marquart, ME; O'Callaghan, RJ; Tang, A | 1 |
Ai, J; D'abbondanza, J; Lass, E; Macdonald, RL; Sabri, M | 1 |
Chen, RP; Chen, TZ; Chen, WJ; Huai, JP; Huang, ZM; Lu, GR; Wang, C; Ye, XH; Zhuge, XJ | 1 |
Chang, CJ; Hung, HC; Lu, FH; Ou, HY; Su, YC; Wu, CL; Wu, HT; Wu, JS; Yang, YC | 1 |
Delpech, M; Valleix, S | 1 |
Bazan, J; Calkosinski, I; Dobrzynski, M; Palka, L; Rosinczuk-Tonderys, J | 1 |
Fan, H; Ju, G; Liu, X; Tang, HB; Wang, YZ; Xiao, P | 1 |
Gaarder, C; Gundersen, Y; Hagemo, JS; Holtan, A; Johansson, PI; Jørgensen, JJ; Næss, PA; Ostrowski, SR | 1 |
Kanaji, S; Kanaji, T; Montgomery, RR; Newman, PJ; Patel, SB | 1 |
Fischer, AM; Gaussem, P; Godier, A; Le Bonniec, B; Marchand-Leroux, C; Martin, AC; Samama, CM | 1 |
Barton, J; Differding, J; Fabricant, L; Kremenevskiy, I; Lee, TH; Sands, C; Schreiber, MA; Watson, K; Watters, JM; Wiles, C | 1 |
Liu, Y; Norris, ZG; Shavit, JA; Swaroop, A; Vo, AH | 1 |
Bedarf, JR; Grosch-Ott, S; Hiebl, B; Kirschfink, M; Russ, M; Unger, JK; Wagner, JJ | 1 |
Kunicki, T; Lillicrap, D; Peyvandi, F | 1 |
Calcaterra, J; Carlson, MA; Cordes, CM; Johanning, JM; Pipinos, II; Velander, WH | 1 |
Luo, X; Ning, Q; Wang, M; Xi, D; Ye, H | 1 |
Araujo, JA; Donaldson, K; Duffin, R; Hadoke, PW; Lawal, AO; McLean, SG; Miller, MR; Mills, NL; Newby, DE; Shaw, CA | 1 |
Braunschweig, T; Czaplik, M; Daniels, M; Grottke, O; Rossaint, R; Tolba, R; Zentai, C | 1 |
Anderson, EL; Cole, JN; Ghosh, P; Nizet, V; Olson, J; Ryba, B | 1 |
Agapov, MA; Gorskiĭ, VA; Iskhakov, RR; Protasov, AV | 1 |
Duque, JC; Faridi, MH; Gupta, V; Martinez, L; Mesa, A; Pena, A; Pham, SM; Rodriguez-Menocal, L; Shehadeh, LA; Vazquez-Padron, RI; Wei, Y | 1 |
Gao, H; Xi, S; Xu, L | 1 |
Chen, N; Chen, ZL; Qiu, Y; Yan, YJ; Zhu, YY | 1 |
Baci, D; Bearzi, C; Condorelli, G; Fortunato, O; Gargioli, C; Kossover, O; Latronico, MV; Rizzi, R; Seliktar, D; Shapira-Schweitzer, K | 1 |
Di Sanza, C; Fish, RJ; Neerman-Arbez, M | 1 |
Li, L; Rong, R; Wang, L; Xu, M; Yang, B; Yang, C; Zhao, T; Zhao, Z; Zhu, T | 1 |
Cruz, C; Degen, JL; Flick, MJ; Frederick, MD; Jone, A; Raghu, H; Rewerts, CL; Thornton, S | 1 |
Cavaco, CK; Doran, KS; Neely, MN; Patras, KA; Rösler, B; Seo, HS; Sullam, PM; Wang, NY | 1 |
Joshi, N; Kopec, AK; Luyendyk, JP; Towery, K; Williams, KJ | 1 |
Cervera, A; Chamorro, Á; de la Rosa, X; Durduran, T; Justicia, C; Kristoffersen, AK; Planas, AM; Valdés, CP; Varma, HM | 1 |
Keibl, C; Nürnberger, S; Ohlinger, W; Redl, H; Schlimp, CJ; Schöchl, H; Solomon, C; Zipperle, J | 1 |
Fabritius, M; Fürst, R; Hessenauer, M; Holzer, M; Khandoga, A; Krombach, F; Praetner, M; Puhr-Westerheide, D; Rehberg, M; Reichel, CA; Uhl, B; Zahler, S; Zuchtriegel, G | 1 |
Ahn, HJ; Glickman, JF; Jno-Charles, OC; Norris, EH; Poon, KL; Strickland, S; Zamolodchikov, D | 1 |
Furie, B; Furie, BC; Furie, RA; Merrill-Skoloff, G; Proulle, V | 1 |
Almond, GW; Choudhary, NR; Fusco, WG; Koch, GG; Leduc, I; Orndorff, PE; Routh, PA; Sempowski, GD; Smith, VA; Ventevogel, MS | 1 |
Braunschweig, T; Grottke, O; Rose, M; Rossaint, R; Schnabel, J; Zentai, C | 1 |
Du, J; Du, X; Fang, Y; Feng, L; Hou, J; Hu, S; Jia, H; Liu, H; Xie, Z; Yu, B; Zhang, L; Zhao, Q | 1 |
Castillo-Sanchez, E; García-Martínez, JA; Lopez-Bernal, Fde A; Muntane-Relat, J; Padillo-Ruiz, J; Tallón-Aguilar, L | 1 |
Beninati, C; Biondo, C; Buscetta, M; Firon, A; Mancuso, G; Midiri, A; Papasergi, S; Pietrocola, G; Romeo, L; Speziale, P; Teti, G; Trieu-Cuot, P | 1 |
Graham, A; Holbert, J; Nothnick, WB; Weiss, MJ | 1 |
Cheng, LJ; Deng, AM; Guo, Q; Lei, H; Li, YS; Xu, J | 1 |
Aleman, MM; Byrnes, JR; Degen, JL; Di Paola, J; Flick, MJ; Lam, WA; Mackman, N; Tran, R; Wang, JG; Wolberg, AS | 1 |
Granger, DN; Russell, J; Seifert, H; Senchenkova, E; Tang, YH; Vital, S | 1 |
Golovin, A; Kopylov, A; Pavlova, G; Revishchin, A; Samoylenkova, N; Zavyalova, E | 1 |
Deng, G; Guo, B; Li, Y; Liu, J; Liu, Y; Ma, Z; Tan, Y; Wang, F; Xu, X; Zhang, J; Zhao, T; Zhu, B; Zou, L | 1 |
Chen, Y; Lu, G; Lu, Z; Song, F | 1 |
Kojima, A; Matsumoto-Nakano, M; Muranaka, Y; Naka, S; Nakano, K; Nomura, R; Ooshima, T; Otsugu, M; Teramoto, N | 1 |
Sakamoto, T; Shirasawa, M; Sonoda, S; Terasaki, H; Uchino, E; Yamashita, T | 1 |
Liles, C; Stern, S; Wang, X; White, NJ | 1 |
Bucht, A; Jonasson, S; Koch, B; Wigenstam, E | 1 |
Grottke, O; Honickel, M; Rossaint, R; Tillmann, S; Treutler, S; van Ryn, J | 1 |
Arihiro, K; Mimae, T; Mimura, T; Miyata, Y; Okada, M; Sasada, S; Tsubokawa, N; Yoshiya, T | 1 |
Cassidy, MR; Heydrick, SJ; Sherburne, AC; Stucchi, AF | 1 |
Deng, SH; Jin, SJ; Liao, LH; Lin, TL; Liu, Y; Luo, XP; Ning, Q | 1 |
Chanley, MA; Kerlin, BA; Nieman, MT; Sharma, R; Smoyer, WE; Waller, AP | 1 |
Baraki, H; Haverich, A; Kutschka, I; Martens, A; Martin, U; Rathert, C; Rojas, SV; Rojas-Hernandez, S; Schecker, N; Schwanke, K; Zweigerdt, R | 1 |
Kong, Y; Li, Z; Wang, Y; Xie, Z; Yang, W | 1 |
Grottke, O; Rossaint, R; Schnabel, J; Solomon, C; Spronk, HM; van der Meijden, PE; Zentai, C | 1 |
Abdalmula, A; Bailey, SR; Dooley, LM; Ghosh, P; Itescu, S; Kaufman, C; Kimpton, WG; Tudor, EM; Washington, EA | 1 |
Cross, RW; Fenton, KA; Geisbert, JB; Geisbert, TW; Mire, CE | 1 |
Nordentoft, T | 1 |
Dong, H; Gu, X; Hamidian Jahromi, A; Tan, TW; Yao, L; Zhang, WW; Zhao, CX | 1 |
Brohi, K; Gwyther, R; Kirkman, E; Midwinter, M; Nordmann, G; Poon, H; Watts, S; Wilson, C; Woolley, T | 1 |
Li, JY; Liu, GR; Liu, XW; Ma, N; Mohamed, I; Yang, YJ; Zhang, JY | 1 |
Anderson, AS; Hu, G; Jansen, KU; Keeney, D; Liberator, PA; Matsuka, YV; McNeil, LK; Nanra, J; Scully, IL; Severina, E; Timofeyeva, Y | 1 |
Allouche, N; Derbali, F; Ellefi, H; Gammoudi, A; Gharsallah, N; Hajji, R; Kadri, A; Khabbabi, G; Mnafgui, K | 1 |
Chen, S; Liu, M | 1 |
Ajzenberg, N; Amarenco, P; Cantier, M; Desilles, JP; Gonzalez-Valcarcel, J; Ho-Tin-Noe, B; Jandrot-Perrus, M; Lapergue, B; Louedec, L; Loyau, S; Mazighi, M; Michel, JB; Syvannarath, V | 1 |
Ai, G; Chen, T; Han, M; Luo, X; Ning, Q; Shen, G; Wang, H; Wang, M; Wang, X; Wu, D; Wu, Z; Xi, D; Yan, W | 1 |
Huang, S; Jin, N; Li, T; Li, W; Liu, K; Long, R; Wang, Z; You, Y | 1 |
Aragno, M; Costelli, P; De Stefanis, D; Mastrocola, R; Nigro, D | 1 |
Liang, J; Song, W; Yang, C; Zhang, M; Zhao, Y; Zheng, W; Zheng, Y | 1 |
Braun, A; Chen, W; Gotru, SK; Haining, EJ; Hermanns, HM; Kraft, P; Lesch, KP; Nieswandt, B; Schuhmann, MK; Stoll, G; Tseng, YL; Wolf, K | 1 |
Gao, M; Liu, Y; Longo, S; McGillis, S; Popescu, M; Wang, D; Zhao, LR | 1 |
Abou-Fard, GM; Shafik, NM | 1 |
Chang, C; Montealegre, MC; Murray, BE; Sillanpää, J; Singh, KV; Somarajan, SR; Spencer, R; Ton-That, H; Yadav, P | 1 |
Dobson, GP; Letson, HL | 1 |
Hagisawa, K; Handa, M; Iwaya, K; Kinoshita, M; Miyawaki, H; Miyazaki, H; Nishida, Y; Saitoh, D; Sato, S; Seki, S; Shono, S; Suzuki, H; Takeoka, S | 1 |
Chung, YC; Feierman, E; Kruyer, A; Norris, EH; Richards, A; Strickland, S; Yao, Y | 1 |
Kopec, AK; Luyendyk, JP | 1 |
Braunschweig, T; Grottke, O; Honickel, M; Hueck, N; Rossaint, R; Spronk, HM; van der Meijden, PE; Zentai, C | 1 |
Chen, X; Fan, L; Li, X; Wang, G; Wang, K; Wei, G | 1 |
Güzel, I; Karasu, H | 1 |
Di Ceglie, I; Ferlin, W; Hatterer, E; Herren, S; Kiyeko, GW; Kosco-Vilbois, M; Reith, W; Shang, L; van Lent, PL | 1 |
Fan, L; Li, X; Wang, G; Wang, K; Wei, G; Zhou, C | 1 |
Fu, F; Huang, S; Lin, C; Ma, K; Shi, H; Yang, G; Yang, Z; Yuan, B | 1 |
Gong, S; Huang, S; Lin, L; Ma, K; Sheng, H; Shi, H; Su, T; Wang, F; Yang, Z; Yuan, B | 1 |
Hasegawa, N; Kato, A; Mizutani, T; Nozaki, M; Ogura, Y; Ohbayashi, M; Ozone, D; Yasukawa, T | 1 |
Ali, MS; Bishop-Bailey, D; Bye, AP; Dombrowicz, D; Dorchies, E; Flora, GD; Gibbins, JM; Kriek, N; Molendi-Coste, O; Moraes, LA; Sage, T; Sasikumar, P; Staels, B; Unsworth, AJ; Vaiyapuri, S | 1 |
Kim, D; Kim, JT; Kim, MS; Koo, MA; Kwon, BJ; Lee, MH; Park, JC; Seomun, Y; Seon, GM | 1 |
Eriksson, M; Larsson, A; Lipcsey, M; Lubenow, N; Strandberg, G | 1 |
Hagiwara, A; Ozamoto, Y; Takagi, T; Torii, H; Tsujimoto, H | 1 |
Brohi, K; Cohen, M; Davenport, RA; Frith, D; Guerreiro, M; Pearse, R; Platton, S; Rourke, C; Thiemermann, C | 1 |
Banadyga, L; Ebihara, H; Feldmann, H; Haddock, E; Horne, EJ; Marzi, A; Scott, DP; Shen, K; Thomas, T | 1 |
Allen, JD; Chen, VM; Curnow, JL; Ehteda, A; Kritharides, L; Reddel, CJ; Robertson, G; Taylor, R | 1 |
Cao, Y; Ding, X; Gamariel, RR; Kong, Y; Li, ZY; Liu, TD; Liu, XD; Ming, X; Wang, CH; Xie, ZL; Zhao, Q | 1 |
Applegate, R; Bull, BS; Gren, EC; Hay, KL; Hayes, WK; Kelln, W; Kim, CH; Lekic, T; McBride, DW; Raval, R; Sherchan, P; Tang, J; Zhang, JH | 1 |
Gijbels, MJJ; Heestermans, M; Ouweneel, AB; Reitsma, PH; Van Eck, M; van Vlijmen, BJM; Verwilligen, RAF | 1 |
Keshamouni, VG; Milam, JE; Narala, VR; Newstead, MW; Reddy, RC; Standiford, TJ | 1 |
Isobe, M; Itai, A; Muto, S; Ogawa, M; Suzuki, J; Yamaguchi, Y | 1 |
Bruno, NE; D'Alessandro-Gabazza, CN; Gabazza, EC; Mizoguchi, A; Morser, J; Qin, L; Sumida, Y; Suzuki, K; Suzuki, T; Taguchi, O; Takei, Y; Yano, Y | 1 |
Cekic, M; Cutler, SM; Hoffman, SW; Johnson, SJ; Miller, D; Stein, DG; VanLandingham, JW; Washington, ER | 1 |
Liu, J; Liu, YM; Qin, H; Wang, B; Wang, CB; Wang, L; Wang, M; Yu, XJ; Zang, WJ; Zhou, XB | 1 |
Huang, JQ; Liu, Y; Yu, HJ | 1 |
Chen, F; Luo, XP; Ning, Q; Pi, B; Su, K; Xi, D; Xu, L; Yan, WM; Zeng, QL | 1 |
Dyson, SW; Evans, GR; Owens, WJ; Scholz, T; Shanbrom, E; Waltzman, J; Wirth, GA | 1 |
Hamada, S; Hirota, M; Kikuta, K; Masamune, A; Satoh, K; Shimosegawa, T; Watanabe, T | 1 |
Allen, GB; Bates, JH; Cloutier, ME; Larrabee, YC; Smiley, ST; Tetenev, K | 1 |
Kjaergaard, B; Kristensen, SR; Larsson, A; Risom, M | 1 |
Ding, SF; Liu, CX; Liu, XL; Ni, M; Wang, Y; Zhang, M; Zhang, PF; Zhang, Y; Zhao, YX | 1 |
Chang, MH; Chen, CJ; Cheng, FC; Ho, SP; Lai, SZ; Liu, MJ; Pan, HC; Wang, YC; Yang, DY | 1 |
Iida, H; Ishii, H; Itoh, F; Kakui, N; Kato, E; Muto, Y; Sakakibara, S; Suzuki, K | 1 |
Olrik Berthelsen, L; Thuri Kristensen, A; Tranholm, M; Wiinberg, B | 1 |
Berger, M; Guimarães, JA; Pinto, AF; Reck, J; Termignoni, C; Terra, RM | 1 |
Albes, JM; Bachmann, S; Claus, T; Erb, MA; Hartrumpf, M | 1 |
Agüero, G; Alvarez, S; Haro, C; Lazarte, S; Zelaya, H | 1 |
Guo, JW; Luo, XP; Ning, Q; Xi, D; Yan, WM | 1 |
Cao, CZ; Cao, MM; Dong, L; Gao, YB; Ge, CH; Li, CY; Li, W; Peng, RY; Wang, QM; Wang, ZD; Xu, WX; Yang, F; Yang, XM; Yu, M; Zhan, YQ | 1 |
Allen Li, X; Baker, JE; Doppalapudi, A; Fish, BL; Harmann, L; Haworth, ST; Hopewell, JW; Komorowski, RA; Migrino, RQ; Moulder, JE; Strande, JL; Su, J | 1 |
Guan, L; Wang, X; Wen, T; Zhang, Y; Zhao, J; Zhu, M | 1 |
Akkerman, JW; de Groot, PG; Moll, FL; Schulte-Merker, S; Tournoij, E; Weber, GJ; Zon, LI | 1 |
Alrehani, N; Cruz, MA; Gushiken, FC; Hyojeong, H; Langlois, KW; Pradhan, S; Rumbaut, RE; Vijayan, KV | 1 |
Bes, M; Bille, J; Entenza, JM; Moreillon, P; Sakwinska, O; Vandenesch, F; Ythier, M | 1 |
Gao, S; Guo, J; Luo, X; Ning, Q; Wang, M; Wang, Z; Xi, D; Yan, W; Ye, H; Zhu, C | 1 |
Antunes, E; Baldissera, L; de Mello, GC; Monteiro, PF; Morganti, RP | 1 |
Braunschweig, T; Coburn, M; Daheim, N; Grieb, G; Grottke, O; Rossaint, R; Tolba, R | 1 |
Bornstein, SR; Cardoso, CC; Hornsby, PJ | 1 |
Iversen, PO; Sioud, M; Sørensen, DR | 1 |
Calvaruso, V | 1 |
Andersson, KE; Hellstrand, P; Lindholm, MW; Oste, R; Svedberg, KA | 1 |
Damgaard, BM; Halekoh, U; Heegaard, PM; Jensen, KH; Langerhuus, SN; Lauridsen, C; Tønnesen, EK | 1 |
Berthelsen, LO; Kristensen, AT; Tranholm, M | 1 |
Beissel, A; Kahl, P; Kalff, JC; Pantelis, D; Vilz, TO; Wehner, S | 1 |
De Visscher, G; Flameng, W; Lebacq, A; Mesure, L; Vranken, I | 1 |
Baldwin, J; Deatrick, KB; Elfline, M; Henke, PK; Luke, CE; Miller, EM; Sood, V; Upchurch, GR; Wakefield, TW | 1 |
Braunschweig, T; Coburn, M; Grottke, O; Kopp, R; Lauritzen, B; Rossaint, R; Tolba, R; Zimmermann, L | 1 |
Baldwin, JF; Deatrick, KB; Diaz, JA; Elfline, MA; Henke, PK; Hogaboam, C; Kunkel, SL; Luke, CE; Mitsuya, M; Sood, V; Upchurch, GR; Wakefield, TW | 1 |
Luyendyk, JP; Mackman, N; Sullivan, BP | 1 |
Akkerman, JW; Cate, HT; Hauer, AD; Hildebrand, RB; Hoekstra, M; Korporaal, SJ; Kuiper, J; Meurs, I; Praticò, D; Van Berkel, TJ; Van Eck, M | 1 |
Huang, DH; Tian, SJ; Wu, L; Wu, WP; Yang, Y | 1 |
Chen, ZY; Inoue, Y; Iwai, T; Terasaki, H; Umeda, M; Yu, KM | 1 |
Cardenas, JC; Church, FC; Machlus, KR; Wolberg, AS | 1 |
Allen, K; Cantor, GH; Copple, BL; Guo, GL; Kassel, KM; Li, G; Luyendyk, JP | 1 |
Bouley, J; Bråtane, BT; Fisher, M; Henninger, N; Lo, E; Sicard, KM; Walvick, RP; Wang, X; Yu, Z | 1 |
Ai, J; Chen, G; Jeon, HJ; Lakovic, K; Macdonald, RL; Sabri, M; Tang, EJ; Tariq, A; Wan, H | 1 |
Bartczak, A; Clark, DA; Gorczynski, RM; Inman, R; Levy, GA; Marsden, PA; Melnyk, MC; Phillips, MJ; Selzner, N; Shalev, I; Zhang, J | 1 |
Brophy, DF; Brueckner, J; Leong, BS; Martin, EJ; Ornato, J; Peberdy, MA; Ward, KR; White, NJ | 1 |
Lin, QQ; Lin, R; Ren, F; Wang, WR; Yang, LN; Zhang, H; Zhang, KF | 1 |
Annichino-Bizzacchi, JM; Costa, DS; de Paula, EV; Montalvao, SA; Ozelo, MC; Picoli-Quaino, SK; Vancine, SM | 1 |
Bhandari, AA; Fuchs, TA; Wagner, DD | 1 |
Degen, JL; Haller, H; Inhester, T; Melk, A; Schmitt, R; Sörensen, I; Susnik, N | 1 |
Chen, Y; Fei, L; Fu, X; Guo, G; Guo, S; Wu, S; Wu, Y; Yang, C | 1 |
Jin, T; Josefsson, E; Kwieciński, J | 1 |
Bult, H; Emmerechts, J; Fransen, P; Hemmeryckx, B; Hoylaerts, MF; Kauskot, A; Lijnen, HR; Van Hove, CE | 1 |
Jensen, AL; Kjalke, M; Knudsen, T; Kristensen, AT; Nichols, TC; Tranholm, M | 1 |
Falk, E; Kim, WY; Paaske, WP; Pedersen, SF; Ringgaard, S; Thim, T; Thrysøe, SA | 1 |
Bicknell, AB; Gibbins, JM; Holbrook, LM; Sasikumar, P; Simmonds, AD; Stanley, RG | 1 |
Arihiro, K; Ikeda, T; Misumi, K; Miyata, Y; Okada, M; Tsutani, Y | 1 |
Bhakta, V; Eltringham-Smith, LJ; Gataiance, S; Sheffield, WP | 1 |
Bryckaert, M; Delignat, S; Jandrot-Perrus, M; Kaveri, SV; Lacroix-Desmazes, S; Rayes, J; Teyssandier, M | 1 |
Floyd, CT; Martin, R; Olson, CE; Risdahl, J; Rothwell, SW | 1 |
Borel Rinkes, IH; Goldschmeding, R; Ruiz, A; van Hillegersberg, R; Verhage, RJ; Verheem, A | 1 |
Brummer, G; Conrad, GW; Littlechild, SL; Zhang, Y | 1 |
Calkovska, A; Curstedt, T; Haegerstrand-Björkman, M; Linderholm, B | 1 |
Abram, C; Lowell, CA; Mori, J; Nash, CA; Senis, YA; Séverin, S; Watson, SP; Zhao, Y | 1 |
Bonderman, D; Lang, IM; Pesavento, R; Yuan, JX | 1 |
Floyd, CT; Martin, R; Olson, CE; Risdahl, J; Rose, N; Rothwell, SW | 1 |
Blackbourne, LH; Cortez, DS; Dubick, MA; Martini, WZ | 1 |
Brzoska, T; Buczko, W; Chlopicki, S; Fedorowicz, A; Grochal, E; Kramkowski, K; Leszczynska, A; Mann, B; Mogielnicki, A; Motterlini, R; Urano, T | 1 |
Campbell, RA; Di Paola, J; Lin, FC; Ma, AD; Mackman, N; Marchi, R; McGary, CS; Pawlinski, R; Walton, BL; Wolberg, AS | 1 |
Chi, X; Gelderman, MP; Vostal, JG; Zhi, L | 1 |
Ai, J; Lakovic, K; Macdonald, RL; Sabri, M | 1 |
Dey, D; Evans, GR; Lin, F; Mowlds, DS; Nam, SB; Owens, JW; Scholz, T; Vetter, TS; Wirth, GA | 1 |
Doi, M; Hagisawa, K; Handa, M; Iwaya, K; Katsuno, S; Kinoshita, M; Nishikawa, K; Saitoh, D; Sakamoto, T; Seki, S; Shono, S; Suzuki, H; Takeoka, S; Yanagawa, R | 1 |
Choi, HS; Ke, K; Kim, HJ; Kim, SY; Kim, WK; Lee, MH; Phan, VT; Sul, OJ | 1 |
Ayas, B; Balli, U; Cetinkaya, BO; Findik, A; Keles, GC; Keles, ZP; Pamuk, F | 1 |
Bentancor, LV; Bozkurt-Guzel, C; Cywes-Bentley, C; Maira-Litrán, T; O'Malley, JM; Pier, GB | 1 |
Choudhury, GR; Lin, ZJ; Liu, H; Liu, R; Qian, H; Ren, M; Yang, SH | 1 |
Elyakoubi, J; Gruszka, A; Hermanns-Sachweh, B; Kuschel, TJ; Sachweh, JS; Schnoering, H; Vázquez-Jiménez, JF | 1 |
Gutiérrez, JM; Herrera, C; Rucavado, A; Warrell, DA | 1 |
Chen, D; Dai, J; Gu, N; Jiang, Q; Shi, D; Wang, C; Xu, Z; Yang, F | 1 |
Baeten, D; Cantaert, T; Tak, PP; Teitsma, C | 1 |
Atefi, M; Belldegrun, AS; Birkhäuser, FD; Chandramouli, GV; Chodon, T; Kabbinavar, FF; Koya, RC; Kroeger, N; Li, G; Lu, X; McBride, WH; Micewicz, ED; Neufeld, C; Pantuck, AJ; Rampersaud, EN; Ribas, A; Riss, J; Said, JW | 1 |
Berthiaume, F; Kang, YH; Yarmush, ML | 1 |
Hatton, MW; Richardson, M; Ross, B; Southward, SM; Timleck-DeReske, M | 1 |
Erlandsson Harris, H; Klareskog, L; Larsson, A; Larsson, E; Lorentzen, JC; Månsson, B; Saxne, T | 1 |
Marx, G; Mou, X | 1 |
De Maio, A; Fulton, WB; Monitto, CL; Paidas, CN; Reeves, RH; Stewart, D; Wilson, C | 1 |
Dabin, C; del C Gayol, M; Herńandez, GN; Rasia, ML | 1 |
Gulledge, AA; Koch, G; Lord, ST; McShea, C; Schwartz, T | 1 |
Aliev, OI; Maslov, MJ; Plotnikov, MB; Tjukavkina, NA; Vasiliev, AS | 1 |
Aguejouf, O; Doutremepuich, C; Doutremepuich, F; Mayo, K; Megraud, F; Monteiro, L | 1 |
Hermida, J; Hurtado, V; Matsukawa, A; Montes, M; Montes, R; Nariuchi, H; Rocha, E; Rodriguez-Wilhelmi, P | 1 |
Ebel, H; Friese, M; Klug, N; Lee, JY; Schillinger, G; Schröder, R | 1 |
Germann, PG; Häfner, D; Ibrahim, M; Wollin, L | 1 |
Cornum, RL; Fitzpatrick, GM; Goodwin, CW; Harris, RA; Hess, JR; Holcomb, JB; Martinez, RS; McManus, AT; Modrow, HE; Mosebar, RH; Nelson, JH; Pusateri, AE; Reid, TJ; Sondeen, JL; Zolock, DT | 1 |
Hans, M; Juhan-Vague, I | 1 |
Cooley, BC; Hendrickson, SB; Hernandez, I; Isermann, BH; Kerlin, B; Lord, S; Mosesson, MW; Sood, R; Weiler, H; Zogg, M | 1 |
Amagasa, H; Murakami, H; Oguchi, K; Okazaki, M | 1 |
Reinhart, WH | 1 |
Björck, L; Cramer, H; Flodgaard, H; Herwald, H; Lindbom, L; Mörgelin, M; Norrby-Teglund, A; Russell, W; Sollenberg, U | 1 |
Advincula, R; Camerer, E; Cornelissen, I; Coughlin, SR; Duong, DN; Qazi, AA | 1 |
Sadler, JE; Shim, K; Westfield, LA; Zhu, H | 1 |
Bajzar, L; Blajchman, MA; Clarke, BJ; Hatton, MW; Legault, KJ; Richardson, M; Ross, BL; Singh, G; Southward, SM | 1 |
Bhattacharyya, TK; O'Grady, K; Shah, A; Siedentop, KH | 1 |
Brown, EJ | 1 |
Dickneite, G; Doerr, B; Kaspereit, F | 1 |
Connolly, RJ | 1 |
Bellinger, D; Chan, MW; Cole, DJ; Connolly, RJ; Nichols, T; Read, M; Schwaitzberg, SD | 1 |
Hogan, KA; Kim, HS; Lord, ST; Merenbloom, BK | 1 |
Collen, D; Nagai, N; Suzuki, Y | 1 |
Gu, F; Lü, J; Yang, M; Yang, W | 1 |
Gao, XY; Hua, ZC; Ju, CW; Ma, GS; Wang, LS; Yang, X | 1 |
Barrionuevo, P; Camerano, G; Dran, G; Fernández, GC; Gómez, SA; Isturiz, MA; Palermo, MS; Rosa, FA | 1 |
Feijge, MA; Giesen, PL; Heemskerk, JW; Jerling, JC; Kloots, W; Kuijpers, MJ; Nieuwenhuys, CM; oude Egbrink, MG | 1 |
Chawda, M; Fehr, M; Giannoudis, P; Harms, O; Harwood, P; Hildebrand, F; Krettek, C; Otto, K; Pape, HC; Probst, C; van Griensven, M | 1 |
Bodary, PF; Dobies, SL; Eitzman, DT; Ginsburg, D; Gu, S; Manning, SL; Shen, Y; Westrick, RJ | 1 |
Delgado, AV; Holcomb, JB; Martini, WZ; Pusateri, AE; Uscilowicz, JM | 1 |
Awaga, Y; Furuichi, Y; Ichise, R; Maeda, M; Matsuoka, N; Nishimura, S; Noda, A; Takamatsu, H; Tatsumi, M; Yamamoto, M | 1 |
Frisbie, JH | 1 |
Amagasa, H; Iwai, S; Kobayashi, S; Kumai, T; Oguchi, K; Okazaki, M | 1 |
Galenko-Yaroshevskii, PA; Kupreishvili, VZ; Lysenkov, SP; Myasnikova, VV; Rizhvadze, MR; Sukoyan, GV | 1 |
Bayer, AS; Kempf, VA; Lucindo, N; Peschel, A; Weidenmaier, C; Yeaman, MR | 1 |
Levy, G; Luo, XP; Ning, Q; Tian, DY; Xi, D; Yan, WM; Zhu, CL; Zhu, F; Zhu, YF | 1 |
Hayashi, K; Kawasaki, T; Miyata, K; Moritani, Y; Saito, T; Takasaki, J; Taniguchi, M; Uchida, W; Uemura, T | 1 |
Luo, X; Ning, Q; Sun, Y; Xi, D; Yan, W; Zhu, C | 1 |
Hamato, N; Hirayama, F; Hirose, M; Kajii, M; Kubo, Y; Mochizuki, S; Ohi, H; Tsukada, M | 1 |
Bayer, AS; Ghebrehiwet, B; Peerschke, EI; Xiong, YQ | 1 |
Fries, D; Haas, T; Innerhofer, P; Klima, G; Klingler, A; Martini, J; Streif, W; Wagner-Berger, H | 1 |
Barnard, MR; Frelinger, AL; Linden, MD; Michelson, AD; Przyklenk, K; Whittaker, P | 1 |
Matchett, G; Ohkuma, H; Shimamura, N; Solaroglu, I; Tsubokawa, T; Zhang, J | 1 |
Castellino, FJ; Ploplis, VA; Xu, H | 1 |
Bejar, J; Boss, J; Peled, E; Seliktar, D; Zinman, C | 1 |
Castellino, FJ; Ganopolsky, JG; Noria, F; Ploplis, VA; Sandoval-Cooper, MJ | 1 |
Bazzoni, G; Bernal, CA; Carnovale, CE; Contini, Mdel C; Mahieu, S | 1 |
Ben, SQ; Huang, JF; Huang, SB; Ni, SS; Shen, HH; Shi, YX; Xu, JH | 1 |
Kralova, H; Krouzecky, A; Matejovic, M; Novak, I; Radej, J; Radermacher, P; Rokyta, R | 1 |
Gomibuchi, H; Iwai, S; Kobayashi, S; Kumai, T; Oguchi, K; Okazaki, M | 1 |
Guo, B; Shi, Y; Zhang, Y; Zhao, X; Zhu, D | 1 |
Emeis, JJ; Jirouskova, M; Johnson, GJ; Muchitsch, EM; Shet, AS; Smyth, SS | 1 |
Kojima, S; Lijnen, HR; Matsuo, O; Smyth, SS; Ueshima, S | 1 |
Boehm, O; Emeis, JJ; Friedl, P; Henning, R; Koch, A; Mastan, P; Petzelbauer, P; Reingruber, S; Rother, RP; Zacharowski, K; Zacharowski, PA | 1 |
Liu, WH; Tsao, SM; Yin, MC | 1 |
Cucarella, C; Foster, TJ; Lasa, Í; Maiques, E; Martí, M; Penadés, JR; Tormo, MÁ; Úbeda, C; Valle, J | 1 |
Dennehy, MK; Fries, DM; Fu, X; Hazen, SL; Heijnen, HF; Ischiropoulos, H; Liebler, DC; Moore, RE; Parastatidis, I; Rader, DJ; Thomson, L; Tohyama, J | 1 |
Chai, CY; Chen, HW; Kuo, HT; Ou, JL; Yang, RC | 1 |
Melchor, JP; Paul, J; Strickland, S | 1 |
Fujii, A; Higami, T; Komatsu, K | 1 |
Badimon, L; Casaní, L; Vilahur, G | 1 |
Boshkov, LK; Farrell, DH; Hanson, SR; Lovely, RS; Marzec, UM | 1 |
Knight, B; Lim, R; Olynyk, JK; Yeoh, GC | 1 |
Holcomb, JB; Martini, WZ | 1 |
Gika, M; Imamura, T; Izumi, Y; Kawamura, M; Kobayashi, K; Miyabashira, S; Nozaki, C; Shinya, N | 1 |
Chhatwal, GS; Courtney, HS; Gillen, CM; Guzman, CA; Nizet, V; Rohde, M; Schulze, K; Timmer, AM; Walker, MJ; Wilson, MR | 1 |
Giannoudis, PV; Hildebrand, F; Krettek, C; Pape, HC; van Griensven, M | 1 |
Chen, X; Gawryluk, JW; Geiger, JD; Ghribi, O; Wagener, JF | 1 |
Inoue, K; Satoh, M; Takano, H | 1 |
Chhatwal, GS; Cole, JN; Cork, AJ; Dinkla, K; Maamary, PG; McArthur, JD; Sanderson-Smith, ML; Walker, MJ | 1 |
Fareed, J; Hoppensteadt, D; Izquierdo, R; Prinz, R; Sandberg, L; Squillaci, G; Walenga, J | 1 |
Nagamatsu, Y; Nagao, N; Naiki, I; Okamoto, U; Sasaki, K | 1 |
Imaoka, S; Kambayashi, J; Kosaki, G | 1 |
Giles, AR; Mann, KG; Nesheim, ME | 1 |
Carlson, RW; Chilton, SM; Hadden, TJ; Schaeffer, RC | 1 |
Fallon, JT; Gold, HK; Grossbard, E; Guerrero, JL; Hoyng, CF; Khaw, BA; Leinbach, RC; Newell, JB; Vislosky, FM; Yasuda, T | 1 |
Hein, B; Ronneberger, H | 1 |
Andrassy, K; Ritz, E; Waldherr, R | 1 |
Read, G; Shatney, CH | 1 |
Ruggeri, ZM; Zimmerman, TS | 1 |
Furukawa, Y; Kondo, M; Murakami, M; Takemura, S; Yoshikawa, T | 2 |
Dupe, RJ; English, PD; Green, J; Smith, RA | 1 |
Chmielewska, J; Donati, MB; Garattini, S; Mussoni, L; Poggi, A | 1 |
Anderson, JH; Cannon, DC; Huchton, JD; Kaufman, HH; Woo, J | 1 |
Chang, AK; Dong, F; Hinshaw, LB; Li, A; Peer, GT; Taylor, FB | 1 |
Craig, RL; Poole, GV | 1 |
Kato, H; Kawai, C; Nagaoka, N; Saito, M; Suzuki, N; Suzuki, S; Yoshitake, S; Yui, Y | 1 |
Braun, M; Hohlfeld, T; Kienbaum, P; Sarbia, M; Schrör, K; Weber, AA | 1 |
Hirata, Y; Nakashima, M; Takiguchi, Y; Uematsu, T; Umemura, K | 1 |
Abela, GS; Federman, M; Friedl, SE; Gebara, OC; Miyamoto, A; Muller, JE; Picon, PD; Tofler, GH | 1 |
Blondé-Cynober, F; Coudray-Lucas, C; Cynober, L; Giboudeau, J; Moukarbel, N; Plassart, F; Poupon, R; Rey, C | 1 |
Bodén, M; Flock, JI; Mamo, W | 1 |
Gurbel, PA; Pieper, KS; Stack, RS; Tapson, VF; Witty, LA | 1 |
Bakker, WW; Baller, JF; Faas, MM; Schuiling, GA; Visscher, CA | 1 |
Lanners, NH; Nimri, LF | 1 |
Hume, EB; Hunter, N; Knox, KW; Manning, JE | 1 |
Gushima, H; Kaku, S; Katoh, M; Kawai, C; Kawasaki, T; Takenaka, T; Yui, Y | 2 |
Fong, M; Neta, R; Strassmann, G; Windsor, S | 1 |
Katoh, S; Kawamura, S; Kawasaki, T; Takenaka, T | 1 |
Bregengård, C; Diness, V; Hedner, U; Nordfang, O; Svendsen, O; Wildgoose, P | 1 |
Beretz, A; Cazenave, JP; Freund, M; Gachet, C; Mantz, F; Meyer, L; Mulvihill, J; Nicolini, P | 1 |
Billiar, TR; Di Silvio, M; Geller, DA; Kispert, PH; Simmons, RL; Su, GL; Tweardy, DJ; Wang, SC | 1 |
Abdulkader, RC; Barreto, OC; Burdmann, EA; Marcondes, M; Prado, EB; Saldanha, LB; Woronik, V | 1 |
Benedict, CR; Cartwright, J; Kuwabara, K; Ryan, J; Stern, D; Tijburg, P; Todd, J | 1 |
Herting, E; Robertson, B; Strayer, DS; Sun, B | 1 |
Flock, JI; Heimdahl, A; Hienz, SA; Schennings, T | 1 |
Golubykh, VL; Maksimenko, AV; Petrova, ML; Tishchenko, EG | 1 |
Davies, MJ | 1 |
Ichikawa, Y; Kaneko, M; Matsui, K; Matsuo, O; Nakahara, H; Sakurama, T; Ueshima, S; Yatani, A; Yokoyama, M | 1 |
Boudignon-Proudhon, C; Brinkhous, KM; Li, TK; Lumeng, L; Parise, LV; Read, MS; Reddick, RL; Sigman, JL; Smith, JS; Smith, SV | 1 |
Darouiche, RO; Fernau, RC; Foster, T; Greene, C; Klima, M; Landon, GC; McDevitt, D; Nguyen, LL; Patti, JM | 1 |
Barry, P; FitzGerald, GA | 1 |
Chabchoub, A; Dellagi, K; Elayeb, M; Gasmi, A; Guermazi, S; Karoui, H | 1 |
Baskurt, OK; Meiselman, HJ; Temiz, A | 1 |
Fujiyoshi, T; Katada, J; Muramatsu, M; Takiguchi, Y; Uno, I | 1 |
Barton, MH; Moore, JN; Norton, N | 1 |
Ajzner, E; Furka, I; Mikó, I; Póti, L; Szepesi, K; Szücs, G | 1 |
Mohammad, SF; Sogawa, M | 1 |
Deberdt, W; Deckmyn, H; Nyström, A; Nyström, E; Stassen, JM; Stockmans, F; Vermylen, J | 1 |
Brugnara, C; Roback, MG; Saladino, RA; Schwarz, HP; Stack, AM; Thompson, C | 1 |
Horvat, M; Johnston, B; Koutalistras, N; Mears, DC; Sheil, AG; Sun, J; Wang, L; Waring, M; Watson, J; Woodman, K | 1 |
Arriaga, AK; Hernández-Pando, R; Larriva-Sahd, J; Madrid-Marina, V; Orozco, EH; Panduro, CA | 1 |
Piguet, PF; Senaldi, G | 1 |
Aguejouf, O; Belougne-Malfatti, E; Doutremepuich, C; Doutremepuich, F | 1 |
Hayashi, H; Ito, T; Kozawa, O; Matsuno, H; Nishida, M; Niwa, M; Tanabe, K; Uematsu, T | 1 |
Courtney, MA; Gigliotti, F; Goss, R; Harmsen, A; Simpson-Haidaris, PJ; Wright, TW | 1 |
Cui, X; Labhasetwar, V; Levy, RJ; Song, C; Underwood, T | 1 |
Beloucif, S; Benessiano, J; Drouet, L; Kermarrec, N; Payen, D; Zunic, P | 1 |
Hermida, J; Montes, R; Muñoz, MC; Orbe, J; Páramo, JA; Rocha, E | 1 |
Blajchman, MA | 2 |
Biemond, BJ; de Groot, PG; Friederich, PW; Harris, R; Heijnen, HF; Levi, M; Levin, J; Middleton, S; ten Cate, JW; Wu, YP | 1 |
Hara, A; Kyogashima, M; Onaya, J; Taketomi, T | 1 |
Andriamampandry, MD; Cazenave, JP; Freund, M; Gachet, C; Leray, C | 1 |
Bartscht, K; Fey, PD; Mack, D; Rupp, ME; Ulphani, JS | 1 |
Brosstad, F; Kvernebo, K; Laerum, F; Roy, S; Sakariassen, KS | 1 |
Desfaits, AC; Raymond, J; Roy, D | 1 |
Day, S; DeReske, M; Hatton, MW; Richardson, M; Ross, B; Southward, SM | 1 |
Alfon, J; Badimon, L; Berrozpe, M; Guasch, JF | 1 |
Drollinger, AG; Netser, JC; Rodgers, GM | 1 |
Asano, H; Suzuki, M; Tanaka, H; Usuda, S | 1 |
Cappelli, D; Ebersole, JL; Holt, SC; Kesavalu, L; Mott, G; Singer, RE | 1 |
Born, GV; Bowyer, DE; Fitzsimmons, C; Shafi, S; Stepanova, IP; Welzel, D | 1 |
Baron, JH; de Bono, DP; Foo, RS; Garner, I; Gershlick, AH; Hogrefe, K; Hussey, AJ; Johnston, TW | 1 |
Costa, DL; Gardner, SY; Lehmann, JR | 1 |
Badimon, JJ; Chesebro, JH; Fuster, V; Rauch, U; Reis, ED; Roqué, M | 1 |
Aagaard, S; Balling, E; Hakami, A; Hjortdal, VE; Husted, SE; Kristensen, SD; Marqversen, J; Thorwest, M | 1 |
Begbie, M; Lillicrap, D; Notley, C; Sawyer, L; Tinlin, S | 1 |
DeGuzman, F; Nurden, AT; Nurden, P; Phillips, DR; Poujol, C; Ramakrishnan, V | 1 |
Bdeir, K; Cines, DB; Higazi, AA; Koniaris, L; Martinez, J; Murciano, JC; Muzykantov, VR; Tomaszewski, J | 1 |
Aguejouf, O; Belon, P; Doutremepuich, C; Malfatti, E | 1 |
Castellino, FJ; Cornelissen, I; DeFord, ME; Liang, Z; McLennan, L; Ploplis, VA; Rosen, ED; Wilberding, J | 1 |
Kinasewitz, G; Taylor, FB; Wada, H | 1 |
Alfón, J; Badimon, L; Berrozpe, M; Royo, T | 1 |
Bugge, TH; Degen, JL; Drew, AF; Grimes, TS; Kiser, JH; Kombrinck, KW; Palumbo, JS | 1 |
Loskutoff, DJ; Quigley, JP | 1 |
Fujimura, A; Sugimoto, K; Tsuruoka, S | 1 |
Beall, LD; Charles, NC; Harris, RA; Hess, JR; Holcomb, JB; MacPhee, MJ; Pusateri, AE | 1 |
Kristensson, K; Mhlanga, JD; Mulenga, C; Robertson, B | 1 |
Castel, D; Freidman, M; Hedner, U; Hess, JR; Holcomb, JB; Macaitis, JM; Martinowitz, U; Onaca, N; Pusateri, AE; Stein, M | 1 |
Chang, SK; Chung, SI; Kim, YM; Lee, IH; Lee, SY | 1 |
Ichikawa, M; Inaba, Y; Inoue, A; Itoh, M; Koh, C; Komiyama, A; Kyogashima, M; Nakamura, S; Sekiguchi, Y | 1 |
Green, FR | 1 |
Gulledge, AA; Lord, ST; Rezaee, F; Verheijen, JH | 1 |
Entenza, JM; François, P; Haefliger, JA; Moreillon, P; Que, YA; Vaudaux, P | 1 |
Andrade-Gordon, P; Corcoran, T; Damiano, BP; de Garavilla, L; Giardino, E; Haertlein, BJ; Hoekstra, WJ; Kauffman, JA; Maryanoff, BE; Mitchell, JA | 1 |
Amorim, S; Arocha-Piñango, CL; Gil San Juan, AG; Guerrero, B; Müller, CA; Perales, J; Pinto, MA | 1 |
Chavakis, T; Colman, RW; Isordia-Salas, I; Kanse, SM; May, AE; Pixley, RA; Preissner, KT | 1 |
Carraway, MS; Ezban, M; Ghio, AJ; Idell, S; Miller, DL; Ortel, TL; Piantadosi, CA; Welty-Wolf, KE | 1 |
Alpard, SK; Deyo, DJ; Jayroe, JB; Murphy, JA; Savage, CM; Zwischenberger, JB | 1 |
Costello, R; Csako, G; Donahue, RE; Krizek, DM; Lozier, JN; Metzger, ME; Mondoro, TH; Morgan, RA; Rick, ME; Vostal, JG | 1 |
Smiley, ST; Szaba, FM | 1 |
Akerström, B; Falkenberg, C; Holmdahl, R; Larsson, A; Nordquist, N; Olofsson, P; Pettersson, U; Vingsbo-Lundberg, C | 1 |
Cachofeiro, V; Cediel, E; de Las Heras, N; Lahera, V; Oubiña, MP; Ruilope, LM; Sanz-Rosa, D; Vázquez-Pérez, S | 1 |
Desfaits, AC; Gevry, G; Raymond, J; Ribourtout, E; Salazkin, I; Sauvageau, E | 1 |
Gu, L; Guan, H; Ji, Y | 1 |
Chang, KC; Lee, DH; Pyo, MK; Yun-Choi, HS | 1 |
Chu, JC; Guo, RF; Huber-Lang, M; Laudes, IJ; Riedemann, N; Sarma, JV; Schmaier, AH; Sikranth, S; Ward, PA | 1 |
Amorena, B; Cucarella, C; Foster, TJ; Knecht, E; Lasa, I; Penadés, JR; Tormo, MA | 1 |
Ihara, H; Nagai, N; Suzuki, Y; Umemura, K; Urano, T; Zhao, BQ | 1 |
Bourdalle-Badie, C; Chatelan, M; Chevais, R; Erny, P; Neverre, G; Pontois, M | 1 |
Conrad, H; Neuhof, H; Roka, L; Schwahn, C; Wolf, H | 1 |
Hanson, SR; Harker, LA | 1 |
Graeff, H; Hafter, R; Rjosk, H; Stein, B; Stemberger, A; von Hugo, R | 1 |
Dormandy, JA; Reid, HL | 1 |
Fazio, TL; Linscheer, WG | 1 |
Abe, T; Kazama, M; Nakamura, K | 1 |
Graeff, H; Hafter, R; Ishikawa, A | 1 |
Chatpar, P; Horowitz, J; Te, A; Wilner, GD | 1 |
Beller, FK; Schmidt, EH | 1 |
Chowdhury, P; Moschos, CB | 1 |
Chiu, HM; Gent, M; Hirsh, J; Regoeczi, E; Yung, WL | 1 |
Daniel, TM; Mckee, PA; Pizzo, SV | 1 |
Haider, B; Moschos, CB; Oldewurtel, HA; Regan, TJ | 1 |
Guckian, JC | 1 |
Deysine, M; Sham, R; Silver, L | 1 |
Hoffmann, J; Markwardt, F; Nowak, G | 1 |
Eger, H; Fiehring, H; Reichelt, D; Reimann, G; Schilling, B; Sedlarik, K; Vollmar, F; Wilde, J | 1 |
Gurewich, V; Lipinski, B; Wetmore, R | 1 |
Beller, FK; Bröcker, W; Pfefferkorn, G; Schmidt, EH; Wagner, H | 1 |
Baxter, CR; Curreri, PW; Rayfield, DL; Vaught, M | 1 |
Corrigan, JJ; Kiernat, JF | 1 |
Burkhardt, K; Peitsch, W | 1 |
Coleman, RE; Harwig, JF; Harwig, SS; Sherman, LA; Welch, MJ | 1 |
Korsan-Bengtsen, K; Olsson, R; Wallerstedt, S | 1 |
Markwardt, F; Meerbach, W; Nowak, G; Rüdiger, KD | 1 |
Abitbol, MM; Gallo, GR; Ober, WB; Pirani, CL | 1 |
Hiraishi, S; Horie, S; Ishii, H; Kazama, M; Ohtani, H; Uchiyama, H | 1 |
Itani, T; Iwamoto, M; Marumoto, Y; Nawa, K; Ono, M; Sakano, K | 1 |
Kharin, GM; Litvinov, RI; Zinkevich, OD | 1 |
Cooley, BC; Dollinger, BM; Gould, JS; Mlsna, JS | 1 |
Hijikata-Okunomiya, A; Katsuura, Y; Okada, Y; Okamoto, S; Wanaka, K | 1 |
Agam, G; Livne, AA | 1 |
Ashton, RC; Lemole, GM; Libutti, SK; Lontz, JF; Nowygrod, R; Oz, MC | 1 |
Roszkowska-Jakimiec, W; Skrzydlewska, E; Worowski, K | 1 |
January, BE; Parker, RF; Toth, LA | 1 |
Craft, TJ; Frank, JD; Jackson, CV; Smith, GF; Sundboom, JL | 1 |
Blick, K; Catlett, R; Chang, A; Esmon, CT; Ferrell, G; Mather, T; Taylor, F | 1 |
Benedict, CR; Gerlach, M; Ramos, R; Ryan, J; Stern, D; Tijburg, P; Wolitzky, B | 1 |
Cheng, A; Esmon, CT; Greenfield, LJ; Sarpa, MS; Taylor, FB; Wakefield, TW; Wrobleski, SK | 1 |
Kawakami, K; Takahashi, A; Yoshimoto, T | 1 |
Follenfant, MJ; Ford, AJ; Hughes, B; Longridge, DJ; Maxwell, MP | 1 |
Hedner, U; Ljundberg, J; Lund-Hansen, T | 1 |
Glagov, S; Kadowaki, MH; Singh, TM; Zarins, CK | 1 |
Atkinson, T; Electricwala, A; Emeis, JJ | 1 |
Dinges, HP; Redl, H; Schiesser, A; Schlag, G; Thurnher, M | 1 |
McCaffrey, TV; Nishihira, S | 1 |
Casavilla, A; Garaycoechea, M; Garcia, H; Gil, O; Hojman, D; Shenk, C; Torino, F | 1 |
Miller, CW; Tu, AT; Willis, TW | 1 |
Blake, KC; de Chalain, TM; Hickman, R; Jones, GE; Michell, WL; Purves, LR; Terblanche, J | 1 |
Higashiyama, M; Kambayashi, J; Mori, T; Sakon, M; Tanaka, T; Tsujinaka, T | 1 |
Bowie, EJ; Daniels, TM; Fass, DN; White, JG | 1 |
Sonoki, H; Sugimoto, T; Tomaru, T; Uchida, Y | 1 |
Bautovich, GJ; Boniface, GR; Bundesen, PG; Khafagi, F; Rylatt, DB; Walker, KZ | 1 |
Andrew, M; Brooker, L; Buchanan, MR; Hirsh, J; Ofosu, F; Schmidt, B | 1 |
Pruett, TL; Rotstein, OD; Simmons, RL; Wells, CL | 1 |
Bell, TG; Emerson, TE; Hassouna, HI; Hauptman, JG; Penner, JA | 1 |
Albrecht, RM; Cooper, SL; Lambrecht, LK; Mosher, DF; Park, K; Stafford, RE; Young, BR | 1 |
Blocker, SH; Crouch, EC; Goldman, CD; Ternberg, JL | 1 |
Griffith, MJ; Marbet, GA | 1 |
Smith, EB | 1 |
Damas, J; Remacle-Volon, G | 1 |
Dormandy, JA; Flute, PT; Hynd, JW; Mahir, MS | 1 |
Boks, AL; Bruinvels, J; de Groot, GH; Jeekel, H; Reuvers, CB; Schalm, SW; ten Kate, FW; Terpstra, OT | 1 |
Malchesky, PS; Nose, Y; Okabe, K; Sakamoto, H; Smith, JW; Takaoka, T; Tuthill, RJ; Usami, M | 1 |
Bäckstrand, B; Jansson, I; Lennquist, S; Rammer, L | 1 |
Edwards, JD; LeBlanc, MH | 1 |
Hotta, T; Kondo, M; Sugino, S; Yoshida, N; Yoshikawa, T | 1 |
Browse, NL; Leach, RD | 1 |
Beideman, R; Blazek, EM; Carlson, RP; Datko, LJ; DeLustro, F; Lewis, AJ; O'Neill-Davis, L | 1 |
Boneu, B; Buchanan, MR; Cade, JF; Fernandez, FF; Hirsh, J; Ofosu, FA; Van Ryn, J | 1 |
Ashbaugh, DG; King, EG; Nakane, PK | 1 |
Wardle, EN | 2 |
Ado, VA; Goriachkina, LA; Podkolzin, AA | 1 |
Harker, LA; Ross, R; Scott, CR; Slichter, SJ | 1 |
Lipiński, B | 1 |
Illig, L; Pannen, F; Winckelmann, G | 1 |
Braselmann, H; Keim, U; Kreher, C; Kunz, J; Nitschkoff, S | 1 |
Back, N; Lassman, HB; Wilkens, HJ | 1 |
Banerjee, RN; Bardhan, J; Rao, S | 1 |
Bellusci, R; Cavallari, A; Faenza, A; Mazziotti, A; Piccinni, L; Ussia, G | 1 |
Brunswig, D; Grün, M; Grün, W; Liehr, H; Rasenack, U | 1 |
Kirby, RE; Lassman, HB; Novick, WJ | 1 |
Dietrich, M; Hoelzer, D; Keller, A; Rasche, H | 1 |
Howard, RJ; Najarian, JS; Sutherland, DE | 1 |
Collen, D; Vermylen, J; Verstraete, M | 1 |
Glover, D; Labadie, EL | 1 |
Barr, CF; Conrad, ME; O'Leary, DS; Wellde, BT | 1 |
Bonanomi, L; Frigeni, V | 1 |
Link, RP; Pedersoli, WM; Safanie, AH | 1 |
Harrold, AJ | 1 |
Rakower, SR; Worth, MH | 1 |
Bowie, EJ; Cooper, HA; Owen, CA | 1 |
Busch, C; Rammer, L | 1 |
Feinstein, DI; Rapaport, SI; Shen, SM | 2 |
Hamlet, ME; Mackie, MJ; Simpson, JG; Stalker, AL | 1 |
Apfelbaum, RI; Guthkelch, AN; Shulman, K | 1 |
Holtkamp, DE; MacKenzie, RD; Petrow, V; Thompson, RJ | 1 |
Bergentz, SE; Ljungqvist, U; Olson, PS | 1 |
Abiko, Y; Ogawa, H; Tomikawa, M | 1 |
Antonovych, TT; Carter, CB; Fortner, RW; Grove, RB; King, LH; Knepshield, JH; Knieser, MR; Nowakowski, A | 1 |
Broersma, RJ; Bullemer, GD; Mammen, EF | 1 |
Areekul, S; Chongsuphajaisiddhi, T; Devakul, K; Kanakakorn, K; Kasemsuth, R; Vivatanasesth, P | 1 |
Kitzmiller, JL; Lucas, WE | 1 |
Miller, SP; Soong, BC | 1 |
Cheng, HF; Fry, GL; Hankenson, RR; Hoak, JC; Warner, ED | 1 |
Carpenter, CB; Galvanek, EG; Rodriguez-Erdmann, F | 1 |
Engstrom, RM; Schneider, CL | 1 |
El'gort, PE; Orlova, NP | 1 |
Merrill, EW; Replogle, RL | 1 |
Ashbaugh, DG; Genton, E; King, EG; Weily, HS | 1 |
Jaques, R; Majer, H; Riesterer, L; Rüegg, M | 1 |
22 review(s) available for fibrinogen and Disease Models, Animal
Article | Year |
---|---|
Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy-Either, Neither, or Both.
Topics: Animals; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Models, Animal; Disseminated Intravascular Coagulation; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Mice; Pandemics; Pneumonia, Viral; Prothrombin Time; SARS-CoV-2; Thrombocytopenia; Thrombophilia; Thrombotic Microangiopathies | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Clinical Consequences and Molecular Bases of Low Fibrinogen Levels.
Topics: Afibrinogenemia; Animals; Disease Models, Animal; Fibrinogen; Humans; Phenotype | 2018 |
The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues.
Topics: Animals; Anticoagulants; Antithrombin III; Cell-Derived Microparticles; Disease Models, Animal; Extracellular Traps; Factor VIII; Factor Xa Inhibitors; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Glucuronidase; Heparin; Humans; Leukocytes; Membrane Glycoproteins; Mice; Molecular Targeted Therapy; Pancreatic Neoplasms; Protein C; Thrombophilia; Thromboplastin; Thrombosis | 2019 |
[Amyloid polyneuropathies--biochemical and genetic aspects].
Topics: Amyloid; Amyloid Neuropathies, Familial; Animals; Apolipoprotein A-I; beta 2-Microglobulin; Disease Models, Animal; Fibrinogen; Gelsolin; Genes, Dominant; Genetic Heterogeneity; Humans; Liver Transplantation; Mice; Mice, Transgenic; Mutation; Prealbumin; Protein Conformation; Retinol-Binding Proteins, Plasma; Structure-Activity Relationship | 2012 |
Genetic sequence analysis of inherited bleeding diseases.
Topics: Animals; Blood Coagulation Factors; Chromosomes, Human, X; Disease Models, Animal; DNA; DNA Mutational Analysis; Factor IX; Factor VIII; Female; Fibrinogen; Genes, X-Linked; Hemophilia A; Hemophilia B; Hemorrhagic Disorders; Humans; Integrins; Male; Mice; Mice, Knockout; Platelet Activation; Sequence Analysis, DNA; von Willebrand Factor | 2013 |
Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association?
Topics: Acute Disease; Animals; Chronic Disease; Disease Models, Animal; Fibrin; Fibrinogen; Humans; Liver Diseases; Mice | 2016 |
Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding.
Topics: Animals; Biopsy; Blood Coagulation; Disease Models, Animal; Fibrinogen; Fibrinolysis; Humans; Hypertension, Pulmonary; Inflammation; Pulmonary Artery; Pulmonary Embolism; Risk Factors; Thromboembolism | 2013 |
[From fibrinogen to fibrin and its dissolution].
Topics: Animals; Arteriosclerosis; Carboxypeptidase B2; Cell Movement; Diabetes Mellitus; Disease Models, Animal; Endothelial Cells; Factor XIII; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Insulin Resistance; Metalloproteases; Mice; Mice, Transgenic; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombin; Thrombosis; Wound Healing | 2003 |
Fibrinogen--marker or mediator of vascular disease?
Topics: Animals; Arteriosclerosis; Biomarkers; Blood Coagulation; Disease Models, Animal; Fibrinogen; Humans | 2003 |
A guide to murine coagulation factor structure, function, assays, and genetic alterations.
Topics: Animals; Blood Coagulation; Disease Models, Animal; Fibrinogen; Hemostasis; Humans; Mice; Models, Biological; Models, Genetic; Partial Thromboplastin Time; Prothrombin Time; Thrombosis | 2007 |
A guide to murine fibrinolytic factor structure, function, assays, and genetic alterations.
Topics: Animals; Disease Models, Animal; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemostasis; Humans; Kinetics; Mice; Models, Biological; Models, Genetic; Plasminogen; Plasminogen Activators; Species Specificity | 2007 |
Von Willebrand's disease.
Topics: Animals; Antigens; Bleeding Time; Blood Platelets; Blood Transfusion; Cattle; Chemical Phenomena; Chemistry, Physical; Deamino Arginine Vasopressin; Disease Models, Animal; Endothelium; Factor VIII; Fibrinogen; Glycoproteins; Humans; Megakaryocytes; Platelet Adhesiveness; Rabbits; Swine; von Willebrand Diseases; von Willebrand Factor | 1982 |
The contribution of thrombosis to the clinical expression of coronary atherosclerosis.
Topics: Animals; Blood Coagulation Factors; Circadian Rhythm; Coronary Artery Disease; Disease Models, Animal; Endopeptidases; Endothelium, Vascular; Fibrinogen; History, 19th Century; History, 20th Century; Humans; Myocardial Infarction; Myocardial Ischemia; Thrombosis | 1996 |
Dietary factors in thrombosis and hemostasis: summary and conclusions.
Topics: Animals; Cardiovascular Diseases; Cholesterol; Diet; Dietary Fats; Disease Models, Animal; Fibrinogen; Hemostasis; Humans; Incidence; Lipids; Platelet Activation; Thrombosis | 1997 |
Novel platelet products, substitutes and alternatives.
Topics: Animals; Blood Platelets; Blood Preservation; Blood Substitutes; Cell Membrane; Clinical Trials as Topic; Cryopreservation; Disease Models, Animal; Dogs; Erythrocytes; Factor VIIa; Factor X; Fibrinogen; Freeze Drying; Furocoumarins; Hemorrhage; Hemostatic Techniques; Histocompatibility; Humans; Ligands; Liposomes; Microspheres; Oligopeptides; Photochemistry; Platelet Transfusion; Ultraviolet Rays | 2001 |
Controlled defibrination in the treatment of peripheral vascular disease.
Topics: Ancrod; Animals; Arteriosclerosis; Blood Viscosity; Disease Models, Animal; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Intermittent Claudication; Thrombophlebitis; Vascular Diseases | 1978 |
[Metabolism of liver proteins in ethanol poisoning].
Topics: Acetaldehyde; Albumins; Alcoholic Intoxication; Animals; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Fibrinogen; Liver; Male; Protein Binding; Rats; Transferrin | 1992 |
Tissue thromboplastin induced reversible DIC and heparin-enhanced inhibitors in dogs.
Topics: Animals; Antithrombin III; Disease Models, Animal; Disseminated Intravascular Coagulation; Dogs; Female; Fibrinogen; Glycoproteins; Glycosaminoglycans; Heparin; Heparin Cofactor II; Male; Thrombin; Thromboplastin | 1986 |
Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis.
Topics: Animals; Arteriosclerosis; Coronary Disease; Disease Models, Animal; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Lipoproteins, LDL; Muscle, Smooth, Vascular; Risk; Thrombosis | 1986 |
Intravascular coagulation in liver disease.
Topics: Animals; Blood Coagulation Factors; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Disseminated Intravascular Coagulation; Ethanol; Fibrinogen; Half-Life; Hemostasis; Humans; Ligation; Liver; Liver Cirrhosis; Liver Diseases; Plasminogen; Portal Vein; Prothrombin | 1974 |
Chronic subdural hematoma: concepts of physiopathogenesis. A review.
Topics: Animals; Blood Proteins; Disease Models, Animal; Fibrin; Fibrinogen; Hematoma, Subdural; In Vitro Techniques; Male; Osmolar Concentration; Osmotic Pressure | 1974 |
1 trial(s) available for fibrinogen and Disease Models, Animal
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
553 other study(ies) available for fibrinogen and Disease Models, Animal
Article | Year |
---|---|
Thermosensitive collagen/fibrinogen gels loaded with decorin suppress lesion site cavitation and promote functional recovery after spinal cord injury.
Topics: Action Potentials; Animals; Biomarkers; Cattle; Cell Survival; Collagen; Decorin; Disease Models, Animal; Extracellular Matrix; Fibrinogen; Ganglia, Spinal; Hydrogels; Matrix Metalloproteinases; Nerve Regeneration; Neuronal Outgrowth; Neurons; Recovery of Function; Regenerative Medicine; Spinal Cord Injuries; Wound Healing | 2021 |
Engineered Small Extracellular Vesicles as a FGL1/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection.
Topics: Animals; B7-H1 Antigen; Disease Models, Animal; Extracellular Vesicles; Fibrinogen; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Mesenchymal Stem Cells; Mice; Transplant Recipients | 2022 |
Suppression of fibrin(ogen)-driven pathologies in disease models through controlled knockdown by lipid nanoparticle delivery of siRNA.
Topics: Afibrinogenemia; Animals; Blood Platelets; Disease Models, Animal; Female; Fibrin; Fibrinogen; Gene Knockdown Techniques; Humans; Liposomes; Male; Mice; Nanoparticles; RNA, Small Interfering | 2022 |
Exacerbation of Thrombotic Responses to Silver Nanoparticles in Hypertensive Mouse Model.
Topics: Angiotensin II; Animals; Disease Models, Animal; Female; Fibrinogen; Hypertension; Male; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Oxidative Stress; Partial Thromboplastin Time; Platelet Aggregation; Polyethylene Glycols; Prothrombin Time; Silver; von Willebrand Factor | 2022 |
[Effects of the ITGA2B Nonsense Mutation (c.2659C > T, p.Q887X) on Platelet Function in a Mouse Model of Glanzmann's Thrombasthenia Generated with CRISPR/Cas9 Technology].
Topics: Animals; Codon, Nonsense; CRISPR-Cas Systems; Disease Models, Animal; Fibrinogen; Humans; Integrin alpha2; Mice; Oligonucleotides; Platelet Glycoprotein GPIIb-IIIa Complex; RNA, Guide, Kinetoplastida; Thrombasthenia; Thrombin | 2022 |
Engineered colorectal cancer tissue recapitulates key attributes of a patient-derived xenograft tumor line.
Topics: Animals; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; Fibrinogen; Heterografts; Humans; Mice; Tissue Engineering; Xenograft Model Antitumor Assays | 2022 |
FGL2-MCOLN3-Autophagy Axis-Triggered Neutrophil Extracellular Traps Exacerbate Liver Injury in Fulminant Viral Hepatitis.
Topics: Acetaminophen; Animals; Autophagy; Calcium; Deoxyribonucleases; Disease Models, Animal; Extracellular Traps; Fibrin; Fibrinogen; Hepatitis, Viral, Animal; Hepatitis, Viral, Human; Inflammation; Mice; Mice, Inbred BALB C; Murine hepatitis virus | 2022 |
Nebulized Non-Immunogenic Staphylokinase in the Mice Acute Lung Injury Model.
Topics: Acute Lung Injury; Animals; COVID-19; Disease Models, Animal; Fibrin; Fibrinogen; Lipopolysaccharides; Lung; Metalloendopeptidases; Mice; Rats; Respiratory Distress Syndrome | 2022 |
Factor VII activating protease (FSAP) inhibits the outcome of ischemic stroke in mouse models.
Topics: Animals; Coagulants; Disease Models, Animal; Factor VII; Fibrinogen; Fibrinolytic Agents; Histones; Ischemic Stroke; Mice; Peptide Hydrolases; Receptors, Proteinase-Activated; Serine Endopeptidases; Stroke; Tissue Plasminogen Activator | 2022 |
The distinctive role of membrane fibrinogen-like protein 2 in the liver stage of rodent malaria infections.
Topics: Animals; Disease Models, Animal; Endothelial Cells; Fibrinogen; Liver; Malaria; Mice; Rodentia | 2023 |
Study on the Mechanism of Allergic Rhinitis Based on the Expression of FIB, PCT, hs-CRP, and Th17/Treg-IL10/IL-17 Axis Balance.
Topics: Animals; C-Reactive Protein; Disease Models, Animal; Female; Fibrinogen; Hemostatics; Immunoglobulin E; Interleukin-10; Interleukin-17; Mice; Mice, Inbred BALB C; Nasal Mucosa; Ovalbumin; Procalcitonin; Pruritus; Rats; Rats, Sprague-Dawley; Rhinitis, Allergic; Sneezing; T-Lymphocytes, Regulatory; Th17 Cells | 2023 |
Fibrinogen Inhibits Metalloproteinase-9 Activation and Syndecan-1 Cleavage to Protect Lung Function in ApoE Null Mice After Hemorrhagic Shock.
Topics: Animals; Apolipoproteins E; Disease Models, Animal; Fibrinogen; Hemorrhage; Hemostatics; Lung; Lung Injury; Matrix Metalloproteinase 9; Mice; Resuscitation; Shock, Hemorrhagic; Syndecan-1 | 2023 |
Slow Intravenous Infusion of a Novel Damage Control Cocktail Decreases Blood Loss in a Pig Polytrauma Model.
Topics: Animals; Disease Models, Animal; Fibrinogen; Fluid Therapy; Hemodynamics; Hemorrhage; Hemostatics; Hydroxyethyl Starch Derivatives; Infusions, Intravenous; Isotonic Solutions; Lactates; Multiple Trauma; Resuscitation; Shock, Hemorrhagic; Swine; Vasopressins | 2023 |
Protective Effects of Rivaroxaban on White Matter Integrity and Remyelination in a Mouse Model of Alzheimer's Disease Combined with Cerebral Hypoperfusion.
Topics: Alzheimer Disease; Animals; Brain Ischemia; Disease Models, Animal; Fibrinogen; Humans; Mice; Remyelination; Rivaroxaban; White Matter | 2023 |
Soluble fibrinogen-like protein 2 promotes the growth of hepatocellular carcinoma via attenuating dendritic cell-mediated cytotoxic T cell activity.
Topics: Animals; Antibodies, Monoclonal; Biomarkers; Carcinoma, Hepatocellular; Cell Line, Tumor; Cytokines; Cytotoxicity, Immunologic; Dendritic Cells; Disease Models, Animal; Female; Fibrinogen; Heterografts; Humans; Immunophenotyping; Liver Neoplasms; Mice; Mice, Knockout; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; T-Lymphocytes, Cytotoxic | 2019 |
Identification of Fibrinogen as a Key Anti-Apoptotic Factor in Human Fresh Frozen Plasma for Protecting Endothelial Cells In Vitro.
Topics: Animals; Apoptosis; Case-Control Studies; Cell Culture Techniques; Cytoprotection; Disease Models, Animal; Endothelial Cells; Fibrinogen; Humans; Plasma; Rats; Shock; Wounds and Injuries | 2020 |
Study on the Effect of Ginsenosides Rb on Blood of Tumor Mice.
Topics: Anemia; Animals; Blood; Blood Platelets; Cell Line, Tumor; Disease Models, Animal; Erythrocytes; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Ginsenosides; Hemoglobins; Hemostatics; Mice; Neoplasms; Panax; Plant Leaves; Thrombosis | 2019 |
The FGL2 prothrombinase contributes to the pathological process of experimental pulmonary hypertension.
Topics: Aged; Animals; Apoptosis; Disease Models, Animal; Down-Regulation; Endothelial Cells; Endothelium, Vascular; Fibrin; Fibrinogen; Humans; Hypertension, Pulmonary; Male; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Rats; Rats, Sprague-Dawley; Signal Transduction; Thromboplastin; Up-Regulation | 2019 |
A critical role for microglia in maintaining vascular integrity in the hypoxic spinal cord.
Topics: Animals; Antigens, Surface; Astrocytes; Central Nervous System; Disease Models, Animal; Endothelium; Female; Fibrinogen; Gray Matter; Hypoxia; Ischemia; Male; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Neuroglia; Organic Chemicals; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Spinal Cord; White Matter | 2019 |
Identification of Key Determinants of Staphylococcus aureus Vaginal Colonization.
Topics: Adhesins, Bacterial; Animals; Disease Models, Animal; Female; Fibrinogen; Gene Expression Profiling; Host Microbial Interactions; Iron; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mutation; Neutrophils; Sequence Analysis, RNA; Vagina; Virulence Factors | 2019 |
Orthopedic Surgery Triggers Attention Deficits in a Delirium-Like Mouse Model.
Topics: Animals; Attention; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cognitive Dysfunction; Delirium; Disease Models, Animal; Encephalitis; Fibrinogen; Hippocampus; Immunoglobulin G; Lysosomal Membrane Proteins; Male; Mice, Inbred C57BL; Orthopedic Procedures; Reaction Time; Tibial Fractures | 2019 |
Practical considerations in the use of a porcine model (Sus scrofa domesticus) to assess prevention of postoperative peritubal adhesions.
Topics: Animals; Bilirubin; Biomarkers; C-Reactive Protein; Disease Models, Animal; Fallopian Tubes; Female; Fibrinogen; Laparoscopy; Ovary; Postoperative Complications; Serum Albumin; Severity of Illness Index; Swine; Tissue Adhesions | 2020 |
Quantitative proteomic analysis of aqueous humor after rabbit lensectomy reveals differences in coagulation and immunomodulatory proteins.
Topics: Animals; Aqueous Humor; Disease Models, Animal; Eye Proteins; Fibrinogen; Inflammation; Lens Implantation, Intraocular; Lens, Crystalline; Male; Proteomics; Rabbits; Retinol-Binding Proteins; Sutures; Transforming Growth Factor beta2; Up-Regulation | 2020 |
Analysis of L-arginine:glycine amidinotransferase-, creatine- and homoarginine-dependent gene regulation in the murine heart.
Topics: Amidinotransferases; Animals; Arginine; Connective Tissue Growth Factor; Creatine; Desmocollins; Disease Models, Animal; Energy Metabolism; Fibrinogen; Gene Expression Regulation; Genetic Association Studies; Homoarginine; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Mice, Transgenic; Myocardial Infarction; Myocardium; Potassium Channels; Transcriptome | 2020 |
ECM Characterization Reveals a Massive Activation of Acute Phase Response during FSGS.
Topics: Animals; Complement System Proteins; Disease Models, Animal; Extracellular Matrix; Fibrinogen; Gene Expression Regulation; Glomerulosclerosis, Focal Segmental; Mice; Mice, Inbred BALB C; Mice, Transgenic; MicroRNAs; Protease Inhibitors | 2020 |
Reconstruction of abdominal wall with scaffolds of electrospun poly (l-lactide-co caprolactone) and porcine fibrinogen: An experimental study in the canine.
Topics: Abdominal Wall; Animals; Cell Death; Cell Proliferation; Collagen; Disease Models, Animal; Dogs; Endothelial Cells; Female; Fibrinogen; Implants, Experimental; Male; Muscle Fibers, Skeletal; Myoblasts; Plastic Surgery Procedures; Polylactic Acid-Polyglycolic Acid Copolymer; Polypropylenes; Porosity; Swine; Tissue Engineering; Tissue Scaffolds | 2020 |
Efficacy of resuscitation with fibrinogen concentrate and platelets in traumatic hemorrhage swine model.
Topics: Albumins; Animals; Blood Component Removal; Blood Platelets; Cardiac Output; Disease Models, Animal; Fibrinogen; Hemodynamics; Hemorrhage; Platelet Count; Resuscitation; Swine | 2020 |
Focal adhesion kinase and Src mediate microvascular hyperpermeability caused by fibrinogen- γC- terminal fragments.
Topics: Animals; Capillary Permeability; Cell Line; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Fibrinogen; Focal Adhesion Kinase 1; Hemorrhage; Humans; Intravital Microscopy; Lung; Male; Mesentery; Microvessels; Phosphorylation; Rats; rho GTP-Binding Proteins; RNA, Small Interfering; Signal Transduction; src-Family Kinases | 2020 |
Toll-Like Receptor 3 Activator Preconditioning Enhances Modulatory Function of Adipose‑Derived Mesenchymal Stem Cells in a Fully MHC-Mismatched Murine Model of Heterotopic Heart Transplantation.
Topics: Animals; Cell Culture Techniques; Disease Models, Animal; Fibrinogen; Graft Rejection; Heart Transplantation; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Toll-Like Receptor 3; Toll-Like Receptor 4 | 2020 |
Verification of a thrombus induction method at the target point inside the blood pump using a fibrinogen coating for a thrombus detection study.
Topics: Animals; Blood Coagulation; Disease Models, Animal; Equipment Design; Fibrinogen; Heart-Assist Devices; Heparin; Heparin Antagonists; Humans; Magnetics; Protamines; Reproducibility of Results; Swine; Thrombosis | 2020 |
Liver gene regulation of hemostasis-related factors is altered by experimental snake envenomation in mice.
Topics: Animals; Antivenins; Blood Coagulation Disorders; Blood Proteins; Bothrops; Disease Models, Animal; Fibrinogen; Gene Expression Regulation; Haptoglobins; Hemorrhage; Hemostasis; Hemostatics; Liver; Male; Mice; RNA, Messenger; Snake Bites; STAT3 Transcription Factor; Thrombocytopenia; Time Factors; Transcription Factors | 2020 |
Exploration in the mechanism of rhubarb for the treatment of hyperviscosity syndrome based on network pharmacology.
Topics: Animals; Aspirin; Blood Platelets; Blood Viscosity; Disease Models, Animal; Fibrinogen; Hematologic Diseases; Male; Plant Extracts; Platelet Aggregation; Platelet Aggregation Inhibitors; Prothrombin; Rats, Sprague-Dawley; Rheum; Signal Transduction; Syndrome; Systems Biology | 2020 |
Bone Microthrombus Promotes Bone Loss in Iron Accumulation Rats.
Topics: Animals; Blood Coagulation; Bone Density; Bone Resorption; Disease Models, Animal; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Iron; Rats; Thrombosis | 2020 |
Controllable gelation of artificial extracellular matrix for altering mass transport and improving cancer therapies.
Topics: Animals; Biological Transport; Biomimetic Materials; Cell Line, Tumor; Cell Proliferation; Chemoradiotherapy; Disease Models, Animal; Extracellular Matrix; Female; Fibrinogen; Gels; Humans; Injections, Intravenous; Metabolomics; Mice; Neoplasms; Thrombin; Ultrasonic Therapy; Ultrasonic Waves | 2020 |
Fibrinogen/AKT/Microfilament Axis Promotes Colitis by Enhancing Vascular Permeability.
Topics: Actin Cytoskeleton; Animals; Biopsy; Capillary Permeability; Case-Control Studies; Cell Line; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Fibrinogen; Healthy Volunteers; Humans; Intestinal Mucosa; Male; Mice; Oligopeptides; Proto-Oncogene Proteins c-akt; Signal Transduction | 2021 |
Vascular surveillance by haptotactic blood platelets in inflammation and infection.
Topics: Actin-Related Protein 2-3 Complex; Adult; Animals; Blood Platelets; Blood Vessels; Cell Movement; Cellular Microenvironment; Chemotaxis; Disease Models, Animal; Fibrinogen; Humans; Inflammation; Lipopolysaccharides; Lung Injury; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred C57BL; Microvessels; Pneumonia; Pseudopodia | 2020 |
Chemical Modulators of Fibrinogen Production and Their Impact on Venous Thrombosis.
Topics: Animals; Animals, Genetically Modified; Anthralin; Blood Coagulation; Disease Models, Animal; Fibrinogen; Fibrinolytic Agents; Hep G2 Cells; Hepatocytes; Humans; Integrin alpha2; Morpholinos; Mutation; Oligonucleotides, Antisense; Proteomics; Small Molecule Libraries; Tretinoin; Venous Thrombosis; Zebrafish; Zebrafish Proteins | 2021 |
Evaluation of real-time thrombus detection method in a magnetically levitated centrifugal blood pump using a porcine left ventricular assist circulation model.
Topics: Animals; Centrifugation; Disease Models, Animal; Equipment Design; Fibrinogen; Heart-Assist Devices; Magnetics; Swine; Thrombosis | 2021 |
Venous Thrombosis and Thrombocyte Activity in Zebrafish Models of Quantitative and Qualitative Fibrinogen Disorders.
Topics: Animals; Base Sequence; Biomarkers; Blood Coagulation; Blood Platelets; Disease Models, Animal; Exons; Fibrinogen; Gene Editing; Gene Expression; Plasmids; Platelet Activation; RNA, Guide, Kinetoplastida; Sequence Deletion; Venous Thrombosis; Zebrafish | 2021 |
Waning efficacy in a long-term AAV-mediated gene therapy study in the murine model of Krabbe disease.
Topics: Animals; Animals, Newborn; Cells, Cultured; Dependovirus; Disease Models, Animal; Female; Fibrinogen; Galactosylceramidase; Genetic Therapy; Genetic Vectors; Leukodystrophy, Globoid Cell; Male; Mice; Recurrence; White Matter | 2021 |
Fibrinogen inhibits microRNA-19b, a novel mechanism for repair of haemorrhagic shock-induced endothelial cell dysfunction.
Topics: Animals; Disease Models, Animal; Endothelial Cells; Fibrinogen; Hemostatics; Humans; Isotonic Solutions; Mice; Mice, Inbred C57BL; MicroRNAs; Resuscitation; Shock, Hemorrhagic | 2021 |
Blood Coagulation Factor Fibrinogen in Tumor Pathogenesis of Central Nervous System B-Cell Lymphoma.
Topics: Animals; Biological Transport; Cell Adhesion; Central Nervous System Neoplasms; Disease Models, Animal; Fibrinogen; Humans; Inflammation; Lymphocytes; Lymphoma, B-Cell; Male; Mice; Mice, Nude | 2021 |
Attempt to Develop Rat Disseminated Intravascular Coagulation Model Using Yamakagashi (
Topics: Animals; Biomarkers; Blood Coagulation; Colubridae; Disease Models, Animal; Disease Progression; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematuria; Male; Rats, Sprague-Dawley; Snake Bites; Snake Venoms; Thrombocytopenia; Time Factors | 2021 |
Citrullinated Fibrinogen Renders Clots Mechanically Less Stable, but Lysis-Resistant.
Topics: Animals; Citrullination; Disease Models, Animal; Fibrinogen; Fibrinolysis; Humans; Male; Mice, Inbred C57BL; Microscopy, Atomic Force; Thrombelastography; Venous Thrombosis | 2021 |
Elimination of fibrin γ-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi.
Topics: Animals; Blood Coagulation; Blood Platelets; Cross-Linking Reagents; Disease Models, Animal; Factor XIIIa; Fibrinogen; Mice, Inbred C57BL; Optical Imaging; Pulmonary Embolism; Vena Cava, Inferior; Venous Thrombosis | 2021 |
Accelerated accumulation of fibrinogen peptide chains with Aβ deposition in Alzheimer's disease (AD) mice and human AD brains.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Fibrinogen; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurodegenerative Diseases; Neurons; Peptides | 2021 |
Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Brain; Dendritic Spines; Disease Models, Animal; Fibrinogen; Fluorescent Dyes; Mice; Microglia; Microscopy; Photons | 2021 |
The Role of
Topics: Allium; Animals; Antioxidants; Dermatitis; Disease Models, Animal; Fibrinogen; Flavonoids; Granulation Tissue; Inflammation; Male; Oxidative Stress; Phenols; Plant Extracts; Plant Oils; Rats, Wistar; Wound Healing | 2021 |
Drug-induced Defibrinogenation as New Treatment Approach of Acute Hearing Loss in an Animal Model for Inner Ear Vascular Impairment.
Topics: Ancrod; Animals; Audiometry, Evoked Response; Auditory Threshold; Cochlea; Disease Models, Animal; Fibrinogen; Fibrinolytic Agents; Guinea Pigs; Hearing Loss, Sensorineural; Male; Microcirculation | 2017 |
The Hepatic Protection Effects of Hepassocin in Hyperglycemic Crisis.
Topics: Adult; Analysis of Variance; Animals; Blotting, Western; Cells, Cultured; Disease Models, Animal; Fibrinogen; Hep G2 Cells; Humans; Hyperglycemia; Hypoglycemic Agents; Liver Failure; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Middle Aged; Neoplasm Proteins; Random Allocation; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; RNA, Small Interfering; Sampling Studies; Streptozocin; Transfection | 2017 |
Fibrinogen links podocyte injury with Toll-like receptor 4 and is associated with disease activity in FSGS patients.
Topics: Actin Cytoskeleton; Adolescent; Adult; Albuminuria; Animals; Apoptosis; Cell Line; Disease Models, Animal; Doxorubicin; Female; Fibrinogen; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Male; Mice, Inbred BALB C; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Podocytes; Prednisone; Remission Induction; RNA Interference; Signal Transduction; Toll-Like Receptor 4; Transcription Factor RelA; Transfection; Treatment Outcome; Young Adult | 2018 |
Prophylactic and therapeutic effect of Punica granatum in trinitrobenzene sulfonic acid induced inflammation in rats.
Topics: Alkaline Phosphatase; Animals; Anti-Inflammatory Agents; Biomarkers; Carrier Proteins; Colitis; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinogen; Gastrointestinal Agents; Glutathione; Inflammation Mediators; Lythraceae; Male; Peroxidase; Phytotherapy; Plant Extracts; Plants, Medicinal; Rats, Wistar; Trinitrobenzenesulfonic Acid | 2017 |
High-fat diet-induced plasma protein and liver changes in obese rats can be attenuated by melatonin supplementation.
Topics: alpha 1-Antitrypsin; Animals; Biomarkers; Blood Glucose; Blood Proteins; Body Weight; Complement C4; Complement Factor B; Diet, High-Fat; Diet, High-Protein; Dietary Carbohydrates; Disease Models, Animal; Fatty Liver; Fibrinogen; Inflammation; Insulin; Liver; Liver Cirrhosis; Male; Mannose-Binding Lectin; Melatonin; Obesity; Plasminogen; Proteomics; Rats; Rats, Wistar | 2017 |
Three- versus four-factor prothrombin complex concentrates for "factor-based" resuscitation in a porcine hemorrhagic shock model.
Topics: Animals; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Component Transfusion; Blood Platelets; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinogen; Hydrogen-Ion Concentration; Plasma; Resuscitation; Shock, Hemorrhagic; Swine | 2017 |
Elevated fibrinogen‑like protein 2 in TNBS‑induced colitis mice: Association with Th17 and regulatory T cells.
Topics: Animals; Colitis; Colon; Cytokines; Disease Models, Animal; Fibrinogen; Gene Expression Regulation; Immunohistochemistry; Inflammation; Inflammation Mediators; Inflammatory Bowel Diseases; Male; Mice, Inbred BALB C; Spleen; T-Lymphocytes, Regulatory; Th17 Cells; Transcription Factors; Trinitrobenzenesulfonic Acid | 2017 |
Neutralization of IFN-γ reverts clinical and laboratory features in a mouse model of macrophage activation syndrome.
Topics: Alanine Transaminase; Animals; Antibodies, Neutralizing; Chemokine CXCL10; Chemokine CXCL9; Cytokines; Disease Models, Animal; Ferritins; Fibrinogen; Inflammation; Interferon-gamma; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation; Macrophage Activation Syndrome; Macrophages; Mice | 2018 |
Histopathological changes associated to an absorbable fibrin patch (Tachosil®) covering in an experimental model of high-risk colonic anastomoses.
Topics: Anastomosis, Surgical; Anastomotic Leak; Animals; Colon; Disease Models, Animal; Drug Combinations; Fibrinogen; Male; Random Allocation; Surgical Wound Dehiscence; Swine; Thrombin; Wound Healing | 2018 |
Fibrinogen-like protein-2 causes deterioration in cardiac function in experimental autoimmune myocarditis rats through regulation of programmed death-1 and inflammatory cytokines.
Topics: Animals; Autoimmune Diseases; Cytokines; Disease Models, Animal; Fibrinogen; Gene Expression Regulation; Myocarditis; Nuclear Receptor Subfamily 1, Group F, Member 3; Programmed Cell Death 1 Receptor; Rats; Rats, Inbred Lew | 2018 |
Fibrinogen cleavage products and Toll-like receptor 4 promote the generation of programmed cell death 1 ligand 2-positive dendritic cells in allergic asthma.
Topics: Allergens; Animals; Asthma; Cell Differentiation; Dendritic Cells; Disease Models, Animal; Fibrinogen; Humans; Hypersensitivity; Immunity, Innate; Interleukin-13; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Peptide Hydrolases; Programmed Cell Death 1 Ligand 2 Protein; Th2 Cells; Toll-Like Receptor 4 | 2018 |
A humanized monoclonal antibody that inhibits platelet-surface ERp72 reveals a role for ERp72 in thrombosis.
Topics: Animals; Antibodies, Monoclonal, Humanized; Blood Platelets; Calcium; Disease Models, Animal; Fibrinogen; Fibrinolytic Agents; Humans; Male; Membrane Glycoproteins; Mice, Inbred C57BL; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Disulfide-Isomerases; Signal Transduction; Thrombosis | 2018 |
Adenovirus-mediated artificial miRNA targetting fibrinogen-like protein 2 attenuates the severity of acute pancreatitis in mice.
Topics: Adenoviridae; Animals; Apoptosis; Caspase 3; Disease Models, Animal; Fibrinogen; Genetic Therapy; HEK293 Cells; Humans; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Pancreatitis; Taurocholic Acid; Tumor Necrosis Factor-alpha | 2017 |
Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types.
Topics: Animals; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; Citrullination; Citrulline; Disease Models, Animal; Fibrinogen; Haptens; Humans; Immunization; Major Histocompatibility Complex; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Protein-Arginine Deiminases; T-Lymphocytes | 2017 |
AK03, a new recombinant fibrinogenase prevents abdominal adhesions in a rat model without systemic side effects.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cyclooxygenase 2; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Fibrinogen; Male; Peritoneum; Random Allocation; Rats, Sprague-Dawley; Swine; Swine, Miniature; Tissue Adhesions; Vimentin | 2018 |
Matrix Metalloproteinase-9 Mediates the Deleterious Effects of α2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke.
Topics: alpha-2-Antiplasmin; Animals; Blood-Brain Barrier; Brain Ischemia; Capillary Permeability; Cerebral Hemorrhage; Disease Models, Animal; Female; Fibrinogen; Male; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Mice, Knockout; Random Allocation; Single-Blind Method; Stroke | 2018 |
Amino-Fucoidan as a Vector for rtPA-Induced Fibrinolysis in Experimental Thrombotic Events.
Topics: Amines; Animals; Carotid Arteries; Dipeptides; Disease Models, Animal; Fibrinogen; Fibrinolysis; Fucose; Glucose; Humans; Intravital Microscopy; Lysine; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred C57BL; Polysaccharides; Serum Albumin; Sulfates; Thrombelastography; Thrombosis; Tissue Plasminogen Activator; Venous Thrombosis | 2018 |
microRNA-219 Reduces Viral Load and Pathologic Changes in Theiler's Virus-Induced Demyelinating Disease.
Topics: Animals; Biomarkers; Cardiovirus Infections; Cell Line; Cholesterol; Cytokines; Demyelinating Diseases; Disease Models, Animal; Female; Fibrinogen; Gene Expression Regulation; Inflammation Mediators; Lipid Metabolism; Mice; Microglia; MicroRNAs; Rats; RNA Interference; Theilovirus; Viral Load | 2018 |
Control of Intestinal Inflammation, Colitis-Associated Tumorigenesis, and Macrophage Polarization by Fibrinogen-Like Protein 2.
Topics: Animals; Biomarkers; Bone Marrow Cells; Cell Transformation, Neoplastic; Colitis; Dextran Sulfate; Disease Models, Animal; Fibrinogen; Gene Expression; Humans; Intestinal Mucosa; Macrophage Activation; Macrophages; Mice; Mice, Knockout | 2018 |
Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function.
Topics: Adult; Animals; CD8-Positive T-Lymphocytes; Cytokines; Disease Models, Animal; Disease Progression; Female; Fibrinogen; Gene Expression; Hepatitis, Autoimmune; Humans; Immunomodulation; Liver Function Tests; Lymphocyte Count; Male; Mice; Middle Aged; T-Lymphocytes, Regulatory | 2018 |
Elimination of intravascular thrombi prevents early mortality and reduces gliosis in hyper-inflammatory experimental cerebral malaria.
Topics: Ammonia; Animals; Antibodies; Anticoagulants; Blood Vessels; Cytokines; Disease Models, Animal; Fibrinogen; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Gliosis; Heparin; Interleukin-10; Leukocytes; Liver; Malaria, Cerebral; Mice; Mice, Inbred C57BL; Mice, Transgenic; Plasmodium chabaudi; Tumor Necrosis Factor-alpha; Vasculitis, Central Nervous System | 2018 |
Inflammation and blood-brain barrier breach remote from the primary injury following neurotrauma.
Topics: Analysis of Variance; Animals; Antigens, CD; Blood-Brain Barrier; Calcium-Binding Proteins; Cytokines; Disease Models, Animal; Ectodysplasins; Encephalitis; Female; Fibrinogen; Functional Laterality; Macrophages; Microfilament Proteins; Microglia; Nitric Oxide Synthase Type II; Optic Nerve; Optic Nerve Injuries; Rats; Time Factors; Visual Pathways | 2018 |
Effects of Increased Intracranial Pressure Gradient on Cerebral Venous Infarction in Rabbits.
Topics: Animals; Brain Edema; Brain Infarction; Cerebral Veins; Diagnostic Errors; Disease Models, Animal; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorheology; Intracranial Hypertension; Intracranial Pressure; Rabbits; Severity of Illness Index; Sinus Thrombosis, Intracranial | 2018 |
Hypoxic pre-conditioning suppresses experimental autoimmune encephalomyelitis by modifying multiple properties of blood vessels.
Topics: Animals; Antigens, CD; Antigens, Surface; Collagen Type IV; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Fibrinogen; Freund's Adjuvant; Gene Expression Regulation; Ischemic Preconditioning; Laminin; Mice; Myelin Proteolipid Protein; Occludin; Peptide Fragments; Vascular Cell Adhesion Molecule-1; Zonula Occludens-1 Protein | 2018 |
Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Carcinogenesis; Cell Line, Tumor; Disease Models, Animal; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Genes, ras; Humans; Immunoconjugates; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms | 2018 |
Ziziphus spina-christi leaf extract ameliorates schistosomiasis liver granuloma, fibrosis, and oxidative stress through downregulation of fibrinogenic signaling in mice.
Topics: Animals; Disease Models, Animal; Down-Regulation; Drug Administration Schedule; Fibrinogen; Gene Expression Regulation; Lipid Peroxidation; Liver Cirrhosis; Liver Function Tests; Male; Mice; NF-E2-Related Factor 2; Oxidative Stress; Plant Extracts; Plant Leaves; Schistosomiasis mansoni; Signal Transduction; Ziziphus | 2018 |
FGL2 prothrombinase contributes to the early stage of coronary microvascular obstruction through a fibrin-dependent pathway.
Topics: Animals; Blood Coagulation; Blotting, Western; Coronary Circulation; Coronary Occlusion; Coronary Vessels; Disease Models, Animal; Endothelium, Vascular; Fibrin; Fibrinogen; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Microcirculation; Time Factors | 2019 |
First Report of Plant-Derived β-Sitosterol with Antithrombotic, in Vivo Anticoagulant, and Thrombus-Preventing Activities in a Mouse Model.
Topics: Animals; Anticoagulants; Antithrombins; Catalysis; Disease Models, Animal; Female; Fibrinogen; Humans; Male; Mice; Plants; Platelet Aggregation Inhibitors; Sitosterols; Thrombin; Thrombosis | 2018 |
Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression.
Topics: Animals; CHO Cells; Coronavirus Infections; Cricetulus; Disease Models, Animal; Female; Fibrinogen; Hepatitis, Viral, Animal; High Mobility Group Proteins; Human Umbilical Vein Endothelial Cells; Humans; Liver; Liver Failure, Acute; Macrophages; Mice; Mice, Inbred BALB C; Murine hepatitis virus; Necrosis; Recombinant Proteins; Repressor Proteins; Survival Rate; THP-1 Cells; Uteroglobin | 2018 |
Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer's Disease Model.
Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Brain; CD11b Antigen; CD18 Antigens; Cognitive Dysfunction; Dendritic Spines; Disease Models, Animal; Fibrinogen; Humans; Imaging, Three-Dimensional; Mice; Microglia; Plaque, Amyloid; Reactive Oxygen Species | 2019 |
Sequence and time course of depletion of cardiac cellular proteins and accumulation of plasma proteins in rat early ischemic myocardium.
Topics: Actins; Animals; Biomarkers; Blood Proteins; Complement C5; Desmin; Disease Models, Animal; Fibrinogen; Fibronectins; Image Processing, Computer-Assisted; Immunohistochemistry; Myocardial Ischemia; Myocardium; Myoglobin; Rats, Sprague-Dawley; Time Factors | 2019 |
In-utero epigenetic factors are associated with early-onset myopia in young children.
Topics: Animals; Child, Preschool; CpG Islands; Disease Models, Animal; DNA Methylation; Epigenesis, Genetic; Eye; Female; Fibrinogen; Gene Expression Regulation; Genome-Wide Association Study; Humans; Keratin-12; Male; Mice; Mice, Inbred C57BL; Myopia; Risk Factors; Umbilical Cord | 2019 |
Plasmin-mediated fibrinolysis enables macrophage migration in a murine model of inflammation.
Topics: Animals; Biomarkers; Chemotaxis, Leukocyte; Disease Models, Animal; Disease Susceptibility; Fibrinogen; Fibrinolysin; Fibrinolysis; Fluorescent Antibody Technique; Humans; Immunophenotyping; Inflammation; Leukocyte Count; Macrophages; Mice; Mice, Knockout; Plasminogen; Protein Binding; Protein Interaction Domains and Motifs; RAW 264.7 Cells | 2019 |
Development of an aerosolized Mannheimia haemolytica experimental pneumonia model in clean-catch colostrum-deprived calves.
Topics: Aerosols; Age Factors; Animals; Bronchopneumonia; Cattle; Cattle Diseases; Colostrum; Disease Models, Animal; Female; Fibrinogen; Haptoglobins; Lung; Mannheimia haemolytica; Neutrophils; Pneumonia, Bacterial; Pulmonary Alveoli | 2019 |
Trauma-targeted delivery of tranexamic acid improves hemostasis and survival in rat liver hemorrhage model.
Topics: Animals; Antifibrinolytic Agents; Blood Platelets; Disease Models, Animal; Fibrinogen; Hemorrhage; Hemostasis; Liposomes; Liver Diseases; Molecular Mimicry; Nanoparticles; Peptides; Rats, Sprague-Dawley; Tranexamic Acid; Wounds and Injuries | 2019 |
Combination therapy using fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes and hemoglobin vesicles for trauma-induced massive hemorrhage in thrombocytopenic rabbits.
Topics: Adenosine Diphosphate; Animals; Blood Substitutes; Disease Models, Animal; Drug Therapy, Combination; Fibrinogen; Hemoglobins; Hemorrhage; Liposomes; Oligopeptides; Rabbits; Wounds and Injuries | 2019 |
Investigation of Extracellular Matrix Protein Expression Dynamics Using Murine Models of Systemic Inflammation.
Topics: Animals; Collagen Type IV; Disease Models, Animal; Endotoxemia; Extracellular Matrix Proteins; Fibrinogen; Inflammation; Mice; Punctures; RNA, Messenger; Time Factors; Tissue Distribution; Vimentin | 2019 |
Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix.
Topics: Animals; Biomimetic Materials; Disease Models, Animal; Extracellular Matrix; Fibrin; Fibrinogen; Human Umbilical Vein Endothelial Cells; Humans; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Mutant Strains; Protein Binding; Wound Healing | 2013 |
Protective effect of plasmin in marginal donor lungs in an ex vivo lung perfusion model.
Topics: Animals; Disease Models, Animal; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Lung; Lung Transplantation; Male; Perfusion; Rats; Rats, Inbred Lew; Reperfusion Injury; Thrombolytic Therapy; Thrombosis; Vascular Resistance | 2013 |
Pseudomonas aeruginosa small protease (PASP), a keratitis virulence factor.
Topics: Animals; Antimicrobial Cationic Peptides; Blotting, Western; Cathelicidins; Complement C3; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; DNA, Bacterial; Eye Infections, Bacterial; Fibrinogen; Mice; Mice, Inbred C57BL; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Serine Endopeptidases; Specific Pathogen-Free Organisms; Tears; Tetracycline Resistance; Virulence; Virulence Factors | 2013 |
Genetic elimination of eNOS reduces secondary complications of experimental subarachnoid hemorrhage.
Topics: Animals; Blotting, Western; Cerebrovascular Circulation; Disease Models, Animal; Fibrinogen; Immunohistochemistry; Intracranial Thrombosis; Mice; Mice, Knockout; Neurons; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Subarachnoid Hemorrhage; Superoxides; Vasospasm, Intracranial; Zinc | 2013 |
Correlation of fibrinogen-like protein 2 with progression of acute pancreatitis in rats.
Topics: Acute Disease; Animals; Biomarkers; Disease Models, Animal; Fibrinogen; Leukocytes, Mononuclear; Male; Pancreas; Pancreatitis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Severity of Illness Index; Taurocholic Acid; Thrombosis; Time Factors; Up-Regulation | 2013 |
The role of hepassocin in the development of non-alcoholic fatty liver disease.
Topics: Aged; Animals; Case-Control Studies; Cells, Cultured; Diet, High-Fat; Disease Models, Animal; Fatty Liver; Female; Fibrinogen; Gene Deletion; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Middle Aged; Neoplasm Proteins; Non-alcoholic Fatty Liver Disease; Oleic Acid | 2013 |
Occurrence of disseminated intravascular coagulation in 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced pneumonia in the rat.
Topics: Animals; Blood Cell Count; Dioxins; Disease Models, Animal; Disseminated Intravascular Coagulation; Erythrocytes; Female; Fibrinogen; Hemolysis; Homeostasis; Inflammation; Lung; Pleurisy; Pneumonia; Polychlorinated Dibenzodioxins; Rats | 2013 |
Protective effects of Batroxobin on spinal cord injury in rats.
Topics: Animals; Batroxobin; Cell Survival; Disease Models, Animal; Fibrinogen; Fibrinolytic Agents; Immunohistochemistry; Laser-Doppler Flowmetry; Microglia; Neurons; Rats; Rats, Sprague-Dawley; Recovery of Function; Spinal Cord; Spinal Cord Injuries | 2013 |
Changes in fibrinogen availability and utilization in an animal model of traumatic coagulopathy.
Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Disease Models, Animal; Femoral Fractures; Fibrinogen; Swine | 2013 |
Platelet hyperreactivity explains the bleeding abnormality and macrothrombocytopenia in a murine model of sitosterolemia.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 5; ATP Binding Cassette Transporter, Subfamily G, Member 8; ATP-Binding Cassette Transporters; Blood Platelets; Disease Models, Animal; Fibrinogen; Filamins; Hemorrhage; Humans; Hypercholesterolemia; Intestinal Diseases; Lipid Metabolism, Inborn Errors; Lipoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Phytosterols; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex | 2013 |
Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis.
Topics: Animals; Blood Coagulation Factors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Factor VIIa; Fibrinogen; Hemorrhage; Male; Pyrazoles; Pyridones; Rabbits; Recombinant Proteins; Thrombosis | 2013 |
Hyperosmolar reconstituted lyophilized plasma is an effective low-volume hemostatic resuscitation fluid for trauma.
Topics: Animals; Blood Coagulation Factors; Disease Models, Animal; Female; Fibrinogen; Fluid Therapy; International Normalized Ratio; Multiple Trauma; Plasma Exchange; Resuscitation; Shock, Hemorrhagic; Swine | 2013 |
Loss of fibrinogen in zebrafish results in symptoms consistent with human hypofibrinogenemia.
Topics: Afibrinogenemia; Animals; Blood Coagulation; Disease Models, Animal; DNA Primers; Fibrinogen; Gene Knockdown Techniques; Hemorrhage; Humans; In Situ Hybridization; Morpholinos; Phenotype; Zebrafish | 2013 |
Impact of different types of resuscitation fluids on coagulation and continuous venovenous hemofiltration hemocompatibility in a porcine model.
Topics: Animals; Anticoagulants; Blood Coagulation; Disease Models, Animal; Female; Fibrinogen; Fluid Therapy; Gelatin; Hemofiltration; Heparin; Hydroxyethyl Starch Derivatives; Platelet Count; Rehydration Solutions; Resuscitation; Swine | 2013 |
A totally recombinant human fibrin sealant.
Topics: Animals; Animals, Genetically Modified; Cattle; Cells, Cultured; Disease Models, Animal; Factor XIIIa; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Hemostasis; Humans; Lacerations; Liver; Male; Recombinant Proteins; Sus scrofa; Thrombelastography; Thrombin; Yeasts | 2014 |
Combined adenovirus-mediated artificial microRNAs targeting mfgl2, mFas, and mTNFR1 protect against fulminant hepatic failure in mice.
Topics: Adenoviridae; Animals; Apoptosis; Caspase 3; CHO Cells; Cricetulus; Disease Models, Animal; fas Receptor; Female; Fibrin; Fibrinogen; Gene Expression Regulation; Genetic Vectors; Liver; Liver Failure, Acute; Mice; MicroRNAs; Plasmids; Receptors, Tumor Necrosis Factor, Type I; RNA Interference | 2013 |
Diesel exhaust particulate increases the size and complexity of lesions in atherosclerotic mice.
Topics: Airway Remodeling; Animals; Aorta, Thoracic; Apolipoproteins E; Blood Coagulation; Brachiocephalic Trunk; C-Reactive Protein; Disease Models, Animal; Fibrinogen; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oropharynx; Oxidative Stress; Particulate Matter; Plaque, Atherosclerotic; Pneumonia; Vehicle Emissions | 2013 |
Fibrin patch in a pig model with blunt liver injury under severe hypothermia.
Topics: Animals; Blood Coagulation; Disease Models, Animal; Drug Combinations; Fibrin Tissue Adhesive; Fibrinogen; Hemodilution; Hemodynamics; Hemorrhage; Hemostatics; Hypothermia; Liver; Male; Severity of Illness Index; Sus scrofa; Thrombelastography; Thrombin; Wounds, Nonpenetrating | 2014 |
The fibrinogen-binding M1 protein reduces pharyngeal cell adherence and colonization phenotypes of M1T1 group A Streptococcus.
Topics: Animals; Antigens, Bacterial; Bacterial Adhesion; Bacterial Outer Membrane Proteins; Bacterial Proteins; Carrier Proteins; Cell Line; Disease Models, Animal; Exotoxins; Fibrinogen; Humans; Keratinocytes; Mice; Pharynx; Streptococcal Infections; Streptococcus pyogenes | 2014 |
[The use of fibrin-collagen substance in case of spleen injuries].
Topics: Animals; Aprotinin; Blood Loss, Surgical; Disease Models, Animal; Dogs; Drug Combinations; Fibrinogen; Hemostasis, Surgical; Spleen; Splenectomy; Thrombin | 2013 |
Macrophage-derived IL-18 and increased fibrinogen deposition are age-related inflammatory signatures of vascular remodeling.
Topics: Age Factors; Aging; Animals; Apoptosis; Cell Adhesion; Cells, Cultured; Chemotaxis; Clodronic Acid; Disease Models, Animal; Fibrinogen; Gene Expression Regulation; Hyperplasia; Inflammation Mediators; Interleukin-18; Macrophages; Male; Monocytes; Muscle, Smooth, Vascular; Neointima; Paracrine Communication; Rats; Rats, Inbred F344; Signal Transduction; Time Factors; Vascular System Injuries | 2014 |
[Effects of raloxifene combined with conjugated equine estrogen on prothrombotic state in ovariectomized rats].
Topics: Animals; Antithrombin III; Disease Models, Animal; Estrogens, Conjugated (USP); Female; Fibrinogen; Fibrinolysis; Ovariectomy; Plasminogen Activator Inhibitor 1; Raloxifene Hydrochloride; Random Allocation; Rats; Rats, Sprague-Dawley; Risk Factors; Selective Estrogen Receptor Modulators; Thrombosis | 2013 |
Study on preparation of fibrinogen-loaded poly (L-lactic) acid nano-fabrics and its haemostatic performance in swine traumatic haemorrhage models.
Topics: Animals; Disease Models, Animal; Fibrinogen; Hemostatics; Humans; Lactic Acid; Microscopy, Electron, Scanning; Surface Properties; Swine | 2014 |
PlGF-MMP9-engineered iPS cells supported on a PEG-fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium.
Topics: Animals; Cell Survival; Cells, Cultured; Disease Models, Animal; Female; Fibrinogen; Genetic Engineering; Hemodynamics; Human Umbilical Vein Endothelial Cells; Humans; Induced Pluripotent Stem Cells; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred NOD; Mice, SCID; Myocardial Contraction; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Neovascularization, Physiologic; Placenta Growth Factor; Polyethylene Glycols; Pregnancy Proteins; Recovery of Function; Regeneration; Time Factors; Tissue Engineering; Tissue Scaffolds; Transduction, Genetic; Transfection | 2014 |
Targeted mutation of zebrafish fga models human congenital afibrinogenemia.
Topics: Afibrinogenemia; Animals; Animals, Genetically Modified; Disease Models, Animal; Fibrinogen; Hemorrhage; Humans; Larva; Mutagenesis, Site-Directed; Phenotype; Zebrafish | 2014 |
Increased peripheral and local soluble FGL2 in the recovery of renal ischemia reperfusion injury in a porcine kidney auto-transplantation model.
Topics: Animals; Apoptosis; Caspase 3; Disease Models, Animal; Fibrinogen; Forkhead Transcription Factors; Gene Expression Regulation; Inflammation; Interleukin-10; Kidney; Kidney Function Tests; Kidney Transplantation; Male; Receptors, IgG; Recovery of Function; Reperfusion Injury; RNA, Messenger; Solubility; Transplantation, Autologous | 2014 |
Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice.
Topics: Animals; Arthritis, Experimental; Disease Models, Animal; Female; Fibrinogen; Joints; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Plasminogen; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2014 |
Group B streptococcal serine-rich repeat proteins promote interaction with fibrinogen and vaginal colonization.
Topics: Adhesins, Bacterial; Animals; Bacterial Adhesion; Cell Line; Disease Models, Animal; Epithelium; Female; Fibrinogen; Membrane Glycoproteins; Mice; Serine; Streptococcal Infections; Streptococcus agalactiae; Vagina; Vaginal Diseases | 2014 |
The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury.
Topics: 1-Naphthylisothiocyanate; Animals; Antifibrinolytic Agents; Bile Duct Diseases; Collagen Type I; Disease Models, Animal; Fibrin; Fibrinogen; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Mice, Knockout; Plasminogen Activator Inhibitor 1; Tranexamic Acid | 2014 |
Mannose-binding lectin promotes local microvascular thrombosis after transient brain ischemia in mice.
Topics: Animals; Antithrombins; Arginine; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Fibrinogen; Infarction, Middle Cerebral Artery; Magnetic Resonance Imaging; Male; Mannose-Binding Lectin; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Pipecolic Acids; Reperfusion Injury; Sulfonamides; Thrombosis | 2014 |
Recovery of fibrinogen concentrate after intraosseous application is equivalent to the intravenous route in a porcine model of hemodilution.
Topics: Animals; Blood Coagulation; Blood Loss, Surgical; Crystalloid Solutions; Disease Models, Animal; Fibrinogen; Hemodilution; Hemorrhage; Hemostatics; Infusions, Intraosseous; Infusions, Intravenous; Isotonic Solutions; Male; Prothrombin Time; Random Allocation; Sensitivity and Specificity; Thrombelastography | 2014 |
Tissue plasminogen activator promotes postischemic neutrophil recruitment via its proteolytic and nonproteolytic properties.
Topics: Animals; Capillary Permeability; Cells, Cultured; Chemotaxis, Leukocyte; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Fibrinogen; Fibrinolysin; Gelatinases; Hemodynamics; Humans; Male; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Microvessels; Muscles; Mutation; Neutrophil Infiltration; Neutrophils; Recombinant Proteins; Reperfusion Injury; Time Factors; Tissue Plasminogen Activator; Transendothelial and Transepithelial Migration | 2014 |
A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fibrinogen; Humans; Maze Learning; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Fluorescence; Molecular Structure; Motor Activity; Protein Binding; Pyrazoles; Pyrimidines; Small Molecule Libraries; Thrombosis; Time-Lapse Imaging | 2014 |
Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS.
Topics: Animals; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Autoantibodies; beta 2-Glycoprotein I; Blood Platelets; Blotting, Western; Cell Membrane; Cells, Cultured; Disease Models, Animal; Endothelium; Fibrin; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; Mice; Mice, Inbred C57BL; Platelet Activation; Thrombosis | 2014 |
The Haemophilus ducreyi trimeric autotransporter adhesin DsrA protects against an experimental infection in the swine model of chancroid.
Topics: Adhesins, Bacterial; Adjuvants, Immunologic; Animals; Antibodies, Bacterial; Bacterial Vaccines; Chancroid; Disease Models, Animal; Fibrinogen; Haemophilus ducreyi; Immune Sera; Immunity, Humoral; Immunoglobulin G; Recombinant Proteins; Sus scrofa | 2014 |
Fibrinogen concentrate does not suppress endogenous fibrinogen synthesis in a 24-hour porcine trauma model.
Topics: Animals; Disease Models, Animal; Fibrinogen; Humans; Liver; Male; Random Allocation; Swine; Time Factors; Wounds, Nonpenetrating | 2014 |
A rabbit model of spontaneous thrombosis induced by lipopolysaccharide.
Topics: Animals; C-Reactive Protein; Disease Models, Animal; Fibrinogen; Lipids; Lipopolysaccharides; Male; Platelet Count; Rabbits; Thrombosis; Tomography, Optical Coherence | 2014 |
The use of TachoSil as sealant in an experimental model of colonic perforation.
Topics: Animals; Digestive System Surgical Procedures; Disease Models, Animal; Drug Combinations; Female; Fibrinogen; Intestinal Perforation; Intraabdominal Infections; Male; Postoperative Complications; Pressure; Rats; Rats, Wistar; Thrombin | 2015 |
FbsC, a novel fibrinogen-binding protein, promotes Streptococcus agalactiae-host cell interactions.
Topics: Animals; Bacterial Adhesion; Bacterial Proteins; Caco-2 Cells; Disease Models, Animal; Endothelial Cells; Epithelial Cells; Fibrinogen; Host-Pathogen Interactions; Humans; Mice; Protein Binding; Streptococcal Infections; Streptococcal Vaccines; Streptococcus agalactiae; Virulence Factors | 2014 |
miR-451 deficiency is associated with altered endometrial fibrinogen alpha chain expression and reduced endometriotic implant establishment in an experimental mouse model.
Topics: Amino Acid Sequence; Animals; Blotting, Western; Cells, Cultured; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Endometriosis; Endometrium; Female; Fibrinogen; Humans; Mice; Mice, Inbred C57BL; MicroRNAs; Molecular Sequence Data; Oligopeptides; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
An increase in the cerebral infarction area during fatigue is mediated by il-6 through an induction of fibrinogen synthesis.
Topics: Animals; Biomarkers; Cerebral Infarction; Disease Models, Animal; Fatigue; Fibrinogen; Interleukin-6; Male; Mice; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
Factor XIII activity mediates red blood cell retention in venous thrombi.
Topics: Animals; Blood Coagulation; Disease Models, Animal; Erythrocytes; Factor XIII; Factor XIII Deficiency; Factor XIIIa; Fibrinogen; Homozygote; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Mutant Proteins; Mutation; Peptide Fragments; Venous Thrombosis | 2014 |
Transient ischemia elicits a sustained enhancement of thrombus development in the cerebral microvasculature: effects of anti-thrombotic therapy.
Topics: Animals; Brain Infarction; Disease Models, Animal; Drug Therapy, Combination; Fibrinogen; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Intracranial Thrombosis; Mice; Mice, Inbred C57BL; Microscopy, Video; Microvessels; Neurologic Examination; Platelet Glycoprotein GPIb-IX Complex; Reperfusion Injury; Statistics, Nonparametric; Time Factors | 2014 |
Evaluation of antithrombotic activity of thrombin DNA aptamers by a murine thrombosis model.
Topics: Animals; Anticoagulants; Antithrombins; Aptamers, Nucleotide; Blood Coagulation; Disease Models, Animal; Drug Evaluation, Preclinical; Fibrinogen; Fibrinolytic Agents; G-Quadruplexes; Hirudins; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Recombinant Proteins; Thrombin; Thrombosis | 2014 |
C5aR, TNF-α, and FGL2 contribute to coagulation and complement activation in virus-induced fulminant hepatitis.
Topics: Animals; Blood Coagulation; Complement Activation; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Gene Expression Regulation; Hepatitis, Viral, Animal; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Murine hepatitis virus; Real-Time Polymerase Chain Reaction; Receptor, Anaphylatoxin C5a; RNA, Messenger; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2015 |
[Protective effect of an angiotensin-converting-enzyme inhibitor on neurogenic pulmonary edema in rabbits].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Enalaprilat; Female; Fibrinogen; Gene Expression Regulation, Enzymologic; Lung; Male; Peptidyl-Dipeptidase A; Pulmonary Edema; Rabbits; Random Allocation; Real-Time Polymerase Chain Reaction; RNA, Messenger | 2014 |
Contribution of the interaction of Streptococcus mutans serotype k strains with fibrinogen to the pathogenicity of infective endocarditis.
Topics: Animals; Disease Models, Animal; Endocarditis; Fibrinogen; Host-Pathogen Interactions; Humans; Male; Platelet Aggregation; Protein Binding; Rats, Sprague-Dawley; Serogroup; Streptococcus mutans; Virulence | 2014 |
Blood components and OCT reflectivity evaluated in animal model.
Topics: Acetates; Adult; Animals; Anterior Chamber; Aqueous Humor; Bilirubin; Blood Cell Count; Blood Proteins; Disease Models, Animal; Drug Combinations; Female; Fibrinogen; Humans; Male; Middle Aged; Minerals; Plasma; Sodium Chloride; Subretinal Fluid; Swine; Tomography, Optical Coherence; Triglycerides | 2014 |
Fibrinogen concentrate improves survival during limited resuscitation of uncontrolled hemorrhagic shock in a Swine model.
Topics: Animals; Aorta; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Fibrinogen; Fluid Therapy; Hemodynamics; Hemostatic Techniques; Hemostatics; Hydroxyethyl Starch Derivatives; Kaplan-Meier Estimate; Resuscitation; Shock, Hemorrhagic; Sus scrofa | 2014 |
N-acetyl cysteine improves the effects of corticosteroids in a mouse model of chlorine-induced acute lung injury.
Topics: Acetylcysteine; Acute Lung Injury; Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Antioxidants; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Chlorine; Cytoprotection; Dexamethasone; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Fibrinogen; Gases; Inhalation Exposure; Lung; Mice, Inbred BALB C; Neutrophil Infiltration; Plasminogen Activator Inhibitor 1; Time Factors | 2015 |
Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.
Topics: Administration, Oral; Animals; Antibodies, Monoclonal, Humanized; Antifibrinolytic Agents; Antithrombins; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Coagulants; Dabigatran; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinogen; Infusions, Intravenous; Male; Multiple Trauma; Swine; Thrombin; Time Factors; Tranexamic Acid | 2015 |
Histologic changes associated with the use of fibrinogen- and thrombin-impregnated collagen in the prevention of pulmonary air leakage.
Topics: Animals; Disease Models, Animal; Dogs; Drug Combinations; Female; Fibrinogen; Pleura; Pneumothorax; Thrombin; Time Factors; Wound Healing | 2015 |
Combined intraoperative administration of a histone deacetylase inhibitor and a neurokinin-1 receptor antagonist synergistically reduces intra-abdominal adhesion formation in a rat model.
Topics: Abdomen; Animals; Disease Models, Animal; Drug Synergism; Fibrinogen; Histone Deacetylase Inhibitors; Intraoperative Care; Male; Neurokinin-1 Receptor Antagonists; Rats; Rats, Wistar; Tissue Adhesions; Valproic Acid; Vascular Endothelial Growth Factor A; Wound Healing | 2015 |
Neuroprotective effects of activated protein C on intrauterine inflammation-induced neonatal white matter injury are associated with the downregulation of fibrinogen-like protein 2/fibroleukin prothrombinase and the inhibition of pro-inflammatory cytokine
Topics: Animals; Apoptosis; Brain Edema; Cerebral Cortex; Cytokines; Disease Models, Animal; Down-Regulation; Female; Fibrinogen; Gene Expression Regulation; Inflammation; Inflammation Mediators; Leukoencephalopathies; Male; Neuroprotective Agents; Placenta Diseases; Pregnancy; Protein C; Rats; Receptor, PAR-1; RNA, Messenger; Transcription Factor RelA | 2015 |
Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome.
Topics: Animals; Antithrombins; Biomarkers; Blood Coagulation; Blood Coagulation Disorders; Disease Models, Animal; Doxorubicin; Elasticity; Fibrinogen; Hemostasis; Hypoalbuminemia; Male; Nephrotic Syndrome; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; Serum Albumin; Severity of Illness Index; Thrombin; Thrombosis | 2015 |
Transplantation Effectiveness of Induced Pluripotent Stem Cells Is Improved by a Fibrinogen Biomatrix in an Experimental Model of Ischemic Heart Failure.
Topics: Animals; Cell Proliferation; Cell Survival; Chickens; Disease Models, Animal; Extracellular Matrix; Fibrinogen; Heart Failure; Humans; Induced Pluripotent Stem Cells; Luminescent Measurements; Magnetic Resonance Imaging; Mice, SCID; Myocardial Ischemia; Time Factors; Tissue Distribution; Ventricular Function, Left | 2015 |
LX0702, a novel snake venom peptide derivative, inhibits thrombus formation via affecting the binding of fibrinogen with GPIIb/IIIa.
Topics: Animals; Bleeding Time; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Fibrinolytic Agents; Male; Mice, Inbred ICR; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Rabbits; Rats, Sprague-Dawley; Snake Venoms; Sulfonamides; Thrombosis; Tryptophan | 2015 |
Effects of Fibrinogen Concentrate on Thrombin Generation, Thromboelastometry Parameters, and Laboratory Coagulation Testing in a 24-Hour Porcine Trauma Model.
Topics: Animals; Blood Coagulation Tests; Disease Models, Animal; Down-Regulation; Fibrinogen; Hemodilution; Hemostasis; Humans; Liver; Male; Random Allocation; Swine; Thrombelastography; Thrombin; Wounds, Nonpenetrating | 2016 |
Effect of mesenchymal precursor cells on the systemic inflammatory response and endothelial dysfunction in an ovine model of collagen-induced arthritis.
Topics: Administration, Intravenous; Animals; Arthritis, Experimental; Bradykinin; Cattle; Coronary Vessels; Disease Models, Animal; Endothelium, Vascular; Fibrinogen; Interleukin-10; Mesenchymal Stem Cell Transplantation; Serum Amyloid A Protein; Sheep; Vasodilator Agents | 2015 |
Modeling the Disease Course of Zaire ebolavirus Infection in the Outbred Guinea Pig.
Topics: Animals; Blood Coagulation; Cell Line; Chlorocebus aethiops; Cytokines; Democratic Republic of the Congo; Disease Models, Animal; Disease Progression; Ebolavirus; Female; Fibrin; Fibrinogen; Guinea Pigs; Hemorrhagic Fever, Ebola; Lymphocytes; Macrophages; Primates; Protein C; Vero Cells | 2015 |
Sealing of gastrointestinal anastomoses with fibrin glue coated collagen patch.
Topics: Anastomosis, Surgical; Anastomotic Leak; Animals; Collagen; Colon; Denmark; Disease Models, Animal; Drug Combinations; Fibrin Tissue Adhesive; Fibrinogen; Peritonitis; Random Allocation; Swine; Thrombin; Tissue Adhesives | 2015 |
Evaluation of urine fibrinogen level in a murine model of contrast-induced nephropathy.
Topics: Acute Kidney Injury; Animals; Biomarkers; Creatinine; Disease Models, Animal; Early Diagnosis; Fibrinogen; Gene Expression Regulation; Indomethacin; Kidney; Male; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Predictive Value of Tests; Time Factors; Triiodobenzoic Acids; Urinalysis | 2016 |
Evaluation of Prehospital Blood Products to Attenuate Acute Coagulopathy of Trauma in a Model of Severe Injury and Shock in Anesthetized Pigs.
Topics: Anesthesia; Animals; Blood Banks; Blood Coagulation; Blood Coagulation Disorders; Disease Models, Animal; Erythrocyte Transfusion; Female; Fibrinogen; Hemorrhage; Partial Thromboplastin Time; Plasma; Prothrombin Time; Resuscitation; Shock; Swine; Thrombelastography; Time Factors; Wounds and Injuries | 2015 |
Preventive Effect of Aspirin Eugenol Ester on Thrombosis in κ-Carrageenan-Induced Rat Tail Thrombosis Model.
Topics: Adenosine Diphosphate; Animals; Aspirin; Blood Platelets; Carrageenan; Disease Models, Animal; Erythrocyte Count; Erythrocytes; Eugenol; Fibrinogen; Hemoglobins; Male; Platelet Aggregation Inhibitors; Platelet Count; Prothrombin Time; Rats; Rats, Wistar; Thrombosis | 2015 |
Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection.
Topics: Animals; Antibodies, Bacterial; Coagulase; Disease Models, Animal; Fibrinogen; Humans; Immunization; Lactococcus lactis; Mice; Protein Binding; Recombinant Proteins; Staphylococcal Infections; Staphylococcus aureus; Virulence | 2015 |
Anti-inflammatory, Antithrombotic and Cardiac Remodeling Preventive Effects of Eugenol in Isoproterenol-Induced Myocardial Infarction in Wistar Rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Blood Coagulation; Cytokines; Disease Models, Animal; Eugenol; Fibrinogen; Fibrinolytic Agents; Hemodynamics; Inflammation Mediators; Isoproterenol; Kidney; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Necrosis; Oxidative Stress; Peptidyl-Dipeptidase A; Rats, Wistar; Renin-Angiotensin System; Ventricular Remodeling | 2016 |
A novel adhesive factor contributing to the virulence of Vibrio parahaemolyticus.
Topics: Adhesins, Bacterial; Animals; Bacterial Adhesion; Bacterial Outer Membrane Proteins; Cell Line; Disease Models, Animal; Epithelial Cells; Fibrinogen; Fibronectins; Gene Deletion; Humans; Mice; Phylogeny; Protein Binding; Vibrio Infections; Vibrio parahaemolyticus; Virulence; Virulence Factors | 2015 |
Alteplase Reduces Downstream Microvascular Thrombosis and Improves the Benefit of Large Artery Recanalization in Stroke.
Topics: Animals; Blood Platelets; Disease Models, Animal; Fibrin; Fibrinogen; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Intracranial Thrombosis; Leukocytes; Male; Microscopy, Fluorescence; Microvessels; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Reperfusion; Tissue Plasminogen Activator | 2015 |
A disparate subset of double-negative T cells contributes to the outcome of murine fulminant viral hepatitis via effector molecule fibrinogen-like protein 2.
Topics: Adoptive Transfer; Animals; Cytokines; Disease Models, Animal; Female; Fibrinogen; Gene Silencing; Hepatitis, Viral, Animal; Immunophenotyping; Liver; Lymphocyte Activation; Mice; Murine hepatitis virus; Phenotype; RNA, Small Interfering; T-Lymphocyte Subsets | 2016 |
Sodium tanshinone IIA sulfonate ameliorates experimental coronary no-reflow phenomenon through down-regulation of FGL2.
Topics: Animals; Coronary Circulation; Disease Models, Animal; Down-Regulation; Endothelial Cells; Fibrin; Fibrinogen; Male; No-Reflow Phenomenon; Phenanthrenes; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, PAR-1; Reperfusion Injury; Signal Transduction | 2015 |
Effects of chronic sugar consumption on lipid accumulation and autophagy in the skeletal muscle.
Topics: Animals; Autophagy; Beclin-1; Blood Glucose; Cholesterol; Disease Models, Animal; Fibrinogen; Fructose; Glucose; Insulin; Insulin Resistance; Interleukin-6; Lipid Metabolism; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Muscle, Skeletal; Suppressor of Cytokine Signaling 3 Protein; Triglycerides | 2017 |
[Hepatopulmonary syndrome-related changes in D-dimer, prothrombin time, fibrinogen, CD4 and CD8 in a rat model system].
Topics: Animals; CD4 Antigens; CD4-CD8 Ratio; CD8 Antigens; Disease Models, Animal; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hepatopulmonary Syndrome; Liver Cirrhosis; Lung; Male; Prothrombin Time; Rats; Rats, Sprague-Dawley | 2015 |
Partially Defective Store Operated Calcium Entry and Hem(ITAM) Signaling in Platelets of Serotonin Transporter Deficient Mice.
Topics: Animals; Blood Platelets; Calcium; Disease Models, Animal; Fibrinogen; Hemostasis; Hydroxyindoleacetic Acid; Melatonin; Mice; Mice, Knockout; Phosphoric Monoester Hydrolases; Serotonin; Serotonin Plasma Membrane Transport Proteins; Signal Transduction; Stroke; Thrombosis | 2016 |
Fibrinogen Reduction and Motor Function Improvement by Hematopoietic Growth Factor Treatment in Chronic Stroke in Aged Mice: A Treatment Frequency Study.
Topics: Aging; Animals; Chronic Disease; Disease Models, Animal; Fibrinogen; Granulocyte Colony-Stimulating Factor; Mice; Motor Activity; Stem Cell Factor; Stroke | 2016 |
Ameliorative Effects of Curcumin on Fibrinogen-Like Protein-2 Gene Expression, Some Oxido-Inflammatory and Apoptotic Markers in a Rat Model of l-Arginine-Induced Acute Pancreatitis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Arginine; Caspase 3; Curcumin; Disease Models, Animal; Fibrinogen; Gene Expression Regulation; Inflammation; Injections, Intraperitoneal; Male; Oxidative Stress; Pancreatitis, Acute Necrotizing; Peroxidase; Protein Carbonylation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tumor Necrosis Factor-alpha | 2016 |
Role of the Emp Pilus Subunits of Enterococcus faecium in Biofilm Formation, Adherence to Host Extracellular Matrix Components, and Experimental Infection.
Topics: Animals; Bacterial Adhesion; Biofilms; Collagen Type I; Disease Models, Animal; Endocarditis, Bacterial; Enterococcus faecium; Extracellular Matrix; Female; Fibrinogen; Fimbriae Proteins; Fimbriae, Bacterial; Gene Deletion; Genetic Complementation Test; Gram-Positive Bacterial Infections; Male; Mice, Inbred ICR; Operon; Organelle Biogenesis; Rats, Sprague-Dawley; Urinary Tract Infections; Virulence Factors | 2016 |
Differential contributions of platelets and fibrinogen to early coagulopathy in a rat model of hemorrhagic shock.
Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Blood Platelets; Disease Models, Animal; Disseminated Intravascular Coagulation; Fibrinogen; Male; Rats, Sprague-Dawley; Shock, Hemorrhagic; Thrombelastography | 2016 |
Fibrinogen γ-Chain Peptide-Coated Adenosine 5' Diphosphate-Encapsulated Liposomes Rescue Mice From Lethal Blast Lung Injury via Adenosine Signaling.
Topics: Adenosine; Adenosine Diphosphate; Animals; Blast Injuries; Disease Models, Animal; Fibrinogen; Liposomes; Lung Injury; Male; Mice; Mice, Inbred C57BL; Oligopeptides; Platelet Aggregation Inhibitors; Signal Transduction | 2016 |
Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Biotinylation; Brain; Cerebral Amyloid Angiopathy; Dementia, Vascular; Disease Models, Animal; Disease Progression; Fibrin; Fibrinogen; Fibrinolysis; Humans; Hyperhomocysteinemia; Immunohistochemistry; Maze Learning; Memory; Methionine; Mice; Mice, Transgenic; Plaque, Amyloid; Protein Binding | 2016 |
Hemostatic Therapy Using Tranexamic Acid and Coagulation Factor Concentrates in a Model of Traumatic Liver Injury.
Topics: Abdominal Injuries; Animals; Antifibrinolytic Agents; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Disease Models, Animal; Drug Therapy, Combination; Fibrinogen; Hemostasis; Liver; Male; Platelet Activation; Platelet Function Tests; Shock, Hemorrhagic; Sus scrofa; Thrombelastography; Thrombin; Time Factors; Tranexamic Acid; Wounds, Nonpenetrating | 2016 |
Effect of Resveratrol on the Prevention of Intra-Abdominal Adhesion Formation in a Rat Model.
Topics: Abdomen; Actins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Collagen; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Interleukin-6; Male; Peritoneum; Postoperative Complications; Rats, Sprague-Dawley; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; Tissue Adhesions; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2016 |
COMPARISON TACHOCOMB WITH SURGIWRAP, SURGICEL AND LYODURA IN EPIDURAL FIBROSIS: AN EXPERIMENTAL RAT MODEL.
Topics: Animals; Aprotinin; Cellulose, Oxidized; Collagen; Disease Models, Animal; Drug Combinations; Epidural Space; Female; Fibrinogen; Fibrosis; Laminectomy; Lumbar Vertebrae; Male; Prospective Studies; Rats; Rats, Sprague-Dawley; Thrombin; Turkey | 2016 |
Spatiotemporal expression of endogenous TLR4 ligands leads to inflammation and bone erosion in mouse collagen-induced arthritis.
Topics: Animals; Antigen-Antibody Complex; Arthritis, Experimental; Arthritis, Rheumatoid; Bone and Bones; Calgranulin A; Cell Differentiation; Collagen; Disease Models, Animal; Fibrinogen; Joints; Ligands; Mice; Mice, Inbred DBA; Osteoclasts; Spatio-Temporal Analysis; Tenascin; Toll-Like Receptor 4 | 2016 |
Keratinocyte Growth Factor Combined with a Sodium Hyaluronate Gel Inhibits Postoperative Intra-Abdominal Adhesions.
Topics: Actins; Animals; Collagen Type I; Disease Models, Animal; Down-Regulation; Epithelium; Fibrinogen; Fibroblast Growth Factor 7; Gels; Hyaluronic Acid; Interleukin-1beta; Interleukin-6; Peritoneum; Postoperative Care; Rats; Regeneration; RNA, Messenger; Tissue Adhesions; Tissue Plasminogen Activator; Transforming Growth Factor beta1 | 2016 |
C5a/C5aR Pathway Plays a Vital Role in Brain Inflammatory Injury via Initiating Fgl-2 in Intracerebral Hemorrhage.
Topics: Animals; Cerebral Hemorrhage; Complement C5a; Cytokines; Disease Models, Animal; Encephalitis; Female; Fibrinogen; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Anaphylatoxin C5a; Signal Transduction | 2017 |
Programmed death (PD)-1 attenuates macrophage activation and brain inflammation via regulation of fibrinogen-like protein 2 (Fgl-2) after intracerebral hemorrhage in mice.
Topics: Animals; Cerebral Hemorrhage; Cytokines; Disease Models, Animal; Encephalitis; Fibrinogen; Gene Expression; Immunohistochemistry; Inflammation Mediators; Macrophage Activation; Macrophages; Mice; Mice, Knockout; Programmed Cell Death 1 Receptor | 2016 |
Tissue Plasminogen Activator as an Antiangiogenic Agent in Experimental Laser-Induced Choroidal Neovascularization in Mice.
Topics: Animals; Choroid; Choroidal Neovascularization; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Fibrin; Fibrinogen; Fibrinolytic Agents; Fluorescein Angiography; Fundus Oculi; Intravitreal Injections; Laser Coagulation; Male; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Platelet Endothelial Cell Adhesion Molecule-1; Retina; Tissue Plasminogen Activator | 2016 |
Farnesoid X Receptor and Its Ligands Inhibit the Function of Platelets.
Topics: Animals; Blood Platelets; Calcium Signaling; Chenodeoxycholic Acid; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinogen; Genotype; Hemostasis; Humans; Isoxazoles; Ligands; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Cytoplasmic and Nuclear; Thrombosis; Time Factors | 2016 |
Functional improvement of hemostatic dressing by addition of recombinant batroxobin.
Topics: Animals; Bandages; Batroxobin; Blood Coagulation; Cattle; Disease Models, Animal; Femoral Artery; Fibrinogen; Hemorrhage; Hemostatics; Liver; Microscopy, Electron, Scanning; Nephelometry and Turbidimetry; Platelet Activation; Rats, Sprague-Dawley; Recombinant Proteins | 2017 |
Analysis of thromboelastography, PT, APTT and fibrinogen in intraosseous and venous samples-an experimental study.
Topics: Animals; Blood Coagulation; Bone Marrow; Disease Models, Animal; Emergencies; Fibrinogen; Hemorrhage; Partial Thromboplastin Time; Prothrombin Time; Swine; Thrombelastography | 2016 |
Two-layer sheet of gelatin: A new topical hemostatic agent.
Topics: Administration, Topical; Animals; Chi-Square Distribution; Disease Models, Animal; Dogs; Drug Combinations; Female; Fibrinogen; Gelatin; Hemostatics; Materials Testing; Postoperative Hemorrhage; Random Allocation; Splenectomy; Swine; Thrombin | 2018 |
Activated Protein C Drives the Hyperfibrinolysis of Acute Traumatic Coagulopathy.
Topics: Adult; Animals; Blood Coagulation; Blood Coagulation Tests; Cohort Studies; Disease Models, Animal; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Male; Mice; Middle Aged; Prospective Studies; Protein C; Thrombelastography; Wounds and Injuries; Young Adult | 2017 |
A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever.
Topics: Animals; Blood Coagulation Disorders; Chlorocebus aethiops; Cricetinae; Cytokines; Disease Models, Animal; Fibrinogen; Hemorrhage; Immunity, Innate; Kaplan-Meier Estimate; Liver; Marburg Virus Disease; Marburgvirus; Mutation; Partial Thromboplastin Time; Prothrombin Time; RNA, Viral; Spleen; Vero Cells | 2016 |
Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin-6 dependent.
Topics: Animals; Blood Coagulation; Cachexia; Cell Line, Tumor; Disease Models, Animal; Fibrin; Fibrinogen; Gene Expression Regulation, Neoplastic; Humans; Inflammation; Interleukin-6; Liver; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms; Thrombin; Tissue Array Analysis | 2017 |
A Naphthalenic Derivative ND-1 Inhibits Thrombus Formation by Interfering the Binding of Fibrinogen to Integrin
Topics: Abciximab; Animals; Antibodies, Monoclonal; Cardiovascular Diseases; Disease Models, Animal; Eptifibatide; Fibrinogen; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Integrin alpha2; Integrin beta3; Mice; Naphthalenes; Peptides; Platelet Aggregation; Rats; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine | 2016 |
Crotalus atrox venom preconditioning increases plasma fibrinogen and reduces perioperative hemorrhage in a rat model of surgical brain injury.
Topics: Animals; Brain Injuries; Crotalus; Disease Models, Animal; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematoma; Hemorrhage; International Normalized Ratio; Intraoperative Complications; Male; Prothrombin Time; Rats; Rats, Sprague-Dawley; Snake Venoms | 2017 |
Silencing of Anticoagulant Protein C Evokes Low-Incident but Spontaneous Atherothrombosis in Apolipoprotein E-Deficient Mice-Brief Report.
Topics: Animals; Antithrombin III; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Coagulation; Diet, Western; Disease Models, Animal; Female; Fibrinogen; Genetic Predisposition to Disease; Liver; Mice, Inbred C57BL; Mice, Knockout; Peptide Hydrolases; Phenotype; Plaque, Atherosclerotic; Protein C; RNA Interference; Thrombosis | 2017 |
Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-{gamma}.
Topics: Actins; Anilides; Animals; Antineoplastic Agents; Cell Adhesion; Chemotaxis; Chromans; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fibrinogen; HL-60 Cells; Humans; Inflammation; Interleukin-4; Interleukin-8; Male; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; N-Formylmethionine Leucyl-Phenylalanine; PPAR gamma; Prostaglandin D2; Sepsis; Thiazolidinediones; Troglitazone; Tumor Necrosis Factor-alpha; Up-Regulation | 2008 |
The effects of pharmacological PAI-1 inhibition on thrombus formation and neointima formation after arterial injury.
Topics: Angioplasty, Balloon, Coronary; Animals; Cell Proliferation; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Fibrinogen; Gene Expression Regulation; Hyperplasia; Male; Mice; Mice, Inbred C57BL; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Thiazolidinediones; Thrombosis; Tunica Intima | 2008 |
Immune complex-mediated glomerulonephritis is ameliorated by thrombin-activatable fibrinolysis inhibitor deficiency.
Topics: Animals; Antigen-Antibody Complex; Batroxobin; Carboxypeptidase B2; Complement C3; Cytokines; Disease Models, Animal; Disease Progression; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Fibrosis; Glomerulonephritis; Kidney; Kidney Function Tests; Matrix Metalloproteinases; Mice; Mice, Knockout; Time Factors | 2008 |
Progesterone and its metabolite allopregnanolone differentially regulate hemostatic proteins after traumatic brain injury.
Topics: Animals; Blood Coagulation; Brain Injuries; Disease Models, Animal; Factor XIII; Fibrinogen; Gene Expression Regulation; Hemostasis; Humans; Male; Neuropeptides; Neuroserpin; Pregnanolone; Progesterone; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serpins; Thrombin; Tissue Plasminogen Activator | 2008 |
Thrombolysis effect of a novel targeted microbubble with low-frequency ultrasound in vivo.
Topics: Acute Disease; Angiography; Animals; Carotid Artery, Common; Disease Models, Animal; Femoral Artery; Fibrin Fibrinogen Degradation Products; Fibrinogen; Microbubbles; Partial Thromboplastin Time; Prothrombin Time; Rabbits; Thrombolytic Therapy; Thrombosis; Ultrasonography, Interventional | 2008 |
[The expression of soluble fibrinogen-like protein 2 in murine experimental autoimmune hepatitis].
Topics: Animals; Disease Models, Animal; Fibrinogen; Hepatitis, Autoimmune; Male; Mice; Mice, Inbred C57BL | 2008 |
Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma.
Topics: Adult; Aged; Animals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Disease Models, Animal; Endothelial Cells; Female; Fibrinogen; Humans; Interferon-gamma; Interleukin-2; Leukemia, Monocytic, Acute; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; RNA, Messenger; Thrombophilia; Thromboplastin | 2008 |
Novel cryoprecipitate for wound healing and skin grafts in rats.
Topics: Administration, Cutaneous; Analysis of Variance; Animals; Bandages; Disease Models, Animal; Drug Evaluation, Preclinical; Factor VIII; Fibrinogen; Male; Necrosis; Rats; Rats, Sprague-Dawley; Safety; Skin Care; Skin Transplantation; Wound Healing | 2008 |
Fibrinogen induces cytokine and collagen production in pancreatic stellate cells.
Topics: Animals; Cell Movement; Cells, Cultured; Collagen Type I; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinogen; Humans; Integrin alpha5beta1; Integrin alphaVbeta3; Interleukin-6; Interleukin-8; Male; Mice; Mice, Nude; Neoplasm Transplantation; Pancreas; Pancreatic Neoplasms; Pancreatitis, Chronic; Peptide Fragments; Procollagen; Rats; Rats, Wistar; Signal Transduction | 2009 |
Neither fibrin nor plasminogen activator inhibitor-1 deficiency protects lung function in a mouse model of acute lung injury.
Topics: Acute Lung Injury; Afibrinogenemia; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Female; Fibrin; Fibrinogen; Inflammation Mediators; Lung; Mice; Mice, Inbred C57BL; Mice, Knockout; Respiratory Mechanics; Serpin E2; Serpins | 2009 |
A porcine model of massive, totally occlusive, pulmonary embolism.
Topics: Animals; Blood Coagulation Tests; Blood Flow Velocity; Blood Pressure; Carbon Dioxide; Creatine Kinase; Disease Models, Animal; Extracorporeal Membrane Oxygenation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hydrogen-Ion Concentration; L-Lactate Dehydrogenase; Oxygen; Pulmonary Artery; Pulmonary Embolism; Sus scrofa; Tidal Volume; Time Factors; Tissue Plasminogen Activator | 2009 |
Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice.
Topics: Animals; Apolipoproteins E; Blood Coagulation; Carotid Arteries; Carotid Artery Diseases; Constriction; Cytokines; Dietary Fats; Disease Models, Animal; Fibrinogen; Fibrosis; Hemodynamics; Inflammation; Injections, Intraperitoneal; Lipopolysaccharides; Macrophages; Male; Matrix Metalloproteinases; Mice; Mice, Knockout; Norepinephrine; Rupture; Stress, Psychological; Thrombosis | 2009 |
Dietary supplement with fermented soybeans, natto, improved the neurobehavioral deficits after sciatic nerve injury in rats.
Topics: Animals; Apoptosis; Blood Coagulation; Blood-Nerve Barrier; Cytokines; Dietary Supplements; Disease Models, Animal; Extracellular Matrix; Fibrin; Fibrinogen; Nerve Crush; Nerve Regeneration; Neural Conduction; Rats; Rats, Sprague-Dawley; Recovery of Function; Sciatic Nerve; Sciatic Neuropathy; Soy Foods | 2009 |
EF6265, a novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor, protects against sepsis-induced organ dysfunction in rats.
Topics: Amino Acids; Analysis of Variance; Animals; Blood Chemical Analysis; Carboxypeptidase B2; Ceftazidime; Disease Models, Animal; Fibrinogen; Heparin; Interleukin-6; Leukocyte Count; Lipopolysaccharides; Male; Multiple Organ Failure; Phosphinic Acids; Platelet Count; Probability; Pseudomonas Infections; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sensitivity and Specificity; Sepsis; Stem Cells | 2009 |
Implementation of the ISTH classification of non-overt DIC in a thromboplastin induced rabbit model.
Topics: Animals; Blood Pressure; Disease Models, Animal; Disseminated Intravascular Coagulation; Dose-Response Relationship, Drug; Female; Fibrinogen; Platelet Count; Prothrombin Time; Rabbits; Thromboplastin; Time Factors | 2009 |
Lonomia obliqua caterpillar envenomation causes platelet hypoaggregation and blood incoagulability in rats.
Topics: Animals; Arthropod Venoms; Blood Coagulation; Brazil; Disease Models, Animal; Fibrinogen; Hemorrhage; Insect Bites and Stings; Larva; Male; Moths; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Time Factors | 2010 |
The use of Tachosil surgical patch or fibrin glue in coronary artery surgery does not affect quality of anastomosis or provoke postoperative adhesions in pigs.
Topics: Anastomosis, Surgical; Animals; Coronary Artery Bypass, Off-Pump; Coronary Vessels; Disease Models, Animal; Drug Combinations; Fibrin Tissue Adhesive; Fibrinogen; Mammary Arteries; Postoperative Care; Sus scrofa; Thrombin; Tissue Adhesions | 2009 |
Yogurt: effect on leukocytes and blood coagulation in an acute liver injury model.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Coagulation; Cattle; Cell Death; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Fibrinogen; Galactosamine; Goats; Leukocyte Count; Leukocytes; Mice; Mice, Inbred BALB C; Neutrophil Infiltration; Neutrophils; Partial Thromboplastin Time; Peroxidase; Probiotics; Prothrombin Time; Yogurt | 2009 |
[Establishment of pig acute liver failure model and the role of pig fibrinogen-like protein 2].
Topics: Animals; Disease Models, Animal; Fibrinogen; Galactosamine; Immunohistochemistry; Liver; Liver Failure, Acute; Liver Function Tests; Male; Polymerase Chain Reaction; Random Allocation; RNA, Messenger; Swine | 2009 |
Recombinant human hepassocin stimulates proliferation of hepatocytes in vivo and improves survival in rats with fulminant hepatic failure.
Topics: Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Fibrinogen; Hepatocytes; Humans; Liver Failure, Acute; Liver Regeneration; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Proteins; Rats; Rats, Wistar; Recombinant Proteins; RNA Interference | 2010 |
10 Gy total body irradiation increases risk of coronary sclerosis, degeneration of heart structure and function in a rat model.
Topics: Animals; Bone Marrow Transplantation; Collagen; Coronary Artery Disease; Disease Models, Animal; Fibrinogen; Fibroblasts; Gamma Rays; Heart; Lipids; Male; Myocardium; Nitric Oxide Synthase; Radiation Dosage; Rats; Rats, Wistar; Receptor, PAR-1; Risk Factors; Whole-Body Irradiation | 2009 |
Hemorheological changes in cerebral circulation of rabbits with acute carbon monoxide poisoning.
Topics: Acute Disease; Animals; Blood Viscosity; Carbon Monoxide Poisoning; Carboxyhemoglobin; Cerebrovascular Circulation; Disease Models, Animal; Erythrocyte Aggregation; Erythrocyte Deformability; Fibrinogen; Hemorheology; Male; Oxygen; Rabbits | 2009 |
Mlck1a is expressed in zebrafish thrombocytes and is an essential component of thrombus formation.
Topics: Animals; Animals, Genetically Modified; Blood Platelets; Cell Shape; Disease Models, Animal; Fibrinogen; Gene Expression Profiling; Gene Expression Regulation, Developmental; Gene Expression Regulation, Enzymologic; Gene Knockdown Techniques; Myosin-Light-Chain Kinase; Oligonucleotide Array Sequence Analysis; Platelet Adhesiveness; Platelet Membrane Glycoprotein IIb; Recombinant Fusion Proteins; RNA, Messenger; Thrombosis; Zebrafish; Zebrafish Proteins | 2010 |
The catalytic subunit of protein phosphatase 1 gamma regulates thrombin-induced murine platelet alpha(IIb)beta(3) function.
Topics: Animals; Blood Platelets; Catalytic Domain; Disease Models, Animal; Fibrinogen; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Isoenzymes; Mice; Phosphoserine; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Phosphatase 1; Proto-Oncogene Proteins c-akt; Receptors, Thrombin; Secretory Vesicles; Signal Transduction; Thrombin; Thrombosis | 2009 |
Natural variability of in vitro adherence to fibrinogen and fibronectin does not correlate with in vivo infectivity of Staphylococcus aureus.
Topics: Adult; Animals; Bacterial Adhesion; Carrier State; Disease Models, Animal; Endocarditis, Bacterial; Fibrinogen; Fibronectins; Gene Expression; Genetic Variation; Humans; Phenotype; Rats; Staphylococcal Infections; Staphylococcus aureus; Young Adult | 2010 |
Dual interference with novel genes mfgl2 and mTNFR1 ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice.
Topics: Animals; Apoptosis; Blotting, Western; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Female; Fibrinogen; Gene Expression; Hydrodynamics; Liver Failure, Acute; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Murine hepatitis virus; Receptors, Tumor Necrosis Factor, Type I; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Thromboplastin; Transcription, Genetic | 2010 |
Platelet adhesion and intracellular calcium levels in antigen-challenged rats.
Topics: Adenosine Diphosphate; Animals; Bronchoalveolar Lavage Fluid; Calcium; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinogen; Immunoglobulin E; Inflammation; Lung; Male; Ovalbumin; Platelet Adhesiveness; Rats; Rats, Wistar; Thrombin; Thrombocytopenia; Time Factors | 2010 |
Effect of TachoSil in a coagulopathic pig model with blunt liver injuries.
Topics: Animals; Blood Cell Count; Blood Coagulation Disorders; Disease Models, Animal; Drug Combinations; Fibrinogen; Hemodynamics; Hemorrhage; Hydroxyethyl Starch Derivatives; Isotonic Solutions; Liver; Male; Plasma Substitutes; Ringer's Lactate; Surgical Sponges; Survival Rate; Sus scrofa; Thrombelastography; Thrombin; Wounds, Nonpenetrating | 2011 |
Optimizing orthotopic cell transplantation in the mouse adrenal gland.
Topics: Adrenal Glands; Animals; Cattle; Cell Line, Tumor; Cell Transplantation; Cells, Cultured; Child; Disease Models, Animal; Female; Fibrin; Fibrinogen; Humans; Mice; Mice, Transgenic; Microspheres; Neoplasm Transplantation; Neuroblastoma; Thrombin; Transplantation, Heterologous | 2010 |
A combined immunostimulatory and immunoinhibitory short interference RNA reduces hypercoagulability in a rat model of acute promyelocytic leukaemia.
Topics: Animals; Antithrombin III; Biomarkers; Blood Coagulation; Cells, Cultured; Dendritic Cells; Disease Models, Animal; Fibrin Fibrinogen Degradation Products; Fibrinogen; Genetic Therapy; Interleukin-10; Leukemia, Promyelocytic, Acute; Male; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Rats; Rats, Inbred BN; RNA Interference; RNA, Small Interfering; Thrombophilia; Thromboplastin; Transfection | 2010 |
Hepassocin as a treatment for fulminant hepatic failure: will it translate from rats to human?
Topics: Animals; Disease Models, Animal; Fibrinogen; Humans; Liver Failure, Acute; Neoplasm Proteins; Rats; Recombinant Proteins; Species Specificity; Translational Research, Biomedical | 2010 |
Oats (Avena sativa) reduce atherogenesis in LDL-receptor-deficient mice.
Topics: Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Aortic Diseases; Atherosclerosis; Avena; Bile Acids and Salts; Biomarkers; Body Weight; Cholesterol; Dietary Fiber; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Feces; Female; Fibrinogen; Hypolipidemic Agents; Inflammation Mediators; Lipoproteins, LDL; Lipoproteins, VLDL; Mice; Mice, Knockout; Nitric Oxide Synthase Type III; Receptors, LDL; Time Factors; Triglycerides; Vascular Cell Adhesion Molecule-1 | 2010 |
Brief report: biomarkers of aortic vascular prosthetic graft infection in a porcine model with Staphylococcus aureus.
Topics: Animals; Aorta; Biomarkers; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; C-Reactive Protein; CD4-CD8 Ratio; Disease Models, Animal; Fibrinogen; Flow Cytometry; Leukocytes; Prosthesis-Related Infections; Random Allocation; Staphylococcal Infections; Staphylococcus aureus; Swine; Tumor Necrosis Factor-alpha | 2010 |
Purified thromboplastin causes haemostatic abnormalities but not overt DIC in an experimental rabbit model.
Topics: Animals; Disease Models, Animal; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; Rabbits; Thrombelastography; Thromboplastin | 2010 |
The effect of sealing with a fixed combination of collagen matrix-bound coagulation factors on the healing of colonic anastomoses in experimental high-risk mice models.
Topics: Anastomosis, Surgical; Anastomotic Leak; Animals; Collagen; Collagen Type I; Collagen Type III; Colon; Disease Models, Animal; Drug Combinations; Fibrin Tissue Adhesive; Fibrinogen; Hydroxyproline; Male; Mice; Mice, Inbred C57BL; Peritonitis; Risk Factors; Thrombin; Wound Healing | 2010 |
Gene expression study of monocytes/macrophages during early foreign body reaction and identification of potential precursors of myofibroblasts.
Topics: Animals; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Fibrinogen; Foreign-Body Reaction; Gene Expression; Gene Expression Profiling; Humans; Macrophages; Male; Monocytes; Myofibroblasts; Rats; Rats, Wistar | 2010 |
Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism.
Topics: Animals; Collagen Type IV; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Interferon-gamma; Interleukin-1beta; Leukocytes; Ligation; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha; Urokinase-Type Plasminogen Activator; Vena Cava, Inferior; Venous Thrombosis | 2010 |
Recombinant factor VIIa reduces bleeding after blunt liver injury in coagulopathic, hypofibrinogenaemic pigs.
Topics: Animals; Blood Coagulation Disorders; Disease Models, Animal; Drug Evaluation, Preclinical; Factor VIIa; Fibrin; Fibrinogen; Hemodilution; Hemodynamics; Hemorrhage; Hemostatics; Liver; Male; Pilot Projects; Prothrombin Time; Recombinant Proteins; Sus scrofa; Thrombelastography; Wounds, Nonpenetrating | 2010 |
Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antithrombin III; Blood Coagulation; Calcium-Binding Proteins; Collagen; Cytokines; Disease Models, Animal; Fibrinogen; Inflammation; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Myeloid Differentiation Factor 88; Neutrophils; Oligodeoxyribonucleotides; Peptide Hydrolases; Signal Transduction; Th1 Cells; Thrombelastography; Time Factors; Toll-Like Receptor 9; Venous Thrombosis | 2011 |
Role of fibrinogen and protease-activated receptors in acute xenobiotic-induced cholestatic liver injury.
Topics: 1-Naphthylisothiocyanate; Acute Disease; Animals; Blood Coagulation; Chemical and Drug Induced Liver Injury; Cholestasis; Disease Models, Animal; Female; Fibrinogen; Liver Function Tests; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Necrosis; Receptor, PAR-1; Receptors, Proteinase-Activated; Xenobiotics | 2011 |
Deletion of the high-density lipoprotein receptor scavenger receptor BI in mice modulates thrombosis susceptibility and indirectly affects platelet function by elevation of plasma free cholesterol.
Topics: Animals; Arterial Occlusive Diseases; Blood Platelets; Bone Marrow Transplantation; Chlorides; Cholesterol, Dietary; Cholesterol, HDL; Disease Models, Animal; Ferric Compounds; Fibrinogen; Mice; Mice, Knockout; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Scavenger Receptors, Class B; Thrombocytopenia; Thrombosis; Time Factors; Up-Regulation | 2011 |
Fibrinogen depleting agent batroxobin has a beneficial effect on experimental autoimmune encephalomyelitis.
Topics: Animals; Batroxobin; Cell Line; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Fibrinogen; Humans; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; Spinal Cord | 2011 |
The periodontal anaerobe Porphyromonas gingivalis induced platelet activation and increased aggregation in whole blood by rat model.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Blood Platelets; Disease Models, Animal; Fibrinogen; Flow Cytometry; Humans; Male; P-Selectin; Periodontitis; Platelet Activation; Platelet Aggregation; Porphyromonas gingivalis; Rats; Rats, Wistar | 2011 |
Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice.
Topics: Animals; Carotid Artery Thrombosis; Chlorides; Disease Models, Animal; Drug Resistance; Ferric Compounds; Fibrinogen; Fibrinolytic Agents; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Platelet Aggregation; Risk Factors; Saphenous Vein; Thrombolytic Therapy; Thrombosis | 2011 |
Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis.
Topics: 1-Naphthylisothiocyanate; Afibrinogenemia; Aged; Animals; Bile Ducts; Cholestasis; Chronic Disease; Collagen; Diet; Disease Models, Animal; Early Growth Response Protein 1; Feeding Behavior; Female; Fibrin; Fibrinogen; Gene Expression Regulation; Humans; Hyperplasia; Inflammation; Liver; Liver Cirrhosis; Male; Mice; Middle Aged; Neutrophils; Xenobiotics | 2011 |
Visualization of clot lysis in a rat embolic stroke model: application to comparative lytic efficacy.
Topics: Animals; Annexin A2; Disease Models, Animal; Drug Therapy, Combination; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Intracranial Embolism; Intracranial Thrombosis; Magnetic Resonance Imaging; Male; Rats; Rats, Wistar; Recombinant Proteins; Thrombolytic Therapy | 2011 |
Different effects of clazosentan on consequences of subarachnoid hemorrhage in rats.
Topics: Analysis of Variance; Animals; Caspase 3; Chi-Square Distribution; Dioxanes; Disease Models, Animal; Electric Stimulation; Fibrinogen; Fluoresceins; Hippocampus; In Situ Nick-End Labeling; In Vitro Techniques; Long-Term Potentiation; Male; Organic Chemicals; Phosphopyruvate Hydratase; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Sulfonamides; Tetrazoles; Vasospasm, Intracranial | 2011 |
The prothrombinase activity of FGL2 contributes to the pathogenesis of experimental arthritis.
Topics: Animals; Antigens, CD; Arthritis, Experimental; Disease Models, Animal; Fibrin; Fibrinogen; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Knockout; Signal Transduction; Synovial Membrane; Thromboplastin; Up-Regulation | 2011 |
Coagulopathy during cardiac arrest and resuscitation in a swine model of electrically induced ventricular fibrillation.
Topics: Animals; Blood Coagulation Disorders; Cardiopulmonary Resuscitation; Disease Models, Animal; Fibrinogen; Heart Arrest; Heart Rate; Male; Platelet Aggregation; Risk Factors; Swine; Thrombelastography; Ventricular Fibrillation | 2011 |
The effects of Buyang Huanwu Decoction on hemorheological disorders and energy metabolism in rats with coronary heart disease.
Topics: Animals; Biomarkers; Blood Glucose; Blood Viscosity; Body Weight; Cardiovascular Agents; Coronary Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Energy Metabolism; Female; Fibrinogen; Hemorheology; Male; Myocardium; Physical Endurance; Platelet Aggregation; Qi; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Swimming; Time Factors; Tongue | 2011 |
Evaluation of the host response to endotoxemia of FVIII and FIX deficient mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Blood Coagulation; Cytokines; Disease Models, Animal; Endotoxemia; Escherichia coli Infections; Fibrinogen; Hemophilia A; Hemophilia B; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Partial Thromboplastin Time; Platelet Count; Survival Analysis | 2011 |
Histones induce rapid and profound thrombocytopenia in mice.
Topics: Animals; Disease Models, Animal; Fibrinogen; Histones; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Severity of Illness Index; Thrombocytopenia; Time Factors; Up-Regulation | 2011 |
Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis.
Topics: Animals; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Fibrinogen; Fibroblasts; Fibrosis; Intercellular Adhesion Molecule-1; Kidney Tubules; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88; Myofibroblasts; Rats; RNA Interference; Time Factors; Toll-Like Receptor 2; Toll-Like Receptor 4; Transfection; Ureteral Obstruction | 2011 |
Programmed death (PD)-1-deficient mice are extremely sensitive to murine hepatitis virus strain-3 (MHV-3) infection.
Topics: Animals; Antibodies, Blocking; Disease Models, Animal; Disease Progression; Fibrinogen; Hepatitis, Viral, Animal; Host-Pathogen Interactions; Interferon-gamma; Liver; Lymphoid Tissue; Mice; Mice, Knockout; Murine hepatitis virus; Programmed Cell Death 1 Receptor; Signal Transduction; Survival Rate; Tissue Array Analysis; Tumor Necrosis Factor-alpha | 2011 |
Fibrinolysis is down-regulated in mouse collagen-induced arthritis, but its normalization does not alleviate the course of disease.
Topics: Animals; Arthritis, Rheumatoid; Collagen; Disease Models, Animal; Disease Progression; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Immunohistochemistry; Interleukin-6; Male; Mice; Mice, Inbred DBA; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 2011 |
Progression of the prothrombotic state in aging Bmal1-deficient mice.
Topics: Aging; Aging, Premature; Animals; ARNTL Transcription Factors; Disease Models, Animal; Disease Progression; Endothelium, Vascular; Fibrinogen; Male; Mice; Mice, Knockout; Platelet Count; Prothrombin Time; Thrombomodulin; Thrombosis; von Willebrand Factor | 2011 |
Development of a flow cytometric assay for detection of coated platelets in dogs and evaluation of binding of coated platelets to recombinant human coagulation factor VIIa.
Topics: Animals; Antibodies; Blood Platelets; Crotalid Venoms; Disease Models, Animal; Dog Diseases; Dogs; Factor VIIa; Fibrinogen; Flow Cytometry; Hemophilia A; Hemophilia B; Humans; Lectins, C-Type; P-Selectin; Platelet Activation; Protein Binding; Recombinant Proteins; Thrombin; von Willebrand Diseases | 2011 |
Determination of edema in porcine coronary arteries by T2 weighted cardiovascular magnetic resonance.
Topics: Animals; Biomarkers; Coronary Artery Disease; Coronary Vessels; Disease Models, Animal; Edema, Cardiac; Female; Fibrinogen; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Observer Variation; Predictive Value of Tests; Reproducibility of Results; Swine; Time Factors | 2011 |
The platelet-surface thiol isomerase enzyme ERp57 modulates platelet function.
Topics: Adenosine Triphosphate; Animals; Antibodies; Blood Platelets; Calcium; Disease Models, Animal; Enzyme Inhibitors; Fibrinogen; Humans; Mice; Mice, Inbred C57BL; Platelet Aggregation; Protein Disulfide-Isomerases; Secretory Vesicles; Thrombosis; Time Factors | 2012 |
Fibrinogen/thrombin-based collagen fleece (TachoComb(R)) promotes regeneration in pulmonary arterial injury.
Topics: Animals; Aprotinin; Blood Loss, Surgical; Collagen; Disease Models, Animal; Dogs; Drug Combinations; Drug Evaluation, Preclinical; Feasibility Studies; Female; Fibrinogen; Hemostasis, Surgical; Hemostatics; Pulmonary Artery; Regeneration; Thoracotomy; Thrombin; Wound Healing | 2012 |
Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins.
Topics: alpha 1-Antitrypsin; Animals; Antithrombins; Carotid Artery Injuries; Chlorides; Disease Models, Animal; Dose-Response Relationship, Drug; Endotoxemia; Endotoxins; Factor Xa; Factor Xa Inhibitors; Factor XIa; Factor XIIa; Ferric Compounds; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Injections, Intravenous; Kinetics; Leukocyte Elastase; Mice; Mutation; NG-Nitroarginine Methyl Ester; Recombinant Fusion Proteins; Thrombin; Thrombosis | 2012 |
Activation state of platelets in experimental severe hemophilia A.
Topics: Animals; Blood Platelets; Cells, Cultured; Crosses, Genetic; Disease Models, Animal; Fibrinogen; Gene Expression; Hemophilia A; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Severity of Illness Index | 2012 |
A salmon thrombin-fibrinogen dressing controls hemorrhage in a swine model compared to standard kaolin-coated gauze.
Topics: Animals; Bandages; Disease Models, Animal; Fibrinogen; Hemorrhage; Hemostatic Techniques; Kaolin; Salmon; Swine; Thrombin | 2012 |
Fibrin-thrombin coated sealant increases strength of esophagogastric anastomoses in a rat model.
Topics: Anastomosis, Surgical; Animals; Body Weight; Disease Models, Animal; Drug Combinations; Esophagectomy; Fibrin Tissue Adhesive; Fibrinogen; Fibroblasts; Male; Postoperative Complications; Pressure; Rats; Rats, Wistar; Rupture, Spontaneous; Thrombin; Tissue Adhesives; Wound Healing | 2012 |
Fibrinogen, riboflavin, and UVA to immobilize a corneal flap--conditions for tissue adhesion.
Topics: Animals; Corneal Stroma; Disease Models, Animal; Drug Therapy, Combination; Fibrinogen; Keratomileusis, Laser In Situ; Myopia; Photosensitizing Agents; Rabbits; Riboflavin; Surgical Flaps; Tissue Adhesions; Ultraviolet Rays; Ultraviolet Therapy; Wound Healing | 2012 |
Properties of modified natural surfactant after exposure to fibrinogen in vitro and in an animal model of respiratory distress syndrome.
Topics: Animals; Disease Models, Animal; Fibrinogen; Humans; Infant, Newborn; Pulmonary Surfactants; Rabbits; Respiratory Distress Syndrome, Newborn; Surface Tension | 2012 |
Distinct and overlapping functional roles of Src family kinases in mouse platelets.
Topics: Animals; Blood Platelets; Carrier Proteins; Cell Shape; Disease Models, Animal; Fibrinogen; Mice; Mice, Knockout; Mutation; Peptides; Platelet Activation; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Signal Transduction; src-Family Kinases; Thrombosis; Time Factors | 2012 |
Salmon thrombin-fibrinogen dressing allows greater survival and preserves distal blood flow compared to standard kaolin gauze in coagulopathic Swine with a standardized lethal femoral artery injury.
Topics: Animals; Bandages; Disease Models, Animal; Femoral Artery; Fibrinogen; Hemorrhage; Hemostatic Techniques; Kaolin; Salmon; Swine; Thrombin | 2012 |
Different recovery profiles of coagulation factors, thrombin generation, and coagulation function after hemorrhagic shock in pigs.
Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Disease Models, Animal; Disease Progression; Fibrinogen; Hemodynamics; Male; Platelet Count; Random Allocation; Risk Factors; Sensitivity and Specificity; Shock, Hemorrhagic; Survival Rate; Sus scrofa; Swine; Thrombelastography; Thrombin Time; Time Factors | 2012 |
Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Topics: Animals; Arterial Occlusive Diseases; Blood Coagulation; Blood Gas Analysis; Blood Platelets; Blood Pressure; Boranes; Carbon Monoxide; Carbonates; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Green Fluorescent Proteins; Injections, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Organometallic Compounds; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Prothrombin Time; Rats; Rats, Wistar; Solubility; Thrombosis; Time Factors; Venous Thrombosis; Water | 2012 |
Dysregulated coagulation associated with hypofibrinogenaemia and plasma hypercoagulability: implications for identifying coagulopathic mechanisms in humans.
Topics: Afibrinogenemia; Amino Acid Substitution; Animals; Biopolymers; Blood Coagulation Tests; Carotid Artery Thrombosis; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Factor VIII; Female; Fibrinogen; Fibrinolysis; Gene Deletion; Hemorrhagic Disorders; Heterozygote; Humans; Ischemic Attack, Transient; Mice; Mice, Mutant Strains; Middle Aged; Mutation, Missense; Point Mutation; Retinal Artery Occlusion; Thrombin; Thrombophilia | 2012 |
Activation of platelet protein kinase C by ultraviolet light B mediates platelet transfusion-related acute lung injury in a two-event animal model.
Topics: Acute Lung Injury; Animals; Biomarkers; Blood Platelets; Blood Safety; Bronchoalveolar Lavage Fluid; Chemokine CXCL2; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Flow Cytometry; Humans; Lipopolysaccharides; Mice; Mice, SCID; Platelet Aggregation; Platelet Transfusion; Protein Kinase C; Ultraviolet Rays | 2013 |
Mechanisms of microthrombosis and microcirculatory constriction after experimental subarachnoid hemorrhage.
Topics: Analysis of Variance; Animals; Constriction, Pathologic; Disease Models, Animal; Fibrinogen; In Situ Nick-End Labeling; Male; Mice; Microcirculation; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Microvessels; Neurons; Nitric Oxide; Subarachnoid Hemorrhage; Thrombosis | 2013 |
Enhanced cryoprecipitate for skin graft and donor site wound healing in pigs.
Topics: Animals; Disease Models, Animal; Factor VIII; Fibrinogen; Fibronectins; Skin Transplantation; Swine; Transplant Donor Site; Wound Healing | 2014 |
Fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes rescue thrombocytopenic rabbits from non-compressible liver hemorrhage.
Topics: Acute Disease; Adenosine Diphosphate; Animals; Blood Coagulation Tests; Blood Platelets; Disease Models, Animal; Feasibility Studies; Fibrinogen; Hemorrhage; Hemostasis; Hemostatics; Liposomes; Liver Diseases; Male; Microscopy, Immunoelectron; Oligopeptides; Platelet Aggregation; Platelet Count; Rabbits; Thrombocytopenia; Time Factors; Wounds, Penetrating | 2012 |
Elevation of fibrinogen due to loss of ovarian function enhances actin ring formation and leads to increased bone resorption.
Topics: Actin Cytoskeleton; Actins; Analysis of Variance; Animals; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Cell Survival; Cells, Cultured; Disease Models, Animal; Female; Fibrinogen; Intracellular Signaling Peptides and Proteins; Macrophage Colony-Stimulating Factor; Male; Mice; Mice, Inbred C57BL; Osteoclasts; Osteoporosis; Ovariectomy; Postmenopause; Receptors, Vitronectin; Signal Transduction; Statistics, Nonparametric; X-Ray Microtomography | 2012 |
Biochemical analysis of pentraxin 3 and fibrinogen levels in experimental periodontitis model.
Topics: Animals; C-Reactive Protein; Connective Tissue; Disease Models, Animal; Fibrinogen; Male; Periodontitis; Periodontium; Random Allocation; Rats; Rats, Wistar; Serum Amyloid P-Component | 2012 |
Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
Topics: Acetylglucosamine; Animals; Antibodies, Bacterial; Antibody Specificity; Bacteremia; Chromatography, Gel; Coagulase; Cytotoxicity, Immunologic; Disease Models, Animal; Female; Fibrinogen; Goats; Immobilized Proteins; Immune Sera; Macaca mulatta; Mice; Microscopy, Confocal; Models, Immunological; Opsonin Proteins; Phagocytes; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vaccines, Conjugate | 2012 |
Embolic middle cerebral artery occlusion model using thrombin and fibrinogen composed clots in rat.
Topics: Animals; Anticoagulants; Disease Models, Animal; Fibrinogen; Infarction, Middle Cerebral Artery; Male; Rats; Rats, Sprague-Dawley; Thrombin; Thrombosis; Tissue Plasminogen Activator | 2012 |
Prevention of postoperative pericardial adhesions with TachoSil.
Topics: Animals; Disease Models, Animal; Drug Combinations; Female; Fibrinogen; Heart Diseases; Pericardium; Postoperative Complications; Postoperative Period; Rabbits; Surgical Sponges; Thoracic Surgical Procedures; Thrombin; Tissue Adhesions | 2013 |
Systemic effects induced by the venom of the snake Bothrops caribbaeus in a murine model.
Topics: Animals; Bothrops; Coagulants; Crotalid Venoms; Disease Models, Animal; Edetic Acid; Fibrinogen; Hemorrhage; Humans; Injections, Intravenous; Lectins, C-Type; Longevity; Lung Diseases; Male; Metalloproteases; Mice; Platelet Aggregation; Species Specificity; Thrombocytopenia; Thrombosis | 2013 |
Intravenous release of NO from lipidic microbubbles accelerates deep vein thrombosis resolution in a rat model.
Topics: Animals; Blotting, Western; Disease Models, Animal; Drug Carriers; Endothelial Cells; Fibrinogen; Fibrinolytic Agents; Gene Expression Regulation; Iliac Vein; Immunohistochemistry; Injections, Intravenous; Ligation; Lipids; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microbubbles; Nitric Oxide; Nitric Oxide Synthase Type III; Partial Thromboplastin Time; Prothrombin Time; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA, Messenger; Thrombin Time; Thrombomodulin; Time Factors; Vascular Cell Adhesion Molecule-1; Vena Cava, Inferior; Venous Thrombosis | 2013 |
Presence and role of anti-citrullinated protein antibodies in experimental arthritis models.
Topics: Adjuvants, Immunologic; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; Citrulline; Collagen Type II; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; False Positive Reactions; Fibrinogen; Freund's Adjuvant; Genetic Predisposition to Disease; Immunotherapy, Active; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Myelin Basic Protein; Protein Processing, Post-Translational; Proteins | 2013 |
Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM·CAIX in immunocompetent mouse models.
Topics: Animals; Antibodies; Cancer Vaccines; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma, Renal Cell; Cell Adhesion Molecules; Cell Line, Tumor; Chemokine CCL1; Dendritic Cells; Disease Models, Animal; Female; Fibrinogen; Gene Expression; Immunotherapy, Adoptive; Kidney Neoplasms; Lectins, C-Type; Mice; Mice, Inbred BALB C; MicroRNAs; NK Cell Lectin-Like Receptor Subfamily A; Receptors, Cell Surface | 2013 |
Long-term stable cultures of rat hepatocytes: an in vitro model to study acute and chronic hepatic inflammation.
Topics: Albumins; Animals; Cell Culture Techniques; Disease Models, Animal; Female; Fibrinogen; Hepatitis, Chronic; Hepatocytes; Interleukin-1; Interleukin-6; Nitric Oxide; Rats; Rats, Inbred Lew; Urea | 2002 |
Platelet and fibrinogen turnover at the exposed subendothelium measured over 1 year after a balloon catheter de-endothelializing injury to the rabbit aorta: thrombotic eruption at the late re-endothelialization stage.
Topics: Animals; Aorta, Thoracic; Catheterization; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Fibrinogen; Hemostasis; Immunohistochemistry; Platelet Adhesiveness; Platelet Count; Rabbits; Radioimmunoassay; Reperfusion Injury; Sensitivity and Specificity; Thrombosis; Tunica Intima | 2002 |
Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats.
Topics: Animals; Arthritis, Experimental; Cartilage, Articular; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Extracellular Matrix Proteins; Fibrinogen; Glycoproteins; Hyaluronic Acid; Male; Matrilin Proteins; Rats; Rats, Inbred Strains; Severity of Illness Index; Synovitis | 2002 |
Characterizing fibrin glue performance as modulated by heparin, aprotinin, and factor XIII.
Topics: Animals; Aprotinin; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Glutaminase; Hemostasis, Surgical; Heparin; Humans; In Vitro Techniques; Kidney; Male; Rats; Rats, Sprague-Dawley; Skin; Stress, Mechanical; Tensile Strength; Thrombin; Wound Healing | 2002 |
Genetic contribution to the septic response in a mouse model.
Topics: Animals; Disease Models, Animal; Fibrinogen; Interleukin-1; Interleukin-10; Interleukin-6; Leptin; Liver; Male; Metallothionein; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Peroxidase; Sepsis; Species Specificity; Survival Rate; Tumor Necrosis Factor-alpha | 2002 |
Haemorheological variables in a rat model of hypertriglyceridaemic obesity and diabetes.
Topics: Animals; Blood Glucose; Blood Viscosity; Body Weight; Cholesterol; Diabetes Mellitus; Disease Models, Animal; Erythrocyte Deformability; Fibrinogen; Glucose Tolerance Test; Hematocrit; Hemoglobins; Male; Obesity; Rats; Rats, Inbred Strains; Rheology; Statistics, Nonparametric; Triglycerides | 2002 |
Effects of hyperfibrinogenemia on vasculature of C57BL/6 mice with and without atherogenic diet.
Topics: Animals; Aorta; Aortic Diseases; Arteriosclerosis; Cholesterol, Dietary; Diet, Atherogenic; Disease Models, Animal; Fasting; Fibrinogen; Frozen Sections; Genotype; Mice; Mice, Inbred C57BL; Mice, Transgenic; Sinus of Valsalva | 2003 |
Correction of haemorheological disturbances in myocardial infarction by diquertin and ascorbic acid.
Topics: Animals; Antioxidants; Ascorbic Acid; Blood Viscosity; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Erythrocyte Aggregation; Fibrinogen; Male; Myocardial Infarction; Phytotherapy; Quercetin; Rats; Rats, Wistar | 2003 |
Increase of arterial thrombosis parameters in chronic Helicobacter pylori infection in mice.
Topics: Animals; Bacterial Proteins; Chronic Disease; Disease Models, Animal; Embolism; Erythrocyte Count; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Lasers; Leukocyte Count; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Platelet Aggregation; Platelet Count; Polymerase Chain Reaction; Thrombosis | 2002 |
Tumor necrosis factor-alpha inhibition reduces CXCL-8 levels but fails to prevent fibrin generation and does not improve outcome in a rabbit model of endotoxic shock.
Topics: Animals; Antibodies, Monoclonal; Blood Pressure; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fibrin; Fibrinogen; Interleukin-8; Kidney; Leukocytes; Lipopolysaccharides; Lung; Male; Rabbits; Shock, Septic; Survival Rate; Tumor Necrosis Factor-alpha | 2003 |
Influence of TachoComb in comparison to local hemostyptic agents on epidural fibrosis in a rat laminectomy model.
Topics: Animals; Aprotinin; Cicatrix; Disease Models, Animal; Drug Combinations; Epidural Space; Fibrin Foam; Fibrinogen; Fibrosis; Intervertebral Disc Displacement; Laminectomy; Lumbar Vertebrae; Postoperative Complications; Rats; Rats, Wistar; Severity of Illness Index; Spinal Diseases; Thrombin; Tissue Adhesives | 2003 |
Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS).
Topics: Acute Disease; Aniline Compounds; Animals; Blood Gas Analysis; Bronchoalveolar Lavage; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Fibrinogen; Injections, Intravenous; Intubation, Intratracheal; Lung; Male; Microscopy, Confocal; Pulmonary Surfactants; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Respiratory Distress Syndrome; Thiophenes | 2003 |
Advanced hemostatic dressing development program: animal model selection criteria and results of a study of nine hemostatic dressings in a model of severe large venous hemorrhage and hepatic injury in Swine.
Topics: Animals; Bandages; Blood Pressure; Collagen; Confidence Intervals; Disease Models, Animal; Female; Fibrinogen; Hemorrhage; Hemostatic Techniques; Hemostatics; Liver; Male; Propyl Gallate; Swine; Thrombin | 2003 |
Cause-effect relation between hyperfibrinogenemia and vascular disease.
Topics: Animals; Carotid Arteries; Chlorides; Cross-Linking Reagents; Dimerization; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Ferric Compounds; Fibrinogen; Mice; Mice, Transgenic; Protein Binding; Thrombin; Thrombosis; Vascular Diseases | 2004 |
Increase in hepatic mRNA expression of coagulant factors in type 2 diabetic model mice.
Topics: Animals; Blood Coagulation Factors; Diabetes Mellitus, Type 2; Disease Models, Animal; DNA, Complementary; Fibrinogen; Mice; Mice, Mutant Strains; Prothrombin; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic | 2003 |
M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage.
Topics: Animals; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Capillary Permeability; Carrier Proteins; CD18 Antigens; Chemotaxis, Leukocyte; Disease Models, Animal; Female; Fibrinogen; Humans; In Vitro Techniques; Inflammation Mediators; Ions; LDL-Receptor Related Protein-Associated Protein; Macromolecular Substances; Metals; Mice; Microscopy, Electron, Scanning; Neutrophils; Peptide Fragments; Pneumonia; Shock, Septic; Signal Transduction; Streptococcal Infections; Streptococcus pyogenes | 2004 |
Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis.
Topics: Animals; Blood Platelets; Cell Line, Tumor; Disease Models, Animal; Female; Fibrinogen; Male; Melanoma; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neoplasm Transplantation; Neoplastic Cells, Circulating; Receptor, PAR-1; Receptor, PAR-2; Receptors, Thrombin; Skin Neoplasms | 2004 |
A recombinant murine meizothrombin precursor, prothrombin R157A/R268A, inhibits thrombosis in a model of acute carotid artery injury.
Topics: Acute Disease; Animals; Carotid Artery Injuries; Cells, Cultured; Cricetinae; Disease Models, Animal; Enzyme Precursors; Fibrinogen; Kidney; Mice; Mice, Mutant Strains; Mutagenesis; Platelet Activation; Protein C; Prothrombin; Recombinant Proteins; Thrombin; Thrombomodulin; Thrombosis | 2004 |
Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
Topics: Animals; Chick Embryo; Chickens; Chorion; Disease Models, Animal; Fibrin Fibrinogen Degradation Products; Fibrinogen; Lung Neoplasms; Neovascularization, Pathologic; Pleural Effusion; Rabbits; Tumor Virus Infections | 2004 |
Fibrin tissue adhesive and autologous concha cartilage for reconstruction of the posterior-superior canal wall of the chinchilla middle ear.
Topics: Animals; Biocompatible Materials; Cartilage; Chinchilla; Disease Models, Animal; Ear Diseases; Ear, Middle; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Humans; Plastic Surgery Procedures; Thrombin; Tissue Adhesives; Turbinates | 2004 |
The molecular basis of streptococcal toxic shock syndrome.
Topics: Animals; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Carrier Proteins; Disease Models, Animal; Fibrinogen; Lymphocyte Activation; Neutrophils; Shock, Septic; Streptococcal Infections; Streptococcus pyogenes | 2004 |
The effect of fibrinogen concentrate administration on coagulation abnormalities in a rat sepsis model.
Topics: Animals; Antithrombin III; Blood Coagulation; Disease Models, Animal; Female; Fibrinogen; Humans; Lipopolysaccharides; Peptide Hydrolases; Plasma; Rats; Shock, Septic; Thrombelastography | 2004 |
Application of the poly-N-acetyl glucosamine-derived rapid deployment hemostat trauma dressing in severe/lethal Swine hemorrhage trauma models.
Topics: Acetylglucosamine; Animals; Aorta, Abdominal; Aprotinin; Bandages; Blood Cell Count; Blood Volume; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Femoral Artery; Fibrinogen; Hemorrhage; Hemostatic Techniques; Hemostatics; Military Medicine; Platelet Count; Survival Rate; Swine; Thrombin; Time Factors; Wounds, Penetrating | 2004 |
Comparison of poly-N-acetyl glucosamine with commercially available topical hemostats for achieving hemostasis in coagulopathic models of splenic hemorrhage.
Topics: Acetylglucosamine; Administration, Topical; Animals; Aprotinin; Body Temperature; Cellulose, Oxidized; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Female; Fibrin Foam; Fibrin Tissue Adhesive; Fibrinogen; Hemophilia B; Hemorrhage; Hemostatic Techniques; Hemostatics; Hypothermia, Induced; Rabbits; Spleen; Swine; Thrombin; Wounds, Penetrating | 2004 |
Neonatal bleeding and decreased plasma fibrinogen levels in mice modeled after the dysfibrinogen Vlissingen/Frankfurt IV.
Topics: Animals; Calcium; Disease Models, Animal; DNA Primers; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Fibrinogens, Abnormal; Fibrinolysin; Genetic Vectors; Genotype; Heterozygote; Homozygote; Immunoblotting; Liver; Male; Mice; Mice, Inbred C57BL; Mutation; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2004 |
Comparative effects of microplasmin and tissue-type plasminogen activator (tPA) on cerebral hemorrhage in a middle cerebral artery occlusion model in mice.
Topics: alpha-2-Antiplasmin; Animals; Bleeding Time; Cerebral Hemorrhage; Disease Models, Animal; Fibrinogen; Fibrinolysin; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Partial Thromboplastin Time; Peptide Fragments; Thrombolytic Therapy; Tissue Plasminogen Activator | 2004 |
[Effect of the extract from Peristrophe roxburghiana on hemorheology in rats].
Topics: Acanthaceae; Animals; Blood Viscosity; Disease Models, Animal; Drugs, Chinese Herbal; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Male; Phototherapy; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Thrombosis | 2002 |
[A study of human annexin V derivative: its effects of anticoagulation and antithrombosis].
Topics: Animals; Annexin A5; Anticoagulants; Blood Coagulation; Disease Models, Animal; Fibrinogen; Humans; Injections, Intravenous; Male; Partial Thromboplastin Time; Prothrombin Time; Rabbits; Random Allocation; Thrombin Time; Thrombosis | 2004 |
Endogenous glucocorticoids modulate neutrophil function in a murine model of haemolytic uraemic syndrome.
Topics: Animals; Apoptosis; Cell Adhesion; Cell Migration Inhibition; Collagen Type II; Disease Models, Animal; Fibrinogen; Glucocorticoids; Hemolytic-Uremic Syndrome; Hormone Antagonists; Leukocyte Count; Male; Mice; Mice, Inbred BALB C; Mifepristone; Neutrophils; Phagocytosis; Reactive Oxygen Species; Receptors, Glucocorticoid; Serum Albumin, Bovine; Shiga Toxin 2; Tetradecanoylphorbol Acetate | 2005 |
Regulation of tissue factor-induced coagulation and platelet aggregation in flowing whole blood.
Topics: Adenosine Monophosphate; Alprostadil; Animals; Blood Coagulation; Disease Models, Animal; Drug Interactions; Fibrin; Fibrinogen; Fibrinolytic Agents; Male; Perfusion; Phosphatidylserines; Platelet Activation; Platelet Aggregation; Rats; Rats, Wistar; Thrombin; Thromboplastin | 2005 |
Secondary effects of femoral instrumentation on pulmonary physiology in a standardised sheep model: what is the effect of lung contusion and reaming?
Topics: Animals; Antibodies; Antithrombin III; Blood Coagulation; Capillary Permeability; Contusions; Disease Models, Animal; Endothelium, Vascular; Factor V; Female; Femoral Fractures; Fibrinogen; Fracture Fixation; Fracture Fixation, Intramedullary; Lung Injury; Neutrophils; Pulmonary Circulation; Pulmonary Edema; Random Allocation; Sheep | 2005 |
Homozygosity for factor V Leiden leads to enhanced thrombosis and atherosclerosis in mice.
Topics: Animals; Aortic Diseases; Arteriosclerosis; Bone Marrow Transplantation; Carotid Artery Injuries; Carotid Artery Thrombosis; Disease Models, Animal; Factor V; Fibrinogen; Homozygote; Mice; Mice, Mutant Strains; Photochemistry; Thrombin; Thrombosis | 2005 |
Independent contributions of hypothermia and acidosis to coagulopathy in swine.
Topics: Acidosis; Animals; Blood Coagulation Disorders; Blood Pressure; Disease Models, Animal; Fibrinogen; Heart Rate; Hypothermia; Platelet Count; Reference Values; Swine; Thrombin; Whole Blood Coagulation Time | 2005 |
Characterization of a novel thrombotic middle cerebral artery occlusion model in monkeys that exhibits progressive hypoperfusion and robust cortical infarction.
Topics: Animals; Biomarkers; Cerebral Cortex; Cerebral Infarction; Cerebrovascular Circulation; Cerebrovascular Disorders; Disease Models, Animal; Disease Progression; Fibrinogen; Infarction, Middle Cerebral Artery; Intracranial Thrombosis; Macaca fascicularis; Male; Middle Cerebral Artery; Peroxidase; Photic Stimulation; Positron-Emission Tomography; Rose Bengal; Surgical Instruments | 2005 |
An animal model for venous thrombosis and spontaneous pulmonary embolism.
Topics: Animals; Autoradiography; Blood Coagulation Factors; Body Weight; Disease Models, Animal; Dogs; Fibrinogen; Humans; Iodine Isotopes; Lung; Platelet Aggregation; Pulmonary Embolism; Radiography; Sodium Morrhuate; Staining and Labeling; Thromboembolism; Time Factors; Tissue Distribution; Venous Thrombosis | 2005 |
Enhancement of the coagulation system in spontaneously hypertensive and hyperlipidemic rats.
Topics: alpha-2-Antiplasmin; Animals; Antithrombin III; Blood Coagulation Factors; Disease Models, Animal; Female; Fibrinogen; Hyperlipidemias; Hypertension; Liver; Peptide Hydrolases; Plasminogen; Prothrombin; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; RNA, Messenger | 2005 |
Pharmacological correction of changes in the lung-placenta system under experimental conditions.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fibrinogen; Hydrocortisone; Lung; Nadroparin; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy, Animal; Rats; Salts; Sodium; Time Factors | 2005 |
DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model.
Topics: Aminoacyltransferases; Animals; Bacterial Proteins; Blood Proteins; Cell Adhesion; Cell Membrane; Disease Models, Animal; Drug Resistance, Bacterial; Endocarditis, Bacterial; Endothelial Cells; Fibrinogen; Fibronectins; Gene Deletion; Membrane Proteins; Mutation; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Teichoic Acids; Virulence | 2005 |
Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B.
Topics: Animals; Disease Models, Animal; Disease Progression; Female; Fibrinogen; Hepatitis B; Hepatitis, Viral, Animal; Humans; Liver; Mice; Mice, Inbred BALB C; Murine hepatitis virus; Thromboplastin | 2005 |
Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Calcium; Cell Shape; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Femoral Artery; Fibrinogen; Fibrinolytic Agents; GTP-Binding Protein alpha Subunits, Gq-G11; Ligation; Macaca fascicularis; P-Selectin; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thrombin; Regional Blood Flow; Stress, Mechanical; Thrombosis | 2006 |
Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice.
Topics: Animals; Cell Line; Cells, Cultured; Disease Models, Animal; DNA, Antisense; Fibrinogen; Gene Expression; Genetic Therapy; Hepatitis, Viral, Animal; Liver; Macrophages; Mice; Mice, Inbred BALB C; Murine hepatitis virus; Plasmids; Survival Rate | 2006 |
Recombinant human antithrombin expressed in Chinese hamster ovary cells shows in vivo efficacy on rat DIC model similarly to plasma-derived antithrombin regardless of different N-glycosylation.
Topics: Alanine Transaminase; Animals; Antithrombin III Deficiency; Antithrombins; Aspartate Aminotransferases; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Disseminated Intravascular Coagulation; Fibrinogen; Glycosylation; Humans; Lipopolysaccharides; Male; Oligosaccharides; Protein Isoforms; Rats; Rats, Wistar; Recombinant Proteins; Stereoisomerism; Thromboplastin; Time Factors | 2007 |
gC1qR/p33 blockade reduces Staphylococcus aureus colonization of target tissues in an animal model of infective endocarditis.
Topics: Animals; Antibodies, Monoclonal; Aortic Valve; Bacterial Adhesion; Complement C1q; Disease Models, Animal; Endocarditis, Bacterial; Fibrinogen; Humans; Kidney; Membrane Glycoproteins; Rats; Receptors, Complement; Spleen; Staphylococcal Infections; Staphylococcus aureus; Virulence | 2006 |
Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy--a porcine model.
Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Loss, Surgical; Disease Models, Animal; Drug Therapy, Combination; Fibrinogen; Fluid Therapy; Hemodynamics; Hemostatics; Hydroxyethyl Starch Derivatives; Microscopy, Electron, Scanning; Swine; Thrombelastography | 2006 |
Preconditioning ischemia attenuates molecular indices of platelet activation-aggregation.
Topics: Animals; Blood Flow Velocity; Blood Platelets; Coronary Circulation; Coronary Thrombosis; Coronary Vessels; Disease Models, Animal; Dogs; Fibrinogen; Ischemic Preconditioning, Myocardial; Myocardial Reperfusion Injury; P-Selectin; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Random Allocation; Vascular Patency | 2006 |
Inhibition of integrin alphavbeta3 reduces blood-brain barrier breakdown in focal ischemia in rats.
Topics: Analysis of Variance; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blood-Brain Barrier; Blotting, Western; Brain Edema; Disease Models, Animal; Evans Blue; Fibrinogen; Gene Expression Regulation; Granulocyte Colony-Stimulating Factor; Immunohistochemistry; Infarction, Middle Cerebral Artery; Integrin alphaVbeta3; Interleukin-3; Male; Neurologic Examination; Peptides, Cyclic; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Recombinant Proteins; Tetraspanin 30; Vascular Endothelial Growth Factor A | 2006 |
A coagulation factor VII deficiency protects against acute inflammatory responses in mice.
Topics: Ancrod; Animals; Anticoagulants; Antithrombin III; Biomarkers; Blood Coagulation; Disease Models, Animal; Down-Regulation; Early Growth Response Protein 1; Endotoxemia; Factor VII Deficiency; Factor Xa; Fibrinogen; Fondaparinux; Hirudins; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Neutrophils; Peptide Hydrolases; Polysaccharides; Recombinant Proteins; Signal Transduction; Thrombin | 2006 |
A novel poly(ethylene glycol)-fibrinogen hydrogel for tibial segmental defect repair in a rat model.
Topics: Absorbable Implants; Animals; Bone Regeneration; Disease Models, Animal; Female; Fibrinogen; Fractures, Bone; Hydrogels; Materials Testing; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Tibia | 2007 |
Focal arterial inflammation is augmented in mice with a deficiency of the protein C gene.
Topics: Animals; Arteritis; Carotid Arteries; Carotid Artery Diseases; Cell Movement; Cell Proliferation; Copper; Disease Models, Animal; Fibrin; Fibrinogen; Mice; Mice, Transgenic; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Necrosis; Protein C; Protein C Deficiency; Time Factors; Tunica Intima | 2006 |
Study of hemorheological parameters following partial hepatectomy in rats with chronic aluminium intoxication.
Topics: Aluminum; Anemia; Animals; Blood Viscosity; Cholesterol; Disease Models, Animal; Erythrocyte Deformability; Erythrocyte Indices; Erythrocytes, Abnormal; Fibrinogen; Hemorheology; Hepatectomy; Male; Random Allocation; Rats | 2006 |
The dynamic changes of LDH isoenzyme 3 and D-dimer following pulmonary thromboembolism in canine.
Topics: Animals; Disease Models, Animal; Dogs; Fibrin Fibrinogen Degradation Products; Fibrinogen; Isoenzymes; Kinetics; L-Lactate Dehydrogenase; Pulmonary Embolism; Thrombin; Time Factors | 2007 |
Coagulation and endothelial dysfunction during longterm hyperdynamic porcine bacteremia--effects of selective inducible nitric oxide synthase inhibition.
Topics: Acid-Base Equilibrium; Animals; Bacteremia; Blood Coagulation; Cardiovascular System; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Fibrinogen; Lysine; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Pseudomonas aeruginosa; Pseudomonas Infections; Swine; Time Factors | 2007 |
Development of hyperfibrinogenemia in spontaneously hypertensive and hyperlipidemic rats: a potentially useful animal model as a complication of hypertension and hyperlipidemia.
Topics: Animals; Antithrombin III; Blood Coagulation; Disease Models, Animal; Fibrinogen; Fibrinolysis; Hyperlipidemias; Hypertension; Male; Plasminogen; Prothrombin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Thrombophilia | 2007 |
Pathogenic implication of a fibrinogen-binding protein of Staphylococcus epidermidis in a rat model of intravascular-catheter-associated infection.
Topics: Animals; Bacterial Adhesion; Bacterial Proteins; Catheterization, Central Venous; Disease Models, Animal; Fibrinogen; Rats; Staphylococcal Infections; Staphylococcus epidermidis | 2007 |
The effects of the fibrin-derived peptide Bbeta(15-42) in acute and chronic rodent models of myocardial ischemia-reperfusion.
Topics: Animals; CD18 Antigens; Cyclic N-Oxides; Disease Models, Animal; Fibrinogen; Free Radical Scavengers; Interleukin-6; Mice; Mice, Inbred BALB C; Models, Biological; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Rats; Reperfusion Injury; Spin Labels | 2007 |
Two diallyl sulphides derived from garlic inhibit meticillin-resistant Staphylococcus aureus infection in diabetic mice.
Topics: Allyl Compounds; Animals; Anti-Bacterial Agents; Antithrombin III; C-Reactive Protein; Colony Count, Microbial; Cytokines; Diabetes Mellitus, Experimental; Disease Models, Animal; Disulfides; Fibrinogen; Fibronectins; Garlic; Humans; Kidney; Male; Malondialdehyde; Methicillin Resistance; Mice; Mice, Inbred BALB C; Microbial Viability; Plasminogen Activator Inhibitor 1; Protein C; Spleen; Staphylococcal Infections; Staphylococcus aureus; Streptozocin; Sulfides | 2007 |
Phase-variable expression of the biofilm-associated protein (Bap) in Staphylococcus aureus.
Topics: Animals; Bacterial Adhesion; Bacterial Proteins; Biofilms; Blotting, Northern; Blotting, Southern; Disease Models, Animal; DNA, Bacterial; Fibrinogen; Fibronectins; Gene Expression Regulation, Bacterial; Mammary Glands, Animal; Polymorphism, Restriction Fragment Length; RNA, Bacterial; RNA, Messenger; Sequence Analysis, DNA; Sheep; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Increased protein nitration burden in the atherosclerotic lesions and plasma of apolipoprotein A-I deficient mice.
Topics: Animals; Aorta; Apolipoprotein A-I; Atherosclerosis; Autoantibodies; Blood Coagulation; Blood Proteins; Cholesterol, HDL; Disease Models, Animal; Female; Fibrin; Fibrinogen; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Immunoelectron; Nitrogen; Oxidants; Proteomics; Tyrosine | 2007 |
Pretreatment of curcumin attenuates coagulopathy and renal injury in LPS-induced endotoxemia.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Platelets; Curcumin; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxemia; Escherichia coli; Fibrin; Fibrinogen; Injections, Intraperitoneal; Kidney Glomerulus; Lipopolysaccharides; Male; Rats; Rats, Sprague-Dawley; Survival Rate; Tumor Necrosis Factor-alpha | 2007 |
Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Disease Models, Animal; Disease Progression; Fibrin; Fibrinogen; Inflammation; Mice; Mice, Transgenic; Models, Biological; Permeability; Plasminogen; Tranexamic Acid | 2007 |
Haemostatic fleece (TachoComb) to prevent intrapleural adhesions after thoracotomy: a rat model.
Topics: Animals; Aprotinin; Disease Models, Animal; Drug Combinations; Fibrinogen; Hemostasis, Surgical; Hemostatics; Male; Pleural Diseases; Postoperative Complications; Rats; Rats, Sprague-Dawley; Thoracotomy; Thrombin; Tissue Adhesions; Treatment Outcome | 2007 |
A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
Topics: Administration, Oral; Animals; Aorta; Aspirin; Bleeding Time; Blood Coagulation; Clopidogrel; Disease Models, Animal; Fibrin; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Naphthalenes; Platelet Activation; Platelet Aggregation Inhibitors; Propionates; Prosthesis Design; Receptors, Thromboxane A2, Prostaglandin H2; Stainless Steel; Stents; Swine; Thrombosis; Ticlopidine; Time Factors | 2007 |
Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway.
Topics: Animals; Anticoagulants; Blood Coagulation; Disease Models, Animal; Dose-Response Relationship, Drug; Factor VIII; Fibrinogen; Male; Papio; Partial Thromboplastin Time; Peptide Fragments; Prothrombin Time; Thrombin; Thrombosis | 2007 |
Interferon-gamma exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chronic Disease; Diet; Disease Models, Animal; Fibrinogen; Hepatocytes; Inflammation; Interferon-gamma; Liver Cirrhosis; Mice; Recombinant Proteins; Stem Cells | 2007 |
Acidosis and coagulopathy: the differential effects on fibrinogen synthesis and breakdown in pigs.
Topics: Acidosis; Animals; Blood Coagulation; Blood Coagulation Tests; Disease Models, Animal; Fibrinogen; Hematocrit; Platelet Count; Swine; Time Factors | 2007 |
Hemostatic efficacy of a recombinant thrombin-coated polyglycolic acid sheet coupled with liquid fibrinogen, evaluated in a canine model of pulmonary arterial hemorrhage.
Topics: Animals; Bandages; Blood Pressure; Disease Models, Animal; Dogs; Female; Fibrin; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Hemostatics; Lacerations; Polyglycolic Acid; Pulmonary Artery; Recombinant Proteins; Thrombin; Treatment Outcome | 2007 |
Opacity factor activity and epithelial cell binding by the serum opacity factor protein of Streptococcus pyogenes are functionally discrete.
Topics: Animals; Antigens, Bacterial; Apolipoprotein A-I; Bacterial Adhesion; Bacterial Proteins; Cell Line; Disease Models, Animal; Epithelial Cells; Fibrinogen; Fibronectins; Immunization; Mice; Mice, Inbred BALB C; Mutation; Peptide Hydrolases; Peptides; Protein Binding; Protein Structure, Tertiary; Streptococcal Infections; Streptococcal Vaccines; Streptococcus pyogenes | 2008 |
Femoral nailing-related coagulopathy determined by first-hit magnitude: an animal study.
Topics: Animals; Antithrombin III; Blood Coagulation Disorders; Bone Nails; Contusions; Disease Models, Animal; Factor V; Femoral Fractures; Fibrinogen; Lung Injury; Postoperative Complications; Risk Factors; Sheep; Shock, Hemorrhagic; Thoracotomy | 2008 |
Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Astrocytes; Blood-Brain Barrier; Caffeine; Central Nervous System Stimulants; Cholesterol; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinogen; Immunoglobulin G; Membrane Proteins; Microglia; Occludin; Rabbits; Random Allocation; Tight Junctions | 2008 |
Protective role of metallothionein in coagulatory disturbance accompanied by acute liver injury induced by LPS/D-GalN.
Topics: Animals; Blood Coagulation; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Disseminated Intravascular Coagulation; Fibrinogen; Galactosamine; Lipopolysaccharides; Liver; Liver Diseases; Metallothionein; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Count; Time Factors | 2008 |
M protein-mediated plasminogen binding is essential for the virulence of an invasive Streptococcus pyogenes isolate.
Topics: Animals; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Base Sequence; Carrier Proteins; Disease Models, Animal; DNA Primers; DNA, Bacterial; Fibrinogen; Genes, Bacterial; Humans; Immunity, Innate; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Phagocytosis; Plasminogen; Protein Binding; Recombinant Proteins; Streptococcal Infections; Streptococcus pyogenes; Virulence | 2008 |
Effects of protease inhibitors on coagulation abnormalities in acute canine pancreatitis.
Topics: Acute Disease; alpha-2-Antiplasmin; Amylases; Animals; Antithrombin III; Aprotinin; Blood Coagulation; Disease Models, Animal; Dogs; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Oligopeptides; Pancreatitis; Peptide Fragments; Platelet Count; Protease Inhibitors; Prothrombin Time | 1984 |
[Fluctuations in pulmonary fibrin decomposing activities (plasmin and non-plasmin activities) in an endotoxin DIC model in rats].
Topics: Animals; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxins; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Lung; Plasminogen Activators; Rats; Rats, Inbred Strains | 1982 |
Application of a synthetic serine protease inhibitor in the treatment of DIC.
Topics: Animals; Chemical Phenomena; Chemistry; Disease Models, Animal; Disseminated Intravascular Coagulation; Fibrinogen; Fibrinolysin; Fibrinolysis; Gabexate; Guanidines; Humans; In Vitro Techniques; Protease Inhibitors; Rats; Rats, Inbred Strains; Thrombin; Thrombosis | 1983 |
Studies of Factors V and VIII:C in an animal model of disseminated intravascular coagulation.
Topics: Animals; Disease Models, Animal; Disseminated Intravascular Coagulation; Dogs; Factor V; Factor VIII; Factor X; Factor Xa; Fibrinogen; Fibrinolysis; Glycoproteins; Heparin; Kinetics; Liposomes; Phosphatidylcholines; Phosphatidylserines; Protein C | 1984 |
Pulmonary fibrin microembolism with Echis carinatus venom in dogs: effects of a synthetic thrombin inhibitor.
Topics: Amino Acid Chloromethyl Ketones; Animals; Body Water; Disease Models, Animal; Dogs; Fibrin; Fibrinogen; Hemodynamics; Leukocyte Count; Lung; Platelet Count; Pulmonary Embolism; Respiration; Thrombin; Viper Venoms | 1984 |
Coronary thrombolysis with recombinant human tissue-type plasminogen activator.
Topics: alpha-2-Antiplasmin; Animals; Coronary Angiography; Coronary Disease; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Fibrinogen; Fibrinolysis; Myocardial Infarction; Plasminogen; Plasminogen Activators | 1984 |
[Studies of a fibrin adhesive on punch wounds in rats].
Topics: Animals; Disease Models, Animal; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Fibronectins; Rats; Skin; Thrombin; Tissue Adhesives; Wound Healing | 1984 |
The involvement of plasmatic and fibrinolytic systems in idiopathic glomerulonephritis (GN).
Topics: Animals; Antigens; Disease Models, Animal; Fibrin; Fibrinogen; Fibrinolysis; Glomerulonephritis; Heparin; Humans; Kidney Glomerulus; Rats; Urokinase-Type Plasminogen Activator | 1984 |
Another unacceptable model of primate septic shock.
Topics: Animals; Blood Glucose; Disease Models, Animal; Escherichia coli Infections; Female; Fibrinogen; Gallbladder; Hemodynamics; Lactates; Leukocyte Count; Macaca mulatta; Male; Platelet Count; Shock, Septic | 1981 |
Effect of dipyridamole on experimental disseminated intravascular coagulation in rats.
Topics: Animals; Dipyridamole; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxins; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Kidney Glomerulus; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; Rats; Rats, Inbred Strains | 1983 |
Effects of ticlopidine and aspirin on endotoxin-induced disseminated intravascular coagulation in rats.
Topics: Animals; Aspirin; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxins; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Kidney Glomerulus; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; Rats; Rats, Inbred Strains; Thiophenes; Ticlopidine | 1983 |
Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy.
Topics: Acylation; alpha-2-Antiplasmin; Animals; Binding Sites; Disease Models, Animal; Dogs; Enzyme Activation; Fibrin; Fibrinogen; Plasminogen; Rabbits; Streptokinase; Thrombophlebitis | 1981 |
Blood coagulation changes in JW sarcoma, a new metastasizing tumour in mice.
Topics: Animals; Blood Cell Count; Blood Coagulation; Disease Models, Animal; Fibrinogen; Fibrinolysis; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Neoplasm Transplantation; Sarcoma, Experimental | 1980 |
Embolus radiolabelling in a new canine model.
Topics: Animals; Carotid Artery Thrombosis; Disease Models, Animal; Dogs; Fibrinogen; Iodine Radioisotopes | 1980 |
Functional assay of plasma antithrombin using polyethylene glycol (PEG) defibrinated plasma.
Topics: Animals; Antithrombin III; Biological Assay; Chemical Precipitation; Disease Models, Animal; Evaluation Studies as Topic; Fibrinogen; Humans; In Vitro Techniques; Papio; Plasma; Polyethylene Glycols; Sensitivity and Specificity; Shock, Septic | 1995 |
Resuscitation in uncontrolled hemorrhage.
Topics: Abdomen; Animals; Blood Pressure; Disease Models, Animal; Fibrinogen; Fluid Therapy; Hematocrit; Hemodilution; Hemorrhage; Hydroxyethyl Starch Derivatives; Hypotension; Isotonic Solutions; Male; Platelet Count; Random Allocation; Rats; Rats, Sprague-Dawley; Resuscitation; Ringer's Lactate; Shock; Survival Rate | 1994 |
Intracoronary infusion of E6010 has more potent thrombolytic activity than tissue plasminogen activator (t-PA) in dogs: a higher plasma level of E6010 than t-PA causes potent thrombolytic activity.
Topics: alpha-2-Antiplasmin; Animals; Antibodies, Monoclonal; Coronary Thrombosis; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Epidermal Growth Factor; Fibrinogen; Fibrinolytic Agents; Half-Life; Humans; Infusions, Intra-Arterial; Plasminogen; Recombinant Proteins; Reperfusion Injury; Tissue Plasminogen Activator | 1993 |
Antiatherosclerotic effects of oral naftidrofuryl in cholesterol-fed rabbits involve inhibition of neutrophil function.
Topics: Acetylcholine; Administration, Oral; Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Endothelium, Vascular; Fibrinogen; Luminescent Measurements; Luminol; Male; Molsidomine; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nafronyl; Neutrophils; Nitric Oxide; Rabbits; Random Allocation; Substance P; Vasodilator Agents; Zymosan | 1995 |
A thrombosis model for evaluating thrombolytic agents in the guinea-pig: comparison of t-PA, scu-PA and a novel thrombolytic agent, staphylokinase, on thrombolytic activity.
Topics: alpha-2-Antiplasmin; Animals; Disease Models, Animal; Femoral Artery; Fibrinogen; Fibrinolysin; Guinea Pigs; Infusions, Intravenous; Male; Metalloendopeptidases; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1993 |
Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Coronary Thrombosis; Disease Models, Animal; Fibrinogen; Histamine; Rabbits; Thrombosis; Viper Venoms | 1995 |
Assessment of the carbon tetrachloride-induced cirrhosis model for studies of nitrogen metabolism in chronic liver disease.
Topics: Amino Acids; Animals; Carbon Tetrachloride; Cholesterol; Disease Models, Animal; Fatty Acids, Nonesterified; Fibrinogen; Liver; Liver Cirrhosis, Experimental; Male; Methylhistidines; Nitrogen; Potassium; Rats; Rats, Sprague-Dawley; Sodium; Triglycerides; Weight Gain | 1994 |
Vaccination with Staphylococcus aureus fibrinogen binding proteins (FgBPs) reduces colonisation of S. aureus in a mouse mastitis model.
Topics: Animals; Antibodies, Bacterial; Bacterial Proteins; Bacterial Vaccines; Cattle; Disease Models, Animal; Female; Fibrinogen; Integrins; Mammary Glands, Animal; Mastitis, Bovine; Mice; Protein Binding; Receptors, Collagen; Staphylococcal Infections; Vaccination | 1994 |
Pharmacomechanical thrombolysis of experimental pulmonary emboli. Rapid low-dose intraembolic therapy.
Topics: Animals; Catheterization, Peripheral; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Fibrinogen; Heparin; Infusions, Intra-Arterial; Pulmonary Artery; Pulmonary Embolism; Radiography; Random Allocation; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator | 1994 |
A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats.
Topics: Albuminuria; Animals; Blood Pressure; Disease Models, Animal; Endotoxins; Female; Fibrinogen; Infusions, Intravenous; Kidney Glomerulus; Platelet Count; Pre-Eclampsia; Pregnancy; Rats; Rats, Wistar | 1994 |
Immune complexes and nephropathies associated with Plasmodium inui infection in the rhesus monkey.
Topics: Albumins; Animals; Antibodies, Anti-Idiotypic; Antibodies, Protozoan; Antigen-Antibody Complex; Complement C3; Complement C4; Complement Pathway, Classical; Disease Models, Animal; Fibrinogen; Fluorescent Antibody Technique; Immunoglobulin G; Immunoglobulin M; Kidney; Macaca mulatta; Malaria; Nephrotic Syndrome; Plasmodium | 1994 |
An appraisal of the virulence factors associated with streptococcal endocarditis.
Topics: Animals; Bacterial Adhesion; Blood Platelets; Disease Models, Animal; Endocarditis, Bacterial; Female; Fibrinogen; Fibronectins; Humans; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Streptococcal Infections; Streptococcus sanguis; Virulence | 1994 |
Thrombolysis with intracoronary administration of YM866, a novel modified tissue-type plasminogen activator, in a canine model of coronary artery thrombosis.
Topics: alpha-2-Antiplasmin; Animals; Coronary Thrombosis; Disease Models, Animal; Dogs; Female; Fibrinogen; Injections, Intravenous; Male; Plasminogen; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator | 1993 |
The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo.
Topics: Analysis of Variance; Animals; Antibodies, Monoclonal; Blood Glucose; Cachexia; Disease Models, Animal; Escherichia coli; Fibrinogen; Hypoglycemia; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Inbred Strains; Triglycerides; Tumor Necrosis Factor-alpha; Weight Loss | 1993 |
Thrombolytic activity of a novel modified tissue-type plasminogen activator, YM866, in a canine model of coronary artery thrombosis.
Topics: Amino Acid Sequence; Animals; Blood Proteins; Coronary Thrombosis; Disease Models, Animal; Dogs; Female; Fibrinogen; Fibrinolytic Agents; Infusions, Intravenous; Male; Molecular Sequence Data; Myocardial Reperfusion; Recombinant Proteins; Tissue Plasminogen Activator | 1993 |
Experimental model of carotid artery thrombosis in rats and the thrombolytic activity of YM866, a novel modified tissue-type plasminogen activator.
Topics: Animals; Carotid Arteries; Carotid Artery Thrombosis; Disease Models, Animal; Electric Stimulation; Fibrinogen; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Tissue Plasminogen Activator | 1993 |
The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
Topics: Animals; Antithrombin III; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxins; Escherichia coli; Factor VII; Factor VIII; Fibrin; Fibrinogen; Kidney; Lipoproteins; Male; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; Rabbits; Thrombin Time | 1993 |
Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
Topics: Animals; Anticoagulants; Arterio-Arterial Fistula; Aspirin; Carotid Artery Thrombosis; Clopidogrel; Collagen; Disease Models, Animal; Drug Evaluation, Preclinical; Fibrin; Fibrinogen; Fibrinolytic Agents; Glass; Heparin; Hirudin Therapy; Hirudins; Male; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Polyethylenes; Rats; Rats, Wistar; Recombinant Proteins; Regional Blood Flow; Silicones; Thrombin; Ticlopidine | 1993 |
Induction of hepatocyte lipopolysaccharide binding protein in models of sepsis and the acute-phase response.
Topics: Acute-Phase Proteins; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bacteremia; Biological Assay; Blotting, Northern; Carrier Proteins; Disease Models, Animal; Endotoxins; Evaluation Studies as Topic; Fibrinogen; Inflammation; Interleukin-6; Liver Diseases; Macrophages; Male; Membrane Glycoproteins; Peritoneum; Rats; Rats, Sprague-Dawley; RNA Probes; Tumor Necrosis Factor-alpha | 1993 |
Snakebite-induced acute renal failure: an experimental model.
Topics: Acute Kidney Injury; Animals; Blood Pressure; Crotalid Venoms; Disease Models, Animal; Fibrinogen; Glomerular Filtration Rate; Hematocrit; Hemoglobins; Infusions, Intravenous; Kidney; L-Lactate Dehydrogenase; Male; Rats; Rats, Wistar; Renal Circulation; Snake Bites; Urine; Vascular Resistance | 1993 |
Active site-blocked factor Xa prevents thrombus formation in the coronary vasculature in parallel with inhibition of extravascular coagulation in a canine thrombosis model.
Topics: Amino Acid Sequence; Animals; Binding Sites; Blood Coagulation; Blood Platelets; Cattle; Coronary Thrombosis; Disease Models, Animal; Dogs; Factor X; Factor Xa; Factor Xa Inhibitors; Fibrin; Fibrinogen; Hemostasis; Heparin; Microscopy, Electron; Molecular Sequence Data | 1993 |
Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo.
Topics: Animals; Antibodies, Monoclonal; Disease Models, Animal; Female; Fibrinogen; Gestational Age; Glycoproteins; Immunoglobulin G; Lung Compliance; Plethysmography; Proteolipids; Pulmonary Alveoli; Pulmonary Edema; Pulmonary Surfactant-Associated Protein A; Pulmonary Surfactant-Associated Proteins; Pulmonary Surfactants; Rabbits; Rats; Rats, Inbred F344; Respiratory Distress Syndrome; Surface Tension | 1996 |
Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis.
Topics: Animals; Collagen; Disease Models, Animal; Endocarditis, Bacterial; Endothelium, Vascular; Female; Fibrinogen; Fibronectins; Gene Expression Regulation, Bacterial; Humans; Integrins; Rats; Rats, Wistar; Receptors, Collagen; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1996 |
[Effects of potentiation and rapid action in models of venous thrombosis in dogs upon combined administration of the plasminogen tissue activator and urokinase modified by fibrinogen].
Topics: Animals; Disease Models, Animal; Dogs; Drug Therapy, Combination; Fibrinogen; Plasminogen Activators; Thrombophlebitis; Time Factors; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1996 |
Comparative studies of thrombolysis with single-chain and two-chain recombinant tissue-type plasminogen activators in canine coronary thrombosis.
Topics: Animals; Coronary Thrombosis; Disease Models, Animal; Dogs; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Male; Myocardial Reperfusion; Plasminogen; Plasminogen Activators; Structure-Activity Relationship; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator | 1996 |
Characterization of a new hereditary thrombopathy in a closed colony of Wistar rats.
Topics: Animals; Bleeding Time; Blood Platelets; Disease Models, Animal; Female; Fibrinogen; Flow Cytometry; Hematologic Diseases; Hematologic Tests; Male; Pedigree; Platelet Aggregation; Rats; Rats, Wistar | 1996 |
Role of Staphylococcus aureus surface adhesins in orthopaedic device infections: are results model-dependent?
Topics: Adhesins, Bacterial; Animals; Bacterial Adhesion; Collagen; Disease Models, Animal; Female; Fibrinogen; Fibronectins; Osteomyelitis; Prosthesis-Related Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 1997 |
Further characterization and thrombolytic activity in a rat model of a fibrinogenase from Vipera lebetina venom.
Topics: Animals; Disease Models, Animal; Factor X; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Humans; In Vitro Techniques; Metalloendopeptidases; Plasminogen; Platelet Aggregation; Protein C; Prothrombin; Rabbits; Radiography; Rats; Thrombophlebitis; Viper Venoms | 1997 |
Red blood cell aggregation in experimental sepsis.
Topics: Animals; Blood Cell Count; Blood Sedimentation; Cecum; Cell Size; Dextrans; Disease Models, Animal; Erythrocyte Aggregation; Erythrocyte Deformability; Erythrocytes; Fibrinogen; Ligation; Lipid Peroxidation; Male; Rats; Rats, Inbred Strains; Sepsis; Thiobarbituric Acid Reactive Substances | 1997 |
The in vitro and in vivo pharmacological profiles of a platelet glycoprotein IIb/IIIa antagonist, NSL-9403.
Topics: Adenosine Diphosphate; Animals; Bleeding Time; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Femoral Artery; Fibrinogen; Humans; Male; Mice; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pulmonary Embolism; Thrombosis | 1997 |
Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin.
Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Animals; Blood Pressure; Body Temperature; Disease Models, Animal; Endotoxemia; Endotoxins; Fibrinogen; Heart Rate; Horse Diseases; Horses; Infusions, Intravenous; Interleukin-6; Leukocyte Count; Pentoxifylline; Plasminogen Inactivators; Respiration; Thromboxane B2; Tumor Necrosis Factor-alpha; Vasodilator Agents | 1997 |
Efficacy of prevention of thromboembolic complications with LMW-heparin in experiment.
Topics: Animals; Anticoagulants; Arthroplasty, Replacement, Hip; Disease Models, Animal; Dogs; Factor Xa Inhibitors; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Injections, Subcutaneous; Nadroparin; Partial Thromboplastin Time; Platelet Count; Premedication; Prothrombin; Pulmonary Embolism; Thrombocytopenia; Thrombophlebitis | 1997 |
Involvement of fibrinogen in protamine-induced pulmonary hypertension.
Topics: Animals; Aspirin; Blood; Blood Pressure; Cattle; Cyclooxygenase Inhibitors; Disease Models, Animal; Fibrinogen; Heparin; Hypertension, Pulmonary; Perfusion; Protamines; Pulmonary Artery; Rats; Rats, Sprague-Dawley | 1997 |
Inhibitory effect of piracetam on platelet-rich thrombus formation in an animal model.
Topics: Animals; Bleeding Time; Cricetinae; Disease Models, Animal; Fibrinogen; Fibrinolytic Agents; Humans; In Vitro Techniques; Male; Piracetam; Platelet Aggregation Inhibitors; Platelet Count; Protein Binding; Rats; Thrombosis | 1998 |
Activated protein C concentrate for the treatment of meningococcal endotoxin shock in rabbits.
Topics: Animals; Disease Models, Animal; Endotoxins; Fibrinogen; Hematocrit; Hemoglobins; Leukocyte Count; Meningococcal Infections; Platelet Count; Protein C; Prothrombin; Rabbits; Shock, Septic; Survival; Thrombosis | 1998 |
Positive biochemical effects of a bioartificial liver support system (BALSS) in a porcine fulminant hepatic failure (FHF) model.
Topics: Adenosine Triphosphate; Amino Acids; Ammonia; Animals; Bioreactors; Cell Adhesion; Cells, Cultured; Collagen; Dextrans; Disease Models, Animal; Fibrinogen; Hepatic Encephalopathy; Lactic Acid; Liver; Liver, Artificial; Magnetic Resonance Spectroscopy; Microspheres; Serum Albumin; Swine | 1998 |
The response of hepatic acute phase proteins during experimental pulmonary tuberculosis.
Topics: Acute-Phase Proteins; Acute-Phase Reaction; Albumins; Animals; Base Sequence; Complement C4; Disease Models, Animal; DNA Primers; Fibrinogen; Gene Expression; Granuloma; Interleukin-6; Kinetics; Liver; Male; Mice; Mice, Inbred BALB C; Orosomucoid; Polymerase Chain Reaction; RNA, Messenger; Tuberculosis, Pulmonary | 1998 |
Mortality and platelet depletion occur independently of fibrinogen consumption in murine models of tumour necrosis factor-mediated systemic inflammatory responses.
Topics: Ancrod; Animals; Blood Platelets; Coagulants; Disease Models, Animal; Female; Fibrinogen; Fibrinolytic Agents; Iodine Radioisotopes; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Plasmodium berghei; Platelet Count; Prothrombin Time; Recombinant Proteins; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha | 1998 |
Fibrinogen as a factor of thrombosis: experimental study.
Topics: Adenosine Diphosphate; Animals; Disease Models, Animal; Fibrinogen; Humans; In Vitro Techniques; Male; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Rats; Rats, Wistar; Risk Factors; Thromboembolism; Thrombophlebitis; Thrombosis | 1998 |
Effect of GR144053, a fibrinogen-receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tPA in the injured carotid artery of the hamster.
Topics: Animals; Bleeding Time; Carotid Artery Thrombosis; Cell Division; Cricetinae; Disease Models, Animal; Drug Interactions; Fibrinogen; Fibrinolytic Agents; Male; Muscle, Smooth; Peptides; Piperazines; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombolytic Therapy; Tissue Plasminogen Activator; Vascular Patency | 1998 |
Induction of fibrinogen expression in the lung epithelium during Pneumocystis carinii pneumonia.
Topics: Acute-Phase Reaction; Animals; Anti-Inflammatory Agents; Base Sequence; Dexamethasone; Disease Models, Animal; DNA, Complementary; Epithelium; Ferrets; Fibrinogen; Gene Expression Regulation; Immunosuppressive Agents; Lung; Mice; Mice, SCID; Molecular Sequence Data; Pneumonia, Pneumocystis | 1998 |
Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model.
Topics: Angioplasty, Balloon; Animals; Arteries; Biocompatible Materials; Biodegradation, Environmental; Chromones; Coronary Disease; Disease Models, Animal; Dogs; Drug Delivery Systems; Endothelium, Vascular; Fibrinogen; Fibrinolytic Agents; Heparin; Infusions, Intra-Arterial; Lactic Acid; Male; Morpholines; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Postoperative Complications | 1998 |
Impact of inhaled nitric oxide on platelet aggregation and fibrinolysis in rats with endotoxic lung injury. Role of cyclic guanosine 5'-monophosphate.
Topics: Administration, Inhalation; Animals; Aorta; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Buffers; Cyclic GMP; Disease Models, Animal; Endotoxins; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemostasis; Lipopolysaccharides; Male; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors; Random Allocation; Rats; Rats, Inbred Strains; Respiratory Distress Syndrome | 1998 |
Effects of low molecular weight heparin, alone or combined with antithrombin III, on mortality, fibrin deposits and hemostatic parameters in endotoxin-induced disseminated intravascular coagulation in rabbits.
Topics: Animals; Antithrombin III; Blood Coagulation Factors; Disease Models, Animal; Disseminated Intravascular Coagulation; Drug Combinations; Endotoxins; Fibrin; Fibrinogen; Heparin, Low-Molecular-Weight; Histological Techniques; Kidney; Male; Platelet Count; Protein C; Rabbits | 1999 |
Substitutes for success.
Topics: Albumins; Animals; Blood Platelets; Blood Substitutes; Capsules; Disease Models, Animal; Fibrinogen; Humans; Rabbits; Thrombocytopenia | 1999 |
Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits.
Topics: Albumins; Animals; Blood Platelets; Blood Substitutes; Capsules; Disease Models, Animal; Fibrinogen; Hemorrhage; Humans; Rabbits; Thrombocytopenia; Thrombosis; Time Factors | 1999 |
Sulfatide can markedly enhance thrombogenesis in rat deep vein thrombosis model.
Topics: Animals; Blood Coagulation; Calcium Chloride; Disease Models, Animal; Factor XII; Fibrinogen; Gangliosides; Kinetics; Male; Protein Binding; Prothrombin Time; Rats; Rats, Sprague-Dawley; Sulfoglycosphingolipids; Venous Thrombosis | 1998 |
Antithrombotic effects of (n-3) polyunsaturated fatty acids in rat models of arterial and venous thrombosis.
Topics: Animals; Disease Models, Animal; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Fibrinogen; Fibrinolytic Agents; Male; Platelet Count; Rats; Rats, Wistar; Thrombosis; Venous Thrombosis | 1999 |
Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model.
Topics: Abscess; Animals; Bacterial Adhesion; Biocompatible Materials; Biofilms; Catheters, Indwelling; Disease Models, Animal; Fibrinogen; Fibronectins; Foreign-Body Reaction; Hemagglutinins; Male; Mice; Mutation; Polysaccharides, Bacterial; Staphylococcal Infections; Staphylococcus epidermidis; Virulence | 1999 |
Selective venous thrombolysis with the nipple-balloon catheter: comparative evaluation in vivo.
Topics: Animals; Anticoagulants; Catheterization; Contrast Media; Coronary Vessels; Disease Models, Animal; Drug Delivery Systems; Equipment Design; Femoral Vein; Fibrinogen; Fibrinolytic Agents; Heparin; Hindlimb; Iliac Vein; Iodine; Ioxaglic Acid; Partial Thromboplastin Time; Pulmonary Embolism; Spectrometry, X-Ray Emission; Swine; Thromboembolism; Thrombolytic Therapy; Tissue Plasminogen Activator; Venous Thrombosis | 1999 |
Fibrinogen and vascular smooth muscle cell grafts promote healing of experimental aneurysms treated by embolization.
Topics: Adenoviridae; Aneurysm; Angiography; Animals; Carotid Artery Diseases; Cells, Cultured; Disease Models, Animal; Dogs; Embolization, Therapeutic; Femoral Artery; Fibrinogen; Follow-Up Studies; Gene Expression; Gene Transfer Techniques; Green Fluorescent Proteins; Indicators and Reagents; Luminescent Proteins; Microscopy, Fluorescence; Muscle, Smooth, Vascular; Tunica Intima; Wound Healing | 1999 |
Plasminogen II accumulates five times faster than plasminogen I at the site of a balloon de-endothelializing injury in vivo to the rabbit aorta: comparison with other hemostatic proteins.
Topics: Animals; Antithrombins; Aorta, Thoracic; Catheterization; Disease Models, Animal; Endothelium, Vascular; Fibrinogen; Glycosylation; Hemostasis; Heparin Cofactor II; Kinetics; Male; Plasminogen; Protein Isoforms; Prothrombin; Rabbits | 1999 |
Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors.
Topics: Animals; Arteriosclerosis; Atorvastatin; Chemokine CCL2; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; DNA; Down-Regulation; Fibrinogen; Gene Expression; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macrophages; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Polymerase Chain Reaction; Pyrroles; Rabbits; Simvastatin; Tunica Intima | 1999 |
Dithiocarbamates ameliorate the effects of endotoxin in a rabbit model of disseminated intravascular coagulation.
Topics: Animals; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxins; Female; Fibrinogen; NF-kappa B; Rabbits; Thiocarbamates; Thromboplastin; Transcription, Genetic | 1999 |
Development and evaluation of a new canine myocardial infarction model using a closed-chest injection of thrombogenic material.
Topics: Animals; Aspartate Aminotransferases; Blood Pressure; Blood Transfusion, Autologous; Coronary Disease; Coronary Thrombosis; Creatine Kinase; Disease Models, Animal; Dogs; Electrocardiography; Fibrinogen; Heart Rate; Hydroxybutyrate Dehydrogenase; Injections, Intra-Arterial; Isoenzymes; Myocardial Infarction; Organ Size; Pulmonary Wedge Pressure; Stroke Volume; Thrombin; Vascular Patency | 1999 |
Systemic manifestations of periodontitis in the non-human primate.
Topics: alpha 1-Antitrypsin; Animals; Apolipoprotein A-I; Arteriosclerosis; Bacterial Translocation; Biomarkers; C-Reactive Protein; Chemokines; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Disease Models, Animal; Endotoxins; Fibrinogen; Gingivitis; Haptoglobins; Hyperlipoproteinemias; Inflammation Mediators; Interleukin-8; Lipopolysaccharides; Macaca fascicularis; Periodontitis; Risk Factors; Triglycerides | 1999 |
Effects of reserpine on expression of the LDL receptor in liver and on plasma and tissue lipids, low density lipoprotein and fibrinogen in rabbits in vivo.
Topics: Animals; Arteriosclerosis; Culture Techniques; Disease Models, Animal; Ethinyl Estradiol; Fibrinogen; Hemodynamics; Injections, Subcutaneous; Lipoproteins, LDL; Liver; Male; Rabbits; Receptors, LDL; Reference Values; Reserpine; Sensitivity and Specificity | 2000 |
Inhibition of platelet thrombosis using an activated protein C-loaded stent: in vitro and in vivo results.
Topics: Adsorption; Animals; Catheterization; Disease Models, Animal; Fibrin; Fibrinogen; Humans; Iliac Artery; In Vitro Techniques; Kinetics; Partial Thromboplastin Time; Platelet Aggregation; Protein C; Rabbits; Stents; Thrombosis | 2000 |
Oil fly ash-induced elevation of plasma fibrinogen levels in rats.
Topics: Air Pollutants; Animals; Blood Cell Count; Blood Coagulation Tests; Blood Viscosity; Carbon; Coal Ash; Disease Models, Animal; Fibrinogen; Intubation, Intratracheal; Lung; Male; Particulate Matter; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Volcanic Eruptions | 2000 |
Comparative study of antithrombotic effect of a low molecular weight heparin and unfractionated heparin in an ex vivo model of deep arterial injury.
Topics: Adenosine Diphosphate; Animals; Arteries; Blood Coagulation Tests; Blood Flow Velocity; Collagen; Disease Models, Animal; Fibrin; Fibrinogen; Fibrinolytic Agents; Hematologic Tests; Heparin; Heparin, Low-Molecular-Weight; Perfusion; Platelet Aggregation; Platelet Function Tests; Swine; Thrombosis | 2000 |
Dietary fish oil reduces microvascular thrombosis in a porcine experimental model.
Topics: Animals; Bleeding Time; Dietary Fats, Unsaturated; Disease Models, Animal; Fatty Acids, Omega-3; Fibrinogen; Fish Oils; Microcirculation; Platelet Count; Reperfusion Injury; Swine; Thrombosis; Thromboxane B2 | 2000 |
The Factor VIII acute phase response requires the participation of NFkappaB and C/EBP.
Topics: Acute-Phase Reaction; Animals; Binding Sites; CCAAT-Enhancer-Binding Protein-alpha; CCAAT-Enhancer-Binding Proteins; Cell Nucleus; Conserved Sequence; Disease Models, Animal; Factor VIII; Female; Fibrinogen; Humans; Inflammation; Lipopolysaccharides; Liver; Male; Mice; Mutagenesis, Site-Directed; NF-kappa B; Nuclear Proteins; Promoter Regions, Genetic; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Thyroid Hormone; Silver Nitrate; Time Factors; Transfection; Tumor Cells, Cultured; von Willebrand Factor | 2000 |
Ultrastructural analysis of megakaryocytes in GPV knockout mice.
Topics: Animals; Bernard-Soulier Syndrome; Blood Coagulation Factors; Blood Platelet Disorders; Blood Platelets; Bone Marrow Cells; Cytoplasmic Granules; Disease Models, Animal; Fibrinogen; Immunohistochemistry; Megakaryocytes; Mice; Mice, Knockout; Mice, Transgenic; Microscopy, Electron; P-Selectin; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Protein Subunits; Receptors, Cell Surface; von Willebrand Factor | 2000 |
Urokinase mediates fibrinolysis in the pulmonary microvasculature.
Topics: Animals; Disease Models, Animal; Fibrin; Fibrinogen; Fibrinolysis; Humans; Immunohistochemistry; Lung; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Mutant Strains; Microspheres; Particle Size; Pulmonary Circulation; Pulmonary Embolism; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Recombinant Proteins; Tissue Distribution; Urokinase-Type Plasminogen Activator | 2000 |
Effects of acetyl salicylic acid therapy on an experimental thrombosis induced by laser beam.
Topics: Adenosine Diphosphate; Animals; Aspirin; Bleeding Time; Disease Models, Animal; Fibrinogen; Lasers; Male; Partial Thromboplastin Time; Platelet Aggregation; Rats; Rats, Wistar; Thrombosis | 2000 |
A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice.
Topics: Afibrinogenemia; Animals; Bleomycin; Collagen; Disease Models, Animal; DNA; Female; Fibrinogen; Fluorescent Antibody Technique, Indirect; Gene Targeting; Heterozygote; Homozygote; Lung; Male; Mice; Mice, Knockout; Polymerase Chain Reaction; Pulmonary Fibrosis | 2000 |
Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a bette
Topics: Animals; Biomarkers; Blood Coagulation Tests; Cytokines; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxemia; Escherichia coli Infections; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Leukocyte Count; Male; Papio; Peritonitis; Platelet Count; Protein C; Thrombin | 2000 |
Effect of gemfibrozil on peripheral atherosclerosis and platelet activation in a pig model of hyperlipidemia.
Topics: Animals; Antibodies; Aorta, Abdominal; Arteriosclerosis; Blood Platelets; Cholesterol; Disease Models, Animal; Fibrinogen; Fluorescent Antibody Technique; Gemfibrozil; Hyperlipidemias; Hypolipidemic Agents; Placebos; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Swine | 2000 |
Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells.
Topics: Animals; Carcinoma, Lewis Lung; Cell Adhesion; Disease Models, Animal; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Hemostasis; Hirudins; Histocytochemistry; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Metastasis; Neoplastic Cells, Circulating; Neovascularization, Pathologic; Thrombin | 2000 |
PAI-1, fibrosis, and the elusive provisional fibrin matrix.
Topics: Animals; Bleomycin; Disease Models, Animal; Fibrin; Fibrinogen; Fibrinolysin; Gene Deletion; Humans; Mice; Mice, Knockout; Plasminogen; Plasminogen Activator Inhibitor 1; Pulmonary Fibrosis | 2000 |
Effect of prolonged nitric oxide synthesis inhibition on plasma fibrinogen concentration in rats.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Enzyme Inhibitors; Fibrinogen; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Tetrazoles | 2001 |
Effect of fibrin bandage fibrinogen concentration on blood loss after grade V liver injury in swine.
Topics: Animals; Bandages; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Fibrin; Fibrinogen; Hemoglobins; Hemorrhage; Injury Severity Score; Liver; Partial Thromboplastin Time; Platelet Count; Prothrombin; Swine | 2001 |
Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model.
Topics: Animals; Blood-Brain Barrier; Brain; Chronic Disease; Disease Models, Animal; Disease Progression; Endothelium, Vascular; Fibrinogen; Glucose Transporter Type 1; Host-Parasite Interactions; Intercellular Adhesion Molecule-1; Male; Membrane Proteins; Microcirculation; Monosaccharide Transport Proteins; Occludin; Phosphoproteins; Rats; Tight Junctions; Trypanosoma brucei brucei; Trypanosomiasis, African; Vascular Cell Adhesion Molecule-1; Zonula Occludens-1 Protein | 2001 |
Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries.
Topics: Animals; Bandages; Blood Coagulation Disorders; Blood Pressure; Combined Modality Therapy; Disease Models, Animal; Drug Evaluation, Preclinical; Exchange Transfusion, Whole Blood; Factor VII; Factor VIIa; Fibrinogen; Hemorrhage; Hypothermia, Induced; Isotonic Solutions; Liver; Partial Thromboplastin Time; Prothrombin Time; Random Allocation; Recombinant Proteins; Resuscitation; Ringer's Lactate; Single-Blind Method; Survival Analysis; Swine; Thrombosis; Time Factors; Wounds and Injuries | 2001 |
Depletion of plasma factor XIII prevents disseminated intravascular coagulation-induced organ damage.
Topics: Animals; Antibodies, Monoclonal; Disease Models, Animal; Disseminated Intravascular Coagulation; Factor XIII; Factor XIII Deficiency; Fibrin; Fibrinogen; Kidney; Kidney Diseases; Lipopolysaccharides; Necrosis; Plasminogen; Rabbits; Sepsis; Shwartzman Phenomenon; Skin; Skin Diseases | 2001 |
Plasma thrombin-antithrombin III complex is associated with the severity of experimental autoimmune encephalomyelitis.
Topics: Animals; Antithrombin III; Biological Assay; Blood Coagulation; Blood Coagulation Disorders; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Rats; Rats, Inbred Lew; Spinal Cord; Thrombin | 2001 |
Taking the hype out of hyperfibrinogenaemia?
Topics: Animals; Disease Models, Animal; Fibrinogen; Humans; Risk Factors; Vascular Diseases | 2001 |
A novel transgenic mouse model of hyperfibrinogenemia.
Topics: Animals; Cloning, Molecular; Disease Models, Animal; Fibrinogen; Liver; Mice; Mice, Inbred C57BL; Mice, Transgenic; Organ Specificity; RNA; Transgenes | 2001 |
Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis.
Topics: Adhesins, Bacterial; Amino Acid Sequence; Animals; Bacterial Adhesion; Bacterial Proteins; Blood Platelets; Carrier Proteins; Coagulase; Disease Models, Animal; Endocarditis, Bacterial; Female; Fibrin; Fibrinogen; Fibronectins; Gene Expression; Humans; Lactococcus lactis; Molecular Sequence Data; Rats; Rats, Wistar; Staphylococcus aureus | 2001 |
Antiplatelet and antithrombotic activity of RWJ-53308, a novel orally active glycoprotein IIb/IIIa antagonist.
Topics: Animals; Biological Availability; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fibrinogen; Guinea Pigs; Humans; Inhibitory Concentration 50; Nipecotic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Pyridines; Rats; Thrombosis | 2001 |
Thrombolytic effect of lonomin V in a rabbit jugular vein thrombosis model.
Topics: alpha-2-Antiplasmin; Animals; Anticoagulants; Arthropod Venoms; Disease Models, Animal; Factor XIII; Female; Fibrinogen; Fibrinolytic Agents; Infusions, Intravenous; Injections, Intravenous; Jugular Veins; Male; Plasminogen; Rabbits; Thrombolytic Therapy; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; Venous Thrombosis | 2001 |
Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen.
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Binding, Competitive; Cell Adhesion; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; K562 Cells; Kininogen, High-Molecular-Weight; Leukocytes; Lymphocyte Function-Associated Antigen-1; Macrophage-1 Antigen; Mice; Mice, Inbred Strains; Molecular Sequence Data; Neutrophil Infiltration; Peptides; Peritonitis; Plasmids; Thioglycolates; U937 Cells | 2001 |
Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons.
Topics: Acute Kidney Injury; Animals; Bacteremia; Blood Coagulation; Disease Models, Animal; Drug Evaluation, Preclinical; Escherichia coli Infections; Factor VIIIa; Fibrinogen; Hemodynamics; Inflammation; Interleukin-6; Kidney Function Tests; Lung Compliance; Male; Papio; Pulmonary Edema; Pulmonary Gas Exchange; Random Allocation; Respiratory Distress Syndrome; Thromboplastin; Tumor Necrosis Factor-alpha | 2001 |
Low-dose versus high-dose heparinization during arteriovenous carbon dioxide removal.
Topics: Acute Disease; Animals; Arteriovenous Shunt, Surgical; Blood Flow Velocity; Carbon Dioxide; Coated Materials, Biocompatible; Disease Models, Animal; Dose-Response Relationship, Drug; Extracorporeal Membrane Oxygenation; Female; Fibrinogen; Heparin; Oxygenators, Membrane; Platelet Count; Respiratory Insufficiency; Sheep; Treatment Outcome; Whole Blood Coagulation Time | 2001 |
Toxicity of a first-generation adenoviral vector in rhesus macaques.
Topics: Adenoviruses, Human; Animals; Blood Cell Count; Creatine Kinase; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme-Linked Immunosorbent Assay; Factor IX; Fibrinogen; Genetic Therapy; Genetic Vectors; Hemophilia B; Humans; Interleukin-6; Isoenzymes; L-Lactate Dehydrogenase; Liver; Macaca mulatta; Muscle, Skeletal; Platelet Aggregation; von Willebrand Factor | 2002 |
Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo.
Topics: Animals; Caenorhabditis elegans Proteins; Cell Adhesion; Chemokine CCL2; Chemokines; Cytokines; Disease Models, Animal; Fibrinogen; Interleukin-6; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; Peritonitis; Protein Serine-Threonine Kinases; Thrombin | 2002 |
Genetic links between the acute-phase response and arthritis development in rats.
Topics: Acute Disease; Acute-Phase Proteins; Animals; Arthritis, Rheumatoid; Breeding; Chronic Disease; Disease Models, Animal; Female; Fibrinogen; Genotype; Immunosuppressive Agents; Interleukin-6; Joints; Lod Score; Male; Orosomucoid; Phenotype; Rats; Rats, Inbred Lew; Specific Pathogen-Free Organisms; Terpenes | 2002 |
Valsartan improves fibrinolytic balance in atherosclerotic rabbits.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Arteriosclerosis; Biomarkers; Blood Pressure; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Dose-Response Relationship, Drug; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hypercholesterolemia; Male; Myocardial Contraction; Rabbits; Tetrazoles; Time; Treatment Outcome; Valine; Valsartan | 2002 |
Role of the endothelial lining in persistence of residual lesions and growth of recurrences after endovascular treatment of experimental aneurysms.
Topics: Aneurysm; Angiography; Animals; Carotid Artery Diseases; Collagen; Disease Models, Animal; Dogs; Embolization, Therapeutic; Endothelium, Vascular; Fibrinogen; Secondary Prevention; Surgical Sponges; Treatment Outcome; Tunica Intima; Vascular Surgical Procedures; Wound Healing | 2002 |
[The significance of thrombosis after experimental pulmonary thromboembolism].
Topics: Animals; Disease Models, Animal; Endothelins; Female; Fibrinogen; Lung; Male; Prothrombin Time; Pulmonary Embolism; Rabbits; Thrombosis; Thromboxane A2 | 2001 |
The effects of higenamine on LPS-induced experimental disseminated intravascular coagulation (DIC) in rats.
Topics: Alkaloids; Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Disease Models, Animal; Disseminated Intravascular Coagulation; Dose-Response Relationship, Drug; Fibrin; Fibrinogen; Injections, Intravenous; Lipopolysaccharides; Male; Multiple Organ Failure; Partial Thromboplastin Time; Plant Roots; Platelet Count; Prothrombin Time; Ranunculaceae; Rats; Tetrahydroisoquinolines | 2002 |
Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis.
Topics: Animals; Antibodies, Monoclonal; Antithrombins; Blood Coagulation Factors; Complement C5a; Disease Models, Animal; Factor IX; Factor V; Factor VII; Factor VIII; Factor XI; Factor XII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Male; Partial Thromboplastin Time; Peptide Fragments; Platelet Count; Prothrombin Time; Rats; Rats, Long-Evans; Sepsis; Specific Pathogen-Free Organisms; Survival Rate; Thrombin | 2002 |
Expression of the biofilm-associated protein interferes with host protein receptors of Staphylococcus aureus and alters the infective process.
Topics: Adhesins, Bacterial; Animals; Bacterial Adhesion; Bacterial Proteins; Biofilms; Breast; Carrier Proteins; Cell Line; Disease Models, Animal; Female; Fibrinogen; Fibronectins; Humans; Microtomy; Sheep; Staphylococcal Infections; Staphylococcus aureus | 2002 |
Tissue-type plasminogen activator has paradoxical roles in focal cerebral ischemic injury by thrombotic middle cerebral artery occlusion with mild or severe photochemical damage in mice.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Fibrinogen; Infarction, Middle Cerebral Artery; Intracranial Thrombosis; Mice; Mice, Inbred C57BL; Mice, Knockout; Photochemistry; Tissue Plasminogen Activator | 2002 |
[Autotransfusion in experimental hemoperitoneum. Hematologic study].
Topics: Animals; Blood Platelets; Blood Transfusion, Autologous; Disease Models, Animal; Dogs; Erythrocytes; Fibrinogen; Hemolysis; Hemoperitoneum; Leukocytes | 1975 |
[Acute pulmonary hypertension--triggered by a heat-induced factor in the plasma and serum. (Studies in vivo and in a model of isolation-perfused and ventilated rabbit lung)].
Topics: Acute Disease; Animals; Burns; Disease Models, Animal; Fibrinogen; gamma-Globulins; Hot Temperature; Hypertension, Pulmonary; Rabbits; Shock | 1975 |
Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Blood Transfusion; Dipyridamole; Disease Models, Animal; Femoral Artery; Femoral Vein; Fibrinogen; Haplorhini; Heparin; Kidney; Male; Papio; Platelet Adhesiveness; Polyurethanes; Regional Blood Flow; Silicone Elastomers; Sulfinpyrazone; Thromboembolism | 1979 |
Incorporation of 125 I-fibrinogen in circulating soluble fibrin monomer complexes during hypercoagulability.
Topics: Animals; Blood Coagulation Disorders; Chromatography, Affinity; Disease Models, Animal; Endotoxins; Fibrin; Fibrinogen; Iodine Radioisotopes; Rabbits; Salmonella enteritidis | 1977 |
Control of upper gastrointestinal hemorrhage by endoscopic spraying of clotting factors.
Topics: Animals; Blood Coagulation Factors; Disease Models, Animal; Dogs; Factor XIII; Fibrinogen; Gastroscopes; Gastroscopy; Male; Peptic Ulcer Hemorrhage; Stomach Ulcer; Thrombin | 1979 |
Participation of kallikrein, coagulation/fibrinolysis parameters in the development of glomerulonephritis.
Topics: Animals; Antithrombins; Blood Coagulation; Disease Models, Animal; Dogs; Fibrinogen; Fibrinolysis; Glomerulonephritis; Kallikreins; Prekallikrein | 1979 |
The effect of heparinized blood exchange transfusion on endotoxin induced disseminated intravascular coagulation (DIC).
Topics: Animals; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxins; Exchange Transfusion, Whole Blood; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Leukocyte Count; Platelet Count; Rabbits | 1979 |
Effects of extravascular clotting on fibrinopeptide A levels in blood.
Topics: Animals; Blood Coagulation; Cross Reactions; Disease Models, Animal; Fibrinogen; Fibrinopeptide A; Half-Life; Hematoma; Humans; Models, Biological; Radioimmunoassay; Rats; Species Specificity | 1978 |
Preparation for disseminated intravascular coagulation by Yoshida sarcoma in rats.
Topics: Animals; Blood Cell Count; Blood Platelets; Capillaries; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxins; Female; Fibrin; Fibrinogen; Hematocrit; Hemoglobins; Kidney Glomerulus; Pregnancy; Rats; Sarcoma, Yoshida | 1978 |
Effects of experimental coronary thrombosis upon regional and systemic plasma chromatographic patterns.
Topics: Animals; Blood Protein Electrophoresis; Blood Proteins; Chromatography, Gel; Coronary Disease; Disease Models, Animal; Dogs; Fibrinogen; Immunodiffusion | 1975 |
Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis.
Topics: Animals; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Chemical Precipitation; Cryoglobulins; Disease Models, Animal; Female; Fibrinogen; Heparin; Infusions, Parenteral; Injections, Intravenous; Iodine Radioisotopes; Male; Rabbits; Thrombophlebitis; Time Factors | 1977 |
Comparison of ancrod and heparin as anticoagulants following endarterectomy in the dog.
Topics: Ancrod; Animals; Disease Models, Animal; Dogs; Endarterectomy; Endopeptidases; Femoral Artery; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Thrombosis; Wound Healing | 1976 |
Effect of coronary thrombus age on fibrinogen uptake.
Topics: Animals; Coronary Disease; Disease Models, Animal; Dogs; Fibrinogen; Male; Time Factors | 1976 |
Coagulopathy in experimental sepsis with Streptococcus pneumoniae in rabbits: effect of drug therapy and splenectomy.
Topics: Animals; Anti-Bacterial Agents; Blood Coagulation Tests; Disease Models, Animal; Disseminated Intravascular Coagulation; Esterases; Fibrinogen; Pneumococcal Infections; Rabbits; Sepsis; Splenectomy; Tosylarginine Methyl Ester | 1976 |
Fibrinogen 131I scans for detection of experimental absesses.
Topics: Abscess; Animals; Disease Models, Animal; Fibrinogen; Iodine Radioisotopes; Radionuclide Imaging; Rats; Thigh | 1976 |
[Determination of the rate of microthrombosis in experimentally induced disseminated intravascular coagulation (DIC)].
Topics: Animals; Disease Models, Animal; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Iodine Radioisotopes; Rats; Thrombosis | 1976 |
[An experimental model of electrically-induced coronary thrombosis in the closed chest].
Topics: Animals; Aspartate Aminotransferases; Blood Gas Analysis; Blood Pressure; Coronary Disease; Coronary Vessels; Creatine Kinase; Disease Models, Animal; Dogs; Electric Injuries; Fibrinogen; Fibrinolysis; Myocardial Infarction; Myocardium; Platelet Count; Time Factors | 1975 |
Inhibition of intravascular fibrin deposition by dipyridamole in experimental animals.
Topics: Aminocaproates; Animals; Autoradiography; Blood Platelets; Dipyridamole; Disease Models, Animal; Endotoxins; Escherichia coli; Fibrin; Fibrinogen; Iodine Radioisotopes; Kidney; Leukocyte Count; Mononuclear Phagocyte System; Protamines; Rabbits; Shwartzman Phenomenon; Thorium Dioxide; Thrombin | 1975 |
Glomerular microcapillary thrombosis demonstrated by the new technique of immunocathodoluminescence.
Topics: Animals; Antigen-Antibody Complex; Disease Models, Animal; Female; Fibrinogen; Fluorescent Antibody Technique; Kidney Glomerulus; Microcirculation; Rats; Shwartzman Phenomenon; Thrombosis | 1975 |
Extravascular fibrinogen degradation in experimental burn wounds: a source of fibrin split products.
Topics: Animals; Burns; Capillary Permeability; Disease Models, Animal; Dogs; Edema; Fibrin; Fibrinogen; Iodine Radioisotopes; Time Factors | 1975 |
Effect of heparin in experimental gram-negative septicemia.
Topics: Animals; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxins; Female; Fibrinogen; Heparin; Male; Pasteurella; Pasteurella Infections; Rabbits; Sepsis | 1975 |
[Changes of the coagulation- and fibrinolysis system in traumatic shock with special reference to the lymph system(author's transl)].
Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Disease Models, Animal; Dogs; Fibrinogen; Fibrinolysis; Fractures, Bone; Hematoma; Lymphatic System; Plasminogen; Rabbits; Shock, Traumatic; Thrombelastography | 1975 |
Radioiodinated soluble canine fibrin. Preparation and evaluation as a thrombus localizing agent in the dog.
Topics: Animals; Coronary Disease; Disease Models, Animal; Dogs; Evaluation Studies as Topic; Fibrin; Fibrinogen; Half-Life; Iodine Radioisotopes; Isotope Labeling; Solubility; Thrombophlebitis; Thrombosis | 1975 |
Effects on lipids, coagulation factors and liver histology of long-term ethanol administration to guinea-pigs.
Topics: Animals; Blood Coagulation Factors; Cholesterol; Diet; Dietary Carbohydrates; Disease Models, Animal; Ethanol; Fibrinogen; Guinea Pigs; Lipid Metabolism; Liver Cirrhosis, Experimental; Rats; Species Specificity; Triglycerides | 1975 |
Studies in experimental animals on disseminated intravascular coagulation (DIC).
Topics: Aminobenzoates; Animals; Antifibrinolytic Agents; Blood Cell Count; Blood Platelets; Blood Vessels; Disease Models, Animal; Disseminated Intravascular Coagulation; Endothelium; Fibrin; Fibrinogen; Hemoglobins; Hemolysis; Lung; Lung Volume Measurements; Male; Pulmonary Edema; Rats; Respiration; Thrombin; Thrombosis | 1975 |
Production of experimental toxemia in the pregnant rabbit.
Topics: Animals; Aorta, Abdominal; Blood Pressure Determination; Constriction; Disease Models, Animal; Female; Fibrinogen; Hypertension; Ischemia; Kidney Glomerulus; Liver; Placenta; Pre-Eclampsia; Pregnancy; Proteinuria; Rabbits | 1976 |
Changes in plasma thrombomodulin antigen in rabbit developing endotoxin-induced disseminated intravascular coagulation and the effect of heparin.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Disseminated Intravascular Coagulation; Endothelium, Vascular; Endotoxins; Fibrinogen; Heparin; Leukocytes; Male; Platelet Count; Rabbits; Receptors, Cell Surface; Receptors, Thrombin | 1992 |
The glycosaminoglycan of recombinant human soluble thrombomodulin affects antithrombotic activity in a rat model of tissue factor-induced disseminated intravascular coagulation.
Topics: Animals; Disease Models, Animal; Disseminated Intravascular Coagulation; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Fibrinolysis; Glycosaminoglycans; Hemorrhage; Heparin; Male; Platelet Count; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Thrombin; Recombinant Proteins; Solubility; Thromboplastin | 1992 |
[The role of plasma fibronectin in the pathogenesis of post- aggressive conditions].
Topics: Adjuvants, Immunologic; Animals; Blood Proteins; Burns; Disease Models, Animal; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibronectins; Male; Mononuclear Phagocyte System; Rats; Shock, Traumatic | 1992 |
Maintenance of patency after vascular trauma by topical irrigation with a peptide homologous to the carboxy-terminus of the fibrinogen gamma chain.
Topics: Administration, Topical; Amino Acid Sequence; Animals; Blood Coagulation; Blood Vessels; Disease Models, Animal; Drug Evaluation, Preclinical; Fibrinogen; Male; Molecular Sequence Data; Peptides; Rats; Rats, Sprague-Dawley; Thrombosis; Vascular Patency; Wounds and Injuries | 1992 |
A finding of highly selective synthetic inhibitor of plasma kallikrein; its action to bradykinin generation, intrinsic coagulation and experimental DIC.
Topics: Animals; Blood Coagulation; Bradykinin; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxins; Fibrinogen; Humans; In Vitro Techniques; Kallikreins; Kaolin; Kinetics; Mice; Partial Thromboplastin Time; Phenylalanine; Rats; Tranexamic Acid | 1992 |
Erythrocytes with covalently bound fibrinogen as a cellular replacement for the treatment of thrombocytopenia.
Topics: Animals; Autoimmune Diseases; Blood Transfusion, Autologous; Cross-Linking Reagents; Disease Models, Animal; Erythrocyte Transfusion; Erythrocytes; Fibrinogen; Formaldehyde; Humans; In Vitro Techniques; Platelet Aggregation; Rats; Thrombocytopenia | 1992 |
Comparison of laser-assisted fibrinogen-bonded and sutured canine arteriovenous anastomoses.
Topics: Animals; Arteriovenous Fistula; Disease Models, Animal; Dogs; Femoral Artery; Femoral Vein; Fibrinogen; Humans; Hyperplasia; Laser Therapy; Microscopy, Electron, Scanning; Muscle, Smooth, Vascular; Platelet Aggregation; Stress, Mechanical | 1992 |
Pathophysiologic correlates of experimental trypanosomiasis in rabbits.
Topics: Anemia; Animals; Blood Proteins; Disease Models, Animal; Fever; Fibrinogen; Leukocyte Count; Male; Rabbits; Time Factors; Triglycerides; Trypanosoma brucei brucei; Trypanosomiasis, African | 1991 |
Comparison of the thrombolytic activity of the novel plasminogen activator, LY210825, to anisoylated plasminogen-streptokinase activator complex in a canine model of coronary artery thrombolysis.
Topics: alpha-2-Antiplasmin; Animals; Anistreplase; Coronary Thrombosis; Disease Models, Animal; Dogs; Fibrinogen; Hemodynamics; Male; Plasminogen; Plasminogen Activators; Thrombolytic Therapy; Tissue Plasminogen Activator | 1992 |
C4b-binding protein exacerbates the host response to Escherichia coli.
Topics: Animals; Blood Pressure; Carrier Proteins; Complement C4b; Complement Inactivator Proteins; Disease Models, Animal; Escherichia coli Infections; Fibrinogen; Glycoproteins; Heart Rate; Humans; Kidney; Necrosis; Papio; Protein S; Renal Circulation; Tumor Necrosis Factor-alpha | 1991 |
Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model.
Topics: Animals; Blood Coagulation; Coronary Thrombosis; Disease Models, Animal; Dogs; Factor IXa; Fibrinogen; Heparin | 1991 |
Deep venous thrombosis in the baboon: an experimental model.
Topics: Animals; Antibodies, Monoclonal; Blood Coagulation; Body Temperature; Disease Models, Animal; Female; Fibrinogen; Hematocrit; Leukocyte Count; Male; Papio; Phlebography; Physical Examination; Platelet Count; Protein C; Reproducibility of Results; Thrombophlebitis; Tumor Necrosis Factor-alpha | 1991 |
[An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model].
Topics: alpha-2-Antiplasmin; Animals; Blood Coagulation; Carotid Artery Thrombosis; Disease Models, Animal; Dogs; Fibrinogen; Fibrinolysis; Thrombolytic Therapy; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1990 |
Enhanced myocardial salvage by maintenance of microvascular patency following initial thrombolysis with recombinant tissue plasminogen activator.
Topics: Animals; Coronary Circulation; Disease Models, Animal; Dogs; Female; Fibrinogen; Infusions, Intravenous; Male; Microcirculation; Myocardial Infarction; Myocardial Reperfusion; Partial Thromboplastin Time; Recombinant Proteins; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Vascular Patency | 1990 |
Comparison of the effect of plasma-derived and recombinant human FVIIa in vitro and in a rabbit model.
Topics: Animals; Blood Coagulation; Disease Models, Animal; Dose-Response Relationship, Drug; Factor VIIa; Fibrinogen; Hemophilia A; Hemophilia B; Humans; Partial Thromboplastin Time; Platelet Count; Rabbits; Recombinant Proteins | 1990 |
Role of fibrinopeptide B in early atherosclerotic lesion formation.
Topics: Animals; Arteriosclerosis; Disease Models, Animal; Endothelium, Vascular; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Foam Cells; Lipopolysaccharides; Rabbits | 1990 |
Evaluation of epithelial tissue plasminogen activator as a thrombolytic agent in a rabbit model of venous thrombosis.
Topics: alpha-2-Antiplasmin; Animals; Disease Models, Animal; Epithelium; Fibrinogen; Fibrinolysis; Fibroblasts; Humans; Keratins; Melanoma; Partial Thromboplastin Time; Phlebitis; Plasminogen Activators; Rabbits; Rats | 1986 |
Morphometric studies on wound healing after systemic administration of adriamycin and local application of fibrin sealant. Application of a new wound healing model using spongiosa implants.
Topics: Animals; Aprotinin; Disease Models, Animal; DNA; Doxorubicin; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Granulation Tissue; Hydroxyproline; Male; Rats; Rats, Inbred Strains; Thrombin; Wound Healing | 1986 |
The use of fibrin glue for the repair of experimental CSF rhinorrhea.
Topics: Animals; Aprotinin; Cerebrospinal Fluid Rhinorrhea; Disease Models, Animal; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Rats; Rats, Inbred Strains; Thrombin; Tissue Adhesives | 1988 |
Pancreatic duct occlusion in the management of acute necrotizing pancreatitis in a canine model.
Topics: Acute Disease; Animals; Aprotinin; Disease Models, Animal; Dogs; Drug Combinations; Factor XIII; Female; Fibrin Tissue Adhesive; Fibrinogen; Male; Necrosis; Pancreatic Ducts; Pancreatitis; Phenylpropanolamine; Silicones; Thrombin; Tissue Adhesives | 1989 |
Thrombolysis with a snake venom protease in a rat model of venous thrombosis.
Topics: Angiography; Animals; Crotalid Venoms; Disease Models, Animal; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; In Vitro Techniques; Metalloendopeptidases; Peptide Hydrolases; Plasminogen Activators; Rats; Rats, Inbred Strains; Thrombophlebitis | 1989 |
Reticuloendothelial function and plasma fibronectin in a murine model of intra-abdominal sepsis.
Topics: Abdomen; Animals; Disease Models, Animal; Escherichia coli Infections; Fibrinogen; Fibronectins; Kidney; Liver; Lung; Male; Mononuclear Phagocyte System; Phagocytosis; Rats; Spleen | 1989 |
Sepsis model with reproducible manifestations of multiple organ failure (MOF) and disseminated intravascular coagulation (DIC).
Topics: alpha-2-Antiplasmin; Animals; Antithrombin III; Bilirubin; Blood Pressure; Creatinine; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxins; Fibrinogen; Liver; Male; Multiple Organ Failure; Platelet Count; Protamines; Rabbits | 1989 |
Platelet storage pool deficiency in pigs.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Blood Platelet Disorders; Blood Platelets; Carbon Radioisotopes; Disease Models, Animal; Factor VIII; Fibrinogen; Infusions, Parenteral; Platelet Aggregation; Platelet Storage Pool Deficiency; Serotonin; Swine | 1986 |
Preventive effects of batroxobin on experimental canine coronary thrombosis.
Topics: Animals; Aspirin; Batroxobin; Coronary Disease; Coronary Thrombosis; Disease Models, Animal; Dogs; Electrocardiography; Fibrinogen; Hemodynamics; Heparin; Recurrence; Serine Endopeptidases; Urokinase-Type Plasminogen Activator | 1988 |
Anti-fibrin monoclonal antibodies for radioimmunodetection: preliminary assessment in a rat model system.
Topics: Animals; Antibodies, Monoclonal; Binding Sites, Antibody; Disease Models, Animal; Drug Implants; Female; Fibrin; Fibrinogen; Humans; Iodine Radioisotopes; Male; Radionuclide Imaging; Rats; Rats, Inbred F344; Thrombosis; Tissue Distribution | 1988 |
Antithrombotic properties of heparin in a neonatal piglet model of thrombin-induced thrombosis.
Topics: Animals; Animals, Newborn; Antithrombin III; Blood Coagulation Tests; Disease Models, Animal; Drug Interactions; Fibrinogen; Heparin; Swine; Thrombin; Thrombosis | 1988 |
The role of Bacteroides encapsulation in the lethal synergy between Escherichia coli and Bacteroides species studied in a rat fibrin clot peritonitis model.
Topics: Animals; Bacteroides; Bacteroides Infections; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Fibrinogen; Male; Peritonitis; Rats; Rats, Inbred Strains; Virulence | 1987 |
Efficacy of antithrombin III in endotoxin-induced disseminated intravascular coagulation.
Topics: Analysis of Variance; Animals; Antithrombin III; Blood Coagulation; Blood Pressure; Disease Models, Animal; Disseminated Intravascular Coagulation; Dogs; Drug Evaluation, Preclinical; Endotoxins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemodynamics; Prothrombin Time; Time Factors | 1988 |
The influence of preadsorbed canine von Willebrand factor, fibronectin and fibrinogen on ex vivo artificial surface-induced thrombosis.
Topics: Adsorption; Animals; Arteriovenous Shunt, Surgical; Blood Platelets; Disease Models, Animal; Dogs; Fibrinogen; Fibronectins; Microscopy, Electron, Scanning; Surface Properties; Thrombosis; von Willebrand Factor | 1986 |
Management of experimental pneumothorax in weanling rabbits with the use of fibrin glue sclerosant.
Topics: Animals; Disease Models, Animal; Drainage; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Humans; Infant, Newborn; Lung; Pneumothorax; Rabbits; Sclerosing Solutions; Thrombin; Weaning | 1986 |
The thrombopenic effect of ellagic acid in the rat. Another model of platelet stimulation "in vivo".
Topics: Animals; Aspirin; Benzopyrans; Blood Platelets; Disease Models, Animal; Ellagic Acid; Female; Fibrinogen; Male; Partial Thromboplastin Time; Pyridazines; Rats; Rats, Inbred Strains; Thrombocytopenia | 1987 |
Effect of defibrinogenation on the early patency rate of experimental small calibre arterial grafts.
Topics: Ancrod; Animals; Arterial Occlusive Diseases; Arteries; Blood Coagulation; Blood Vessel Prosthesis; Blood Viscosity; Disease Models, Animal; Fibrinogen; Graft Occlusion, Vascular; Male; Postoperative Complications; Rabbits | 1987 |
A reproducible model of acute hepatic failure by transient ischemia in the pig.
Topics: Amino Acids; Ammonia; Animals; Disease Models, Animal; Electroencephalography; Electrophysiology; Fibrinogen; Guinea Pigs; Hemodynamics; Ischemia; Liver; Liver Diseases; Necrosis; Platelet Count; Portacaval Shunt, Surgical | 1987 |
Chronic liver disease animal model for evaluation of artificial liver support systems.
Topics: Animals; Body Weight; Chronic Disease; Disease Models, Animal; Dogs; Fibrinogen; Galactosamine; Hepatitis, Chronic; Liver Diseases; Male; Necrosis; Partial Thromboplastin Time; Prothrombin Time | 1985 |
Experimental posttraumatic pulmonary microembolism. Effects of methylprednisolone on its development.
Topics: Animals; Blood Platelets; Disease Models, Animal; Female; Fibrinogen; Lung; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Platelet Count; Pulmonary Embolism; Swine; Time Factors; Wounds and Injuries | 1985 |
Acute polycythemia increases the disappearance rate of clottable fibrinogen in the newborn dog.
Topics: Animals; Animals, Newborn; Blood Coagulation Disorders; Blood Viscosity; Disease Models, Animal; Dogs; Enterocolitis, Pseudomembranous; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Iodine Radioisotopes; Lactates; Male; Polycythemia; Time Factors | 1986 |
Lipopolysaccharide-induced colitis in rabbits.
Topics: Animals; Colitis, Ulcerative; Disease Models, Animal; Endotoxins; Female; Fibrinogen; Fibrinolysis; Immunity; Lipopolysaccharides; Male; Partial Thromboplastin Time; Rabbits; Time Factors | 1986 |
Effect of venous hypertension on canine hind limb lymph.
Topics: Acute Disease; Animals; Chronic Disease; Disease Models, Animal; Dogs; Fibrinogen; Hindlimb; Hypertension; Lymph; Male; Venous Pressure | 1985 |
Comparison of inflammatory changes in established type II collagen- and adjuvant-induced arthritis using outbred Wistar rats.
Topics: Animals; Antibody Formation; Arthritis; Arthritis, Experimental; Blood Proteins; Collagen; Copper; Disease Models, Animal; Fibrinogen; Hypersensitivity, Delayed; Inflammation; Ketamine; Male; Rats; Zinc | 1985 |
Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth in vivo.
Topics: Animals; Anticoagulants; Disease Models, Animal; Female; Fibrin; Fibrinogen; Glycosaminoglycans; Heparin; Infusions, Parenteral; Injections, Intravenous; Male; Rabbits; Structure-Activity Relationship; Thrombophlebitis | 1985 |
The canine oleic acid model of fibrin localization in fat embolism.
Topics: Animals; Autoradiography; Clinical Enzyme Tests; Disease Models, Animal; Dogs; Embolism, Fat; Fibrin; Fibrinogen; Iodine Isotopes; Methods; Oleic Acids; Pulmonary Artery; Staining and Labeling | 1971 |
Studies of animal models of "toxaemia" with respect of fibrinogen and platelet survival and selectivity of proteinuria.
Topics: Albumins; Alpha-Globulins; Animals; Blood Coagulation; Blood Platelets; Cell Survival; Desoxycorticosterone; Disease Models, Animal; Disseminated Intravascular Coagulation; Female; Fibrinogen; Half-Life; Hypertension; Kidney Cortex Necrosis; Kidney Glomerulus; Methionine; Pre-Eclampsia; Pregnancy; Proteinuria; Rabbits; Radioisotopes; Rats; Selenium; Time Factors; Vasoconstrictor Agents | 1973 |
[Immunologic tolerance in guinea pigs to contact dermatitis caused by 2,4-dinitrochlorbenzol and dinitrophenol-protein compounds].
Topics: Animals; Dermatitis, Contact; Dinitrophenols; Disease Models, Animal; Fibrinogen; gamma-Globulins; Guinea Pigs; Hydrocarbons, Halogenated; Immune Tolerance; Methods; Skin | 1970 |
Homocystinemia. Vascular injury and arterial thrombosis.
Topics: Adolescent; Adult; Animals; Blood Cell Count; Blood Coagulation; Blood Platelets; Blood Vessels; Dipyridamole; Disease Models, Animal; Endothelium; Female; Fibrinogen; Fibrinolysis; Haplorhini; Homocystine; Homocystinuria; Humans; Male; Papio; Plasminogen; Platelet Adhesiveness; Pyridoxine; Thrombosis | 1974 |
Experimental models of defibrination states.
Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelet Disorders; Blood Platelets; Coagulase; Disease Models, Animal; Dogs; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Mice; Rabbits; Rats; Streptodornase and Streptokinase; Thrombin; Thrombosis; Venoms | 1971 |
[Experimental studies on the problem of local Shwartzman phenomenon in the skin. V. Observations on the significance of blood coagulation disorders during provocation of the phenomenon in an endotoxin-free guinea pig model].
Topics: Animals; Arsenicals; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Disease Models, Animal; Endotoxins; Escherichia coli; Factor V; Fibrinogen; Guinea Pigs; Hydrocarbons, Halogenated; Nitrobenzenes; Prothrombin; Shwartzman Phenomenon; Thrombelastography; Thrombin | 1973 |
[Intramural and perivasal deposition of plasma proteins in experimented hypertension (author's transl)].
Topics: Animals; Aorta; Arteries; Autoradiography; Blood Proteins; Cerebral Arteries; Coronary Vessels; Disease Models, Animal; Fibrinogen; Glycosaminoglycans; Humans; Hypertension; Iodine Radioisotopes; Male; Mesenteric Arteries; Permeability; Rats; Serum Albumin, Radio-Iodinated; Sulfates; Sulfur Radioisotopes | 1973 |
Biochemical pharmacology of the fibrinolysin system of the rat. I. The effect of alloxan-induced hyperglycemia.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Hematocrit; Humans; Intestines; Kidney; Liver; Male; Pancreas; Plasminogen; Rats; Streptokinase; Thrombin | 1974 |
Experimental production of diabetes mellitus by a nonendocrinal approach.
Topics: Animals; Blood Coagulation; Blood Glucose; Diabetes Mellitus; Disease Models, Animal; Fibrinogen; Rabbits; Thrombin | 1974 |
[Experimental liver assistance].
Topics: Animals; Bilirubin; Calcium; Disease Models, Animal; Fibrinogen; Galactose; Hepatic Encephalopathy; Hydrogen-Ion Concentration; Liver; Perfusion; Sulfobromophthalein; Swine; Transaminases | 1974 |
Influence of liver-RES on toxic liver damage due to galactosamine.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Blood Coagulation Factors; Blood Platelets; Blood Proteins; Chemical and Drug Induced Liver Injury; Cholesterol; Disease Models, Animal; Fibrinogen; Galactosamine; Hemolysis; Male; Mononuclear Phagocyte System; Phagocytosis; Rats | 1974 |
Alterations in platelet aggregation associated with adjuvant arthritis in rats.
Topics: Adenosine Diphosphate; Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Arthritis; Aspirin; Collagen; Disease Models, Animal; Female; Fibrinogen; Indomethacin; Mycobacterium; Phenylbutazone; Platelet Adhesiveness; Platelet Aggregation; Rats; Time Factors | 1974 |
Hemostatic defects in experimental leukemia.
Topics: Animals; Antithrombins; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Disease Models, Animal; Factor XII; Female; Fibrinogen; Hemorrhagic Disorders; Leukemia, Experimental; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Rats; Rats, Inbred Strains; Thrombelastography | 1974 |
The relevance of intravascular coagulation to pre-eclampsia.
Topics: 5-Hydroxytryptophan; Abruptio Placentae; Animals; Blood Coagulation Factors; Desoxycorticosterone; Disease Models, Animal; Disseminated Intravascular Coagulation; Female; Fibrinogen; Fibrinolysis; Humans; Hypertension; Platelet Adhesiveness; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Hematologic; Pulmonary Circulation; Rabbits; Rats; Thrombocytopenia; Thromboplastin | 1973 |
Detection of renal allograft rejection with (125I) fibrinogen.
Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Diagnosis, Differential; Disease Models, Animal; Fibrin; Fibrinogen; Graft Rejection; Hydronephrosis; Iodine Radioisotopes; Kidney Transplantation; Ligation; Protein Binding; Rabbits; Renal Artery Obstruction; Renal Veins; Thrombophlebitis; Thrombosis; Transplantation, Homologous | 1973 |
Experimental infection with Plasmodium falciparum in Aotus monkeys. 3. The development of disseminated intravascular coagulation.
Topics: Animals; Blood Cell Count; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Disease Models, Animal; Disseminated Intravascular Coagulation; Fibrinogen; Haplorhini; Malaria; Monkey Diseases; Plasmodium falciparum | 1972 |
[Behavior of rat serum proteins and SH groups during the course of experimental arthritis].
Topics: Animals; Arthritis; Arthritis, Infectious; Arthritis, Rheumatoid; Blood Proteins; Disease Models, Animal; Fibrinogen; Freund's Adjuvant; Mycoplasma Infections; Rats; Sulfhydryl Compounds | 1972 |
Effect of exercise on development of atherosclerosis in swine.
Topics: Animals; Aorta; Arteries; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol, Dietary; Cottonseed Oil; Diet, Atherogenic; Disease Models, Animal; Female; Fibrinogen; Iliac Artery; Lipids; Male; Physical Exertion; Renal Artery; Sex Factors; Swine; Triglycerides | 1972 |
Elimination of fibrinogen from synovial joints.
Topics: Absorption; Animals; Citrates; Disease Models, Animal; Female; Fibrin; Fibrinogen; Hemarthrosis; Heparin; Hindlimb; Humans; Injections, Intra-Articular; Iodine Isotopes; Plasma; Rabbits; Synovial Membrane; Time Factors | 1973 |
Autotransfusion: perspective and critical problems.
Topics: Animals; Blood; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Blood Transfusion, Autologous; Disease Models, Animal; Dogs; Fibrinogen; Hematocrit; Hemolysis; Hemorrhage; Heparin; Humans; Hydrogen-Ion Concentration; Oxygen; Vascular Surgical Procedures; Wounds and Injuries | 1973 |
Chronic induced intravascular coagulation in dogs.
Topics: Animals; Blood Platelets; Depression, Chemical; Disease Models, Animal; Disseminated Intravascular Coagulation; Dogs; Factor V; Factor VII; Factor VIII; Factor XI; Factor XII; Factor XIII; Fibrinogen; Fibrinolysis; Prothrombin Time; Stimulation, Chemical; Thromboplastin | 1973 |
Impaired fibrin elimination in the kidneys of burned rats.
Topics: Animals; Burns; Capillaries; Disease Models, Animal; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Fibrinolysis; Hematocrit; Iodine Radioisotopes; Kidney; Kidney Glomerulus; Rats; Thrombin; Time Factors | 1973 |
The effects of injection of human factor VIII antibody into rabbits.
Topics: Animals; Antibodies; Blood Coagulation Tests; Blood Platelets; Complement System Proteins; Disease Models, Animal; Factor VIII; Fibrinogen; Hematocrit; Hemolysis; Hemophilia A; Humans; Immune Sera; Iodine; Iodine Radioisotopes; Leukocyte Count; Rabbits | 1973 |
Intravascular clotting after endotoxin in rabbits with impaired intrinsic clotting produced by a factor VIII antibody.
Topics: Animals; Antibodies; Blood Coagulation Tests; Blood Platelets; Blood Volume; Cortisone; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxins; Factor VIII; Fibrin; Fibrinogen; Hematocrit; Hemophilia A; Iodine Radioisotopes; Kidney; Kidney Cortex Necrosis; Rabbits | 1973 |
Intravascular coagulation and plasma fibrinogen in pregnancy.
Topics: Animals; Disease Models, Animal; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Humans; Placenta; Pre-Eclampsia; Pregnancy; Rabbits; Thromboplastin | 1973 |
Experimental production of subdural hematomas.
Topics: Animals; Blood Coagulation; Blood Coagulation Factors; Cats; Cattle; Disease Models, Animal; Dogs; Dura Mater; Female; Fibrinogen; Hematoma, Subdural; Humans; In Vitro Techniques; Male; Membranes; Thrombin | 1974 |
The effect on blood coagulation of ovariectomy and hysterectomy in rats given ethinyl estradiol.
Topics: Animals; Antithrombins; Blood Coagulation; Blood Coagulation Factors; Body Weight; Castration; Disease Models, Animal; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Fibrinogen; Fibrinolysis; Hysterectomy; Organ Size; Rats; Thromboplastin; Uterus | 1974 |
Thrombus formation in stainless steel tubes used as vascular implants in the dog.
Topics: Animals; Arteries; Blood Cell Count; Blood Platelets; Disease Models, Animal; Dogs; Erythrocyte Count; Fibrinogen; Hematocrit; Stainless Steel; Thrombosis; Time Factors; Veins | 1974 |
Experimental model of pulmonary thrombosis in rat.
Topics: Angiography; Animals; Antifibrinolytic Agents; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Disease Models, Animal; Disseminated Intravascular Coagulation; Epinephrine; Fibrin; Fibrinogen; Fibrinolysis; Glass; Immune Sera; Kidney; Lactates; Liver; Lung; Lung Diseases, Obstructive; Male; Platelet Adhesiveness; Rats; Serum Globulins; Spleen; Thrombelastography | 1974 |
Goodpasture's syndrome: recovery from severe pulmonary hemorrhage after bilateral nephrectomy.
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Autoantibodies; Azathioprine; Complement System Proteins; Creatinine; Disease Models, Animal; Fibrinogen; Hematocrit; Hemorrhage; Humans; Immunoglobulin G; Kidney; Kidney Glomerulus; Kidney Transplantation; Lung Diseases; Male; Microscopy, Electron; Microscopy, Fluorescence; Nephrectomy; Prednisone; Transplantation, Homologous | 1971 |
Blood coagulation changes in hemorrhagic shock and acidosis.
Topics: Acidosis; Animals; Blood Coagulation; Blood Coagulation Tests; Blood Pressure; Cardiac Output; Disease Models, Animal; Dogs; Factor VIII; Fibrinogen; Heart Rate; Kidney Glomerulus; Prothrombin; Respiration; Shock, Hemorrhagic; Thrombelastography | 1969 |
Metabolism of 131 I-labelled fibrinogen in monkeys infected with Plasmodium coatneyi.
Topics: Animals; Blood Coagulation; Disease Models, Animal; Fibrinogen; Haplorhini; Hematocrit; Hemoglobins; Iodine Radioisotopes; Macaca; Malaria; Monkey Diseases; Plasma Volume; Plasmodium; Time Factors | 1971 |
The role of intravascular coagulation in feline endotoxin shock.
Topics: Animals; Blood Pressure; Cats; Disease Models, Animal; Disseminated Intravascular Coagulation; Fibrinogen; Hematocrit; Hydrogen-Ion Concentration; Leukocyte Count; Shock, Septic | 1972 |
Defibrination and the hypercoagulable state: a model using papain in rabbits.
Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Disease Models, Animal; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Male; Papain; Prothrombin Time; Rabbits; Thrombin | 1972 |
Hemangioma with thrombocytopenia and microangiopathic anemia (Kasabach-Merritt syndrome): an animal model.
Topics: Anemia; Animals; Blood Cell Count; Blood Coagulation; Blood Platelets; Cell Aggregation; Cell Survival; Disease Models, Animal; Fibrinogen; Hemangioma; Hematocrit; Heparin; Iodine Isotopes; Mice; Microscopy, Electron; Plasma Volume; Purpura, Thrombocytopenic; Skin Neoplasms; Thrombosis | 1971 |
Experimental dysfibrinogenemia: in vivo studies with arvin.
Topics: Animals; Blood Coagulation Disorders; Blood Coagulation Tests; Disease Models, Animal; Factor V; Female; Fibrinogen; Immunoelectrophoresis; Male; Peptide Hydrolases; Prothrombin; Rabbits; Snakes; Thrombelastography; Venoms | 1971 |
Inhibition of coagulation by fibrinopeptides released during fibrinolysis.
Topics: Animals; Antithrombins; Blood Coagulation; Blood Coagulation Tests; Disease Models, Animal; Dogs; Fibrin; Fibrinogen; Fibrinolysis; Humans; Lethal Dose 50; Methods; Placental Extracts; Shock, Hemorrhagic; Tachyphylaxis; Thromboplastin | 1969 |
[Changes in blood coagulation activity following multiple short-term disturbances in coronary circulation in dogs under chronic experimental conditions].
Topics: Animals; Blood Coagulation; Coronary Disease; Disease Models, Animal; Dogs; Fibrinogen; Fibrinolysis; Heparin; Methods; Prothrombin Time; Thrombelastography; Thromboplastin; Time Factors | 1970 |
Experimental polycythemia and hemodilution. Physiologic and rheologic effects.
Topics: Animals; Blood Flow Velocity; Blood Pressure Determination; Blood Volume; Cardiac Output; Dextrans; Disease Models, Animal; Dogs; Fibrinogen; Heart; Heart Function Tests; Hemodynamics; Lactates; Oxygen; Perfusion; Plasma; Polycythemia; Pyruvates; Serum Albumin | 1970 |
Consumption coagulopathy in the canine oleic acid model of fat embolism.
Topics: Animals; Blood Cell Count; Blood Coagulation Disorders; Blood Gas Analysis; Blood Platelets; Carbon Dioxide; Chromatography, Gas; Disease Models, Animal; Disseminated Intravascular Coagulation; Dogs; Embolism, Fat; Fatty Acids; Fibrinogen; Fibrinolysis; Hemodynamics; Hydrogen-Ion Concentration; Linoleic Acids; Oleic Acids; Oxygen; Palmitic Acids; Plasminogen; Stearic Acids | 1971 |
Mast cell count in the peritoneal fluid of rats with adjuvant-induced polyarthritis.
Topics: Adjuvants, Immunologic; Animals; Arthritis; Ascitic Fluid; Blood Sedimentation; Cell Count; Copper; Disease Models, Animal; Fibrinogen; Fibrinolysis; Hydrocortisone; Iron; Male; Mast Cells; Rats; Serum Albumin; Serum Globulins | 1971 |